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Abstract
Transposons are integrally tied to the spread of antibiotic resistance among bacterial species,
and cellular stress can cause increased transposition (which might benefit the bacteria as a
species by increasing genetic plasticity). It is therefore important to understand how
transposons have become integrated into bacterial regulatory networks. The goals of this
thesis are to further investigate 1) new host-factors that regulate transposition, 2) posttranscriptional regulation as a means of regulating transposase expression, and 3) how
cellular stress-response is tied to transposon mobility. I use the well studied Tn10/IS10 and
Tn5/IS50 transposons in Escherichia coli as model systems. I show that Tn10 transposition is
strongly repressed at the level of transposase translation by the global post-transcriptional
regulator, Hfq—an RNA chaperone that enhances the base-pairing interactions of transencoded small regulatory RNAs (sRNAs) with their target mRNAs. As translation of the
IS10 transposase mRNA (RNA-IN) is strongly repressed by an antisense regulator (RNAOUT), I investigated whether Hfq was enhancing this negative regulation. Further evidence
shows that Hfq down-regulates IS10 transposase translation by two pathways, one of which
involves RNA-OUT. Hfq had not previously been shown to function in regulation by a cisantisense RNA. I show that Hfq binds RNA-IN and RNA-OUT via known mRNA- and
sRNA-binding sites, and that it enhances the rate of RNA-IN/OUT pairing in vitro. This
ability was lost, along with in vivo regulation of transposition, to Hfq mutants lacking RNAbinding specificity at these surfaces. Evidence is presented that Hfq alters the secondary
structures of both RNA-IN and RNA-OUT such that inter-molecular base pairing would be
facilitated. I also show that Hfq strongly down-regulates Tn5 transposition. Unlike Tn10, this
regulation is exercised at the level of transposase transcription. Evidence is presented that
Hfq and the global transcription factor Crp work in the same regulatory network to limit Tn5
transposition. Finally, I demonstrate that Tn5 transposition is induced by nutrient starvation.
Taken together, this work implicates Hfq as a component of a cellular defense mechanism
against transposons and shows that Tn5 is able to respond to environmental conditions.
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Chapter 1

1

General Introduction

1.1 A brief history of mobile DNA
The geneticist Emerson postulated early in the 20th century that ‘unstable mutations’ in
maize—which did not obey Mendelian rules of inheritance—were due to temporary locus
restrictions caused by irregular inhibition (Emerson, 1914). In the mid-twentieth century,
McClintock was interested in determining a pattern of inheritance in maize. She
attributed the phenotypes to particular gene fragments that ‘moved’ which she dubbed
‘controlling elements’ (i.e. Ac/Ds). The Ds locus, along with the unlinked Ac locus,
tended to cause breakage of chromosome 9, which coincided with the movement (or
‘transposition’) of Ds to a new location (McClintock, 1950; McClintock, 1956). Since
this discovery, mobile genetic elements have been studied in almost every organism.
In 1963 a bacteriophage was found to cause a ‘mutator’ phenotype when it
inserted into bacterial DNA (Taylor, 1963). The phage was named Mu, and provided the
first example of a DNA-based transposon that uses a replicative mechanism of
transposition.
DNA transposons have been studied most thoroughly in bacteria, although they
have been found in most other organisms that have been examined (Galas and Chandler,
1989). Prominent examples include P elements in Drosophila melanogaster and Tc1 in
Caenorhabditis elegans (Engels, 1983; Levin and Moran, 2011). The simplest bacterial
transposons are insertion sequences (IS elements), which encode the genes necessary for
their own transposition. Composite transposons (Tn elements) are more complex, and
encode two insertion sequences flanking ‘extra’ genes that typically confer a selective
advantage (usually antibiotic resistance determinants). The IS elements that comprise the
transposons are not necessarily identical—for instance, only one must encode a
functional transposase so long as the protein recognizes the termini (often, inverted
repeats) of the Tn element. A schematic of typical DNA transposons is shown in Figure
1.1.
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Figure 1.1. Schematic overview of DNA transposons in bacteria.
(A) Insertion sequences (ISs) consist only of the DNA necessary for the act of
transposition. An IS element consists of the transposase gene, flanked by a pair of
inverted repeat sequences. The transposase protein recognizes the inverted repeats as the
edges of the transposon and cuts the transposon from its initial site and inserts it into a
target site. (B) Composite transposons (Tn elements) encode extra genes between two IS
elements. The extra genes typically confer a selective advantage (e.g. antibiotic
resistance, as indicated). Flanking host DNA is shown in light blue.
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The first retrotransposons were discovered in yeast (Ty1) (Eickbush and Malik,
2002). These elements transpose via an RNA-intermediate. Elements termed long
terminal repeat (LTR)-containing retrotransposons are similar to animal retroviruses, but
they lack an infection cycle and do not encode envelope (env) proteins.
More examples of transposable elements have since been documented, such as
mariner elements in various species, and Alu sequences in humans (Hormozdiari et al.,
2011; Kramerov and Vassetzky, 2005).
Advancements in genome sequencing have revealed the presence of mobile
genetic elements in the ‘junk’ DNA (i.e. non-coding DNA) of various organisms. For
instance, almost half of the non-coding DNA in the human genome contains longinactive transposable elements, RNA viruses and retrotransposons (Cordaux and Batzer,
2009; Lander et al., 2001).

1.2 Transposition and human health
Transposition events can cause double-strand breaks, insertions, deletions, and other
chromosomal rearrangements through a number of complex DNA breakage and joining
reactions. Consequently, the medical community has been interested in the direct effects
of transposition reactions on genomic stability. There are several documented diseases in
humans that result from rearrangements mediated by transposons and retrotransposons:
L1 insertions cause diseases such as hemophilia, muscular dystrophy and colon cancer,
and more than 20 different Alu element insertions have been implicated in diseases like
Apert’s syndrome and breast cancer (Kazazian, 1998).
Mobile genetic elements can also affect gene expression by shuffling regulatory
elements or by inserting such that a promoter encoded by the element can drive
transcription of otherwise poorly expressed (or promoter-less) genes. In humans, an L1
insertion was responsible for enhancing transcription from the apolipoprotein(a) gene,
and insertion of a segment from a LINE 3’ UTR caused transcriptional activation of a
growth hormone gene cluster (Shewchuk et al., 2001; Yang et al., 1998). In the bacterial
species Burkholderia cepacia, insertion of IS1490 places a transposon-encoded promoter
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in the correct orientation to activate catabolic genes for the toxin 2,4,5trichlorophenoxyacetic acid, allowing the cells to survive in otherwise toxic growth
conditions (Hubner and Hendrickson, 1997). In Escherichia coli, activation of the bgl
operon involves insertion of IS1, IS5 and Mu (Manna et al., 2001; Reynolds et al., 1981;
Schnetz and Rak, 1992).
DNA transposons have potential uses in gene therapy, in that they can be used as
vehicles for gene delivery. An advantage of using transposons rather than viruses as
carriers is that they do not trigger immunological reactions. The Sleeping Beauty
Transposon System (SBTS) was created as a non-viral carrier of genes to be incorporated
into human chromosomes (Hackett et al., 2010; Hong et al., 2014; Ivics and Izsvak,
2011). The SB transposon was generated by reassembly of inactive mariner-like elements
in salmon to form an element that functions in humans and other eukaryotic cells, and it
has been used to treat Fanconi anemia (Hyland et al., 2011) and haemophilia A
(Aronovich et al., 2011; Liu et al., 2006).
Bacterial transposons are intimately involved in antimicrobial resistance, which is
a mounting health concern. The number of resistant organisms has increased
dramatically, along with the geographic distribution of these organisms, in large part
because bacteria become resistant to antimicrobial agents within a short time of exposure.
Penicillin-resistant Staphylococcus aureus appeared only a few years after the discovery
of penicillin (Medeiros, 1997). Over time, new species of bacteria continued to obtain
resistance to new antibiotics and this pattern led health workers to believe that drug
resistance is mobile—a hypothesis that was later confirmed (Levy and Marshall, 2004;
Watanabe, 1963). Several transposons were discovered in bacterial samples taken directly
from patients infected with antibiotic-resistant bacteria, and more transposons are
discovered alongside antibiotic resistance to this day, such as Tn5382 (Carias et al.,
1998), Tn502 and Tn512 (Petrovski et al., 2011), and CTn6002 (Warburton et al., 2007).
Currently, vancomycin is the preferred treatment for methicillin-resistant
Staphylococcus aureus (MRSA)—a major cause of clinical morbidity and mortality
(Klevens et al., 2007). As feared, vancomycin-resistant S. aureus (VRSA) have recently
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emerged; these isolates have acquired the vanA operon encoded by Tn1546 present on a
conjugal plasmid (Qureshi et al., 2014).

1.3 Lateral gene transfer and mobile genetic elements in
bacteria
The evolution of bacteria is driven to a large extent by lateral gene transfer (LGT), a
phenomenon wherein DNA is promiscuously transferred among the cells of one or more
species. LGT, rather than the accumulation of point mutations over generations, is
thought to be responsible for the high adaptability of bacteria to new environments
(Ochman et al., 2000). Interestingly, none of the major phenotypic distinctions between
E. coli and Salmonella enterica arose through point mutations of common ancestral genes
(Lawrence and Ochman, 1998). Mobile genetic elements—including bacteriophage,
plasmids and transposons—all contribute to LGT and can thus be seen as beneficial to
microbes from an evolutionary point of view (Boucher et al., 2003). LGT is typically
mediated by natural plasmid transformation, conjugation and/or phage transduction
(Figure 1.2) (Thomas and Nielsen, 2005). Transduction describes the spread of DNA
from one bacterial cell to another via a bacteriophage (such as phage λ or P1).
Conjugation is the transfer of unique ‘F’ (fertility) plasmids from one bacterial cell to
another through inter-cellular contact. Some bacteria can take up DNA from the
surrounding environment through natural transformation. These processes can all mediate
shuffling of chromosomal DNA between cells; phage can package cellular rather than
phage-encoded DNA and subsequently introduce this genetic information by infecting
another cell, and F plasmids can accumulate chromosomal segments and become F’
(Frost et al., 2005). These ‘agents’ of LGT greatly facilitate the dissemination of
transposons between bacterial species, as transposons can insert into plasmids or phage
genomes, which can then spread among bacterial cells. Transposition compounds the
effects of LGT in two ways: first, transposition events occur within the host genome,
providing a source of intrinsic mutability; second, transposition is typically autonomous
(i.e. does not require host-encoded functions, such as homologous recombination).

medically, agriculturally and environmentally important
processes, and the unique challenges of MGE genomics.

Plasmids must replicate, control their copy number,
and ensure their inheritance at each cell-division by
a process known as partitioning. It is impossible for
plasmids with the same replication mechanism to coexist in the same cell, a phenomenon termed ‘incompatibility’ (Inc). The Inc trait provided the basis for the
initial classification of some plasmids that is still in use
today. Incompatibility groups have been defined for
plasmids of the enterobacteriaceae (26 groups), the

Plasmids and other conjugative elements

A plasmid is a collection of functional genetic modules that are organized into a stable, self-replicating
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Figure 1 | Transfer of DNA between bacterial cells. Transduction (1). The DNA genome (yellow) of a temperate phage inserts
into the chromosome (dark blue) as a prophage; it later replicates, occasionally packaging host DNA alone (generalized
transduction) or with its own DNA (specialized transduction), lyses the cell, and infects a naive recipient cell in which the novel
DNA recombines into the recipient host cell chromosome (red). Conjugation (2). Large, low copy number conjugative plasmids
(orange) and integrated conjugative elements (ICEs; not shown) use a protein structure (known as a pilus) to establish a
connection with the recipient cell and to transfer themselves to the recipient cell. Alternatively, a copy of a small, multicopy plasmid
or defective genomic island or a copy of the entire bacterial chromosome can be transferred to a naive cell, in which these genetic
elements either insert into the chromosome or replicate independently if compatible with the resident plasmids (light green).
Conjugative transposons and plasmids of Gram-positive bacteria (not shown) do not use pili. Transposition (3). Transposons (pink)
integrate into new sites on the chromosome or plasmids by non-homologous recombination. Integrons (dark green) use similar
mechanisms to exchange single gene cassettes (brown). Details of these and other MGEs can be found in REFS 119,120.

Figure 1.2. Transfer of DNA between bacterial cells.

Transduction (1). The DNA genome (yellow) of a temperate phage inserts into the
chromosome (dark blue) as a prophage; it later replicates, occasionally packaging host
DNA alone (generalized transduction) or with its own DNA (specialized transduction),
lyses the cell, and infects a naive recipient cell in which the novel DNA recombines into

NATURE REVIEWS | MICROBIOLOGY

VOLUME 3 | SEPTEMBER 2005 | 723

!
the recipient host cell !chromosome
(red). Conjugation (2). Large, low copy-number
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conjugative plasmids (orange) and integrated conjugative elements (not shown) use a
protein structure (known as a pilus) to establish a connection with the recipient cell and to
transfer themselves to the recipient cell. Alternatively, a copy of a multi-copy plasmid,
defective genomic island or a copy of the entire bacterial chromosome can be transferred
to a naive cell, in which these genetic elements either insert into the chromosome or
replicate independently if compatible with the resident plasmids (light green).
Conjugative transposons and plasmids of Gram-positive bacteria (not shown) do not use
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pili. Transposition (3). Transposons (pink) integrate into new sites on the chromosome
or plasmids by non-homologous recombination. Integrons (dark green) use similar
mechanisms to exchange single gene cassettes (brown). Natural transformation (not
shown). Some bacteria can take up DNA from their immediate surroundings. Reprinted
by permission from Macmillan Publishers Ltd: [Nature Reviews Microbiology] (Frost et
al., 2005), copyright (2005).
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A particular talent of transposons is to disseminate genes encoding antibiotic
resistance (Gentry, 1991; Lupski, 1987), as transposons often encode such genes
(Kleckner, 1981). As many as half of recent antibiotic resistance cases are thought to
have been caused by transposons (Levy and Marshall, 2004) and the general spread of
(multiple) antibiotic resistance factors might be viewed as transposon evolution rather
than purely bacterial evolution (Reanney, 1976). For instance, the IncM plasmids
encoding resistance to gentamicin were first isolated in 1972. When they were isolated
years later, they contained many additional resistance determinants, including
transposons such as Tn6, Tn7 and Tn9 (Datta et al., 1980). Mobile genetic elements are
also key to the acquisition of virulence factors (reviewed in Gyles and Boerlin, 2014;
Keen, 2012).
The transposons mentioned above are members of the Tn family—that is, they are
composite transposons, which encode ‘extra’ genes flanked by insertion sequences.
While it is clear that composite transposons have been maintained in bacterial
populations largely due to the selective advantage conferred by the extra genes they
encode (particularly antibiotic resistance determinants), it is notable that IS elements have
also persisted outside of the context of a Tn element. In Yersinia pestis, the causative
agent of plague, characterization of mutations conferring immunological ‘escape’
phenotypes within immunized murine hosts lead to the discovery that IS1541 transposed
into the caf1A gene. This gene encodes a cell-surface protein that was targeted by the
host’s antibodies, and disruption of caf1A by IS1541 prevented expression of this ligand,
enabling the bacterium to evade the immune response (Cornelius et al., 2009). It is
tempting to speculate that IS elements can contribute to the fitness of their hosts simply
be providing an efficient source of intrinsic mutability in times of severe cellular stress.
LGT and transposons are thus major contributors to the acquisition of multipledrug resistance as well as virulence in a variety of bacterial species (Davies, 1994;
Espedido and Gosbell, 2012; Keen, 2012; Levy and Marshall, 2004; Quesada-Gomez,
2011).
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1.4 Host-transposon interactions
Mobile genetic elements are present in some form in virtually all organisms and can pose
a threat to genomic stability if left unchecked (Curcio and Derbyshire, 2003). Therefore,
most organisms are thought to have evolved stringent mechanisms to inhibit the mobility
of foreign genetic elements. For instance, elaborate mechanisms like RNA interference
(RNAi) impose post-transcriptional silencing on many genes but are widely believed to
have evolved to silence foreign genes, including transposons (reviewed in Feschotte,
2008).
Frequent mobilization of transposons would be detrimental to bacteria (i.e. a
major source of genomic instability) as well as to the transposons themselves (since they
would kill their own host). It therefore makes sense that, in order to be maintained in
bacterial populations, transposons have evolved mechanisms to intrinsically limit (though
not abolish) their own mobility, which supplement the repressive strategies employed by
the host. Moreover, it has been proposed that transposon mobilization in times of severe
cellular stress would provide an evolutionary benefit to both the transposable element and
its host (Boucher et al., 2003). In the case of the element, elevated transposition
frequency would increase its chances of mobilizing into a healthy host. While individual
bacterial cells might fall prey to increased genomic instability, the host as a population
would benefit from increased genetic plasticity as well as increased LGT, since any one
cell could gain the ability to survive the stress at hand and rapidly pass this advantage to
other bacterial cells.
Therefore, mechanisms for both repressing and activating transposition are
employed by the transposons (‘intrinsic’ factors) and their hosts (‘extrinsic’ or ‘hostencoded’ factors) in order to maintain transposition at low—but not altogether
negligible—frequencies in bacteria.

1.4.1

Intrinsic regulation of bacterial transposition

Transposase proteins catalyze the chemical steps in bacterial transposition reactions. It
follows that the regulation of expression of these genes is a critical feature in dictating the
transposition frequency of most transposons.
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In many instances, including the well-studied Tn10/IS10 and Tn5/IS50
transposons, transposase gene promoters are inherently weak. Weak translational
initiation, frame-shifting and protein instability can also reduce transposition. To prevent
transposase expression due to transcriptional read-through from an adjacent gene, IS10
and IS50 encode sequences that can form an RNA secondary structure in order to
sequester the translation initiation signals (TIR). Inverted repeat sequences located close
to the left end include the TIR. Transcripts from the resident transposase promoter
include only one repeat (which cannot form the secondary structure by itself) while
transcripts from neighbouring DNA include both repeats (Kleckner, 1990; Mahillon and
Chandler, 1998; Nagy and Chandler, 2004).
There are also examples where translation of transposase transcripts is subject to
intrinsic regulation. In the case of IS10 transposase, the ribosome binding site is
inherently weak and the transposon encodes an antisense RNA (RNA-OUT) that binds
the translation initiation region (TIR) of the transposase mRNA (RNA-IN), blocking
ribosome binding (Ma and Simons, 1990; Simons and Kleckner, 1983).
At the ‘post-translational’ level (i.e. after synthesis of the transposase protein),
Tn5 encodes an inhibitor protein that forms inactive dimers with transposase (de la Cruz
et al., 1993).
Finally, formation of the transpososome (the higher order complex of transposase
with transposon DNA) and the reactions catalyzed by transposase are often inefficient,
due to sub-optimal binding sites for transposase proteins and inefficient catalysis by
transposase itself (Gueguen et al., 2005).

1.4.2

Host-imposed regulation of bacterial transposition

DNA Adenine Methyltransferase (Dam)-methylation is a major mechanism by which
bacteria limit transcription of transposase messages (Yoder et al., 1997). For instance,
Dam methylase limits initiation of IS10 and IS50 transposase gene transcription by
methylating promoter elements, and Dam-methylation of transposon ends also reduces
transposition by interfering with transposase binding to the ends (Roberts et al., 1985;
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Yin et al., 1988). This represents a cooperation between intrinsic and extrinsic regulation,
since the Dam-recognition sequences (GATC) are encoded by the transposons but Dam
methylase is a host-encoded enzyme. There is evidence that IS50 transposase expression
is also negatively regulated by LexA, an SOS-inducible transcriptional repressor (Kuan
and Tessman, 1991). However, there is little else known with regard to host proteins that
influence either transposase transcription or translation in bacteria.
Several nucleoid-associated proteins impact on transposition. Examples include
IHF (integration host factor), HU (histone-like, strain U93), Fis (factor for inversion
stimulation) and H-NS (histone-like nucleoid structuring protein). IHF, HU, and H-NS
have all been shown to bind directly to transposon sequences in vitro or in vivo and
directly stimulate transpososome assembly or transposition (e.g. Mu, Tn10, Tn5, Tn1000)
(Lavoie and Chaconas, 1993; Signon and Kleckner, 1995; Surette et al., 1989; Wardle et
al., 2005; Whitfield et al., 2009). Alternatively, H-NS indirectly affects IS1 transposition
by stabilizing the IS1 transposase insAB’ (Rouquette et al., 2004). Regulation of Mu is
also mediated by H-NS, which stabilizes the Mu repressor-DNA complex that controls
transposase activity (Falconi et al., 1991).
While many examples exist of host-encoded factors influencing transpososome
dynamics or other aspects of transposition in the context of a mature transposase protein,
an exhaustive search of the literature failed to turn up examples of transposase expression
being regulated by host-factors at the post-transcriptional level in bacteria. Posttranscriptional machinery thus represents a previously unrecognized means for the
bacterial host to regulate transposase expression. Given that expression of the transposase
protein is essential for transposition, such mechanisms have powerful potential for
transposon regulation.

1.5 Post-transcriptional regulation in bacteria
Like eukaryotes, bacteria have innate defense systems (e.g. restriction endonucleases).
More recently, CRISPR elements (clustered regularly interspaced short palindromic
repeats) and Argonaut-based systems have emerged as a form of bacterial adaptive
immune response (see reviews by Olovnikov et al., 2013; Raivio, 2011; van der Oost et
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al., 2009; Wiedenheft et al., 2012) for degrading foreign DNA. Bacteria have also
evolved a system for post-transcriptional regulation with functional similarities to
eukaryotic microRNAs (miRNAs). The actuators of this system are small regulatory
RNAs (sRNAs); these are a major component of bacterial gene regulation, and tend to
mediate cellular response to a wide variety of external stress stimuli (Gottesman and
Storz, 2011; Vogel and Papenfort, 2006). Small RNAs can be categorized as cis-encoded
(classical antisense RNAs, which are expressed from the strand opposite their target) or
trans-encoded (i.e. expressed from distinct genes on the bacterial chromosome). The
latter is thought to represent the major class of bacterial regulatory RNAs, although an
increasing number of cis-encoded antisense RNAs are being shown to have a defined
physiological role (see reviews by Gottesman and Storz, 2011; Waters and Storz, 2009).
Note that ‘sRNAs’ will hereafter refer to the trans-encoded variety, while cis-encoded
sRNAs will be referred to as ‘antisense RNAs’ (asRNAs). An important feature of
sRNAs is that they share only partial sequence complementarity to their mRNA targets,
with small ‘seed regions’ reminiscent of eukaryotic miRNAs. Also like miRNAs, sRNAs
can regulate multiple mRNAs (Lease et al., 1998) and, conversely, multiple sRNAs can
converge on one mRNA (reviewed in Repoila and Darfeuille, 2009).
The consequence of base pairing between an sRNA and its mRNA target can be
either activation or, more commonly, repression of translation. The paradigm for
activation has been established largely from studies of the sRNA:mRNA pair DsrA:rpoS.
In this case, secondary structure in the 5’ un-translated region (5’ UTR) of the rpoS
mRNA sequesters the Shine-Dalgarno (SD) ribosome-binding site, preventing translation
initiation. Cold-shock induces DsrA-expression, and this sRNA base pairs with the 5’
UTR of rpoS to relieve the self-inhibitory stem-loop structure by an ‘anti-antisense’
mechanism, allowing expression of the rpoS-encoded σS protein (Majdalani et al., 1998;
Soper et al., 2010). More recently, a new mechanism for activation was established for
the sRNA SgrS, which was shown to activate YigL synthesis in a translation-independent
manner by selectively stabilizing a decay intermediate of the dicistronic pldB-yigL
transcript (Papenfort et al., 2013).
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The consequence of sRNA:mRNA pairing is usually repression rather than
activation. Repression is almost always due to sequestration of the TIR of the mRNA
target, although enhanced mRNA turnover through ribonuclease recruitment is also
observed in many cases (Waters and Storz, 2009).

1.6 Hfq: a global post-transcriptional regulator
In eukaryotes, miRNAs or siRNAs are responsible for targeting RNA but ultimately,
elaborate protein machinery is responsible for silencing (reviewed in Hammond, 2005).
Conversely, as discussed above, bacterial sRNAs themselves are usually directly
responsible for translational silencing (or activation) due to base-pairing interactions with
specific regions of their mRNA targets. Nevertheless, the major class of sRNAs functions
alongside an abundant Sm-like protein called Hfq (Moller et al., 2002; Valentin-Hansen
et al., 2004). Originally identified as the host factor for replication of phage Qβ, Hfq has
become recognized as a central player in post-transcriptional regulation in bacteria (De
Lay et al., 2013). The most intensely studied function of Hfq is to facilitate base pairing
between sRNAs and their targets. However, other functions of Hfq have come to light
(reviewed in De Lay et al., 2013; Vogel and Luisi, 2011). The diverse regulatory
functions of Hfq (some of which are illustrated in Figure 1.3) make it central to
expression of up to half of all proteins in model organisms like S. enterica (Ansong et al.,
2009). Hfq homologues have been found in more than half of all sequenced Gramnegative and Gram-positive bacteria, and there is at least one Hfq-like protein in an
archaeal species (Sun et al., 2002). While it is not essential for viability under optimal
growth conditions, hfq- cells display highly pleiotropic phenotypes, including slow
growth and sensitivity to multiple stresses (Tsui et al., 1994). Given that Hfq is central to
most sRNA regulatory circuits, which are themselves effectors of cellular stress-response,
Hfq is a hub for the regulation of multiple stress-response pathways (Gottesman and
Storz, 2011; Guisbert et al., 2007; Muffler et al., 1996; Vogel and Papenfort, 2006).
Notably, Hfq is required for the proper expression of virulence genes; indeed, Hfqencoding pathogenic bacteria lose virulence when mutated to hfq- (Ding et al., 2004;
Sittka et al., 2007).
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for 30S binding. (C) Hfq protects some sRNAs from ribonuclease cleavage, which is
carried out by ribonuclease E (RNase E) in many cases. (D) Hfq can induce the cleavage
(often by RNase E) of some sRNAs and their target mRNAs. (E) Hfq can stimulate the
polyadenylation of an mRNA by poly(A) polymerase (PAP), which in turn triggers 3′-to5′ degradation by an exoribonuclease (Exo). In E. coli, the exoribonuclease can be
polynucleotide phosphorylase, RNase R or RNase II. Adapted by permission from
Macmillan Publishers Ltd: [Nature Reviews Microbiology] (Vogel and Luisi, 2011),
copyright (2011)
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1.6.1

Canonical regulation: Hfq-dependent sRNAs

The canonical function of Hfq is to enhance the rate and/or stability of base-pairing
interactions between sRNAs and their target mRNAs (reviewed in De Lay et al., 2013;
Vogel and Luisi, 2011).
The exact mechanism by which Hfq facilitates these interactions remains unclear.
Crystal structures have shed some light on its multiple RNA-binding surfaces. Hfq forms
a homo-hexameric ring or ‘toroid’ structure. U-rich RNA winds around the central cavity
of the ring structure on one face of Hfq termed the ‘proximal’ face (Schumacher et al.,
2002), while A-rich RNA preferentially binds the opposite face, termed the ‘distal’ face
(Link et al., 2009). Analyses of Hfq mutants have confirmed the RNA-binding specificity
of these two surfaces (Mikulecky et al., 2004).
The proximal face is thought to be the site for sRNA interactions. One basis for
this interaction may be rho-independent terminators with poly(U) tails, which are
characteristic of sRNAs (Ishikawa et al., 2012; Otaka et al., 2011; Sauer and
Weichenrieder, 2011). Additionally, ‘internal’ binding sites for Hfq have been identified
in many sRNAs, such as OxyS, DsrA and RyhB (Brescia et al., 2003; Geissmann and
Touati, 2004; Zhang et al., 2002). This internal binding motif was further characterized in
a study on SgrS, which required an internal U-rich sequence adjacent to a stem-loop—in
addition to its rho-independent terminator—for stable Hfq binding and subsequent
regulation of its target mRNA (Ishikawa et al., 2012). This motif is present in many of
the currently characterized sRNAs. Studies with mutant forms of Hfq suggest that these
interactions are abrogated upon mutation of proximal site residues, and these mutations
also lead to reduced sRNA accumulation in vivo (Zhang et al., 2013).
Studies on the distal face of Hfq have further characterized it as a site for binding
A-rich RNA/mRNA (Mikulecky et al., 2004; Sauer et al., 2012). The distal surface has a
high affinity for mRNAs containing an ‘ARN’ binding motif (where R is a purine and N
is any base) (Link et al., 2009). The ARN motif was first reported to be required for Hfq
binding and sRNA-mediated gene regulation in the DsrA:rpoS system (Soper and
Woodson, 2008), and subsequent studies have confirmed the importance of this motif for
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other sRNA/mRNA pairs (Beisel et al., 2012; Salim and Feig, 2010; Salim et al., 2012).
Moreover, mutations in the distal surface disrupt regulation by Hfq-dependent sRNAs
(Zhang et al., 2013).
A third site for interaction has been characterized on the rim of the Hfq ring,
termed the ‘lateral’ surface. This surface is rich in positively charged residues and has
been implicated in sRNA binding. The lateral surface is thought to play an important role
in the association with sRNAs that leads to sRNA:mRNA pairing and dissociation of the
pair from Hfq (Panja et al., 2013; Sauer et al., 2012; Zhang et al., 2013).
As previously mentioned, the mechanism by which Hfq facilitates sRNA-mRNA
pairing remains unclear. One hypothesis for the role of Hfq is to increase the local
concentration of the RNAs in the cell, thereby increasing the likelihood of base pairing.
This simply requires that a given Hfq hexamer bind both the sRNA and its mRNA target
simultaneously. Additionally, Hfq may play a more active role, by restructuring the
RNAs to make the appropriate sequences available for base pairing (Geissmann and
Touati, 2004; Soper et al., 2011). Both models (or other models) could apply for different
sRNA/mRNA systems.
While Hfq is an abundant protein, recent studies suggest that there is competition
for binding to Hfq (Hussein and Lim, 2011; Moon and Gottesman, 2011; Olejniczak,
2011). Each Hfq hexamer appears to bind one sRNA and one mRNA at a time
(Updegrove et al., 2011). The implication is that an imbalance of sRNA or mRNA
concentration (such as increased expression of a particular sRNA during a stressresponse) could essentially sequester intra-cellular Hfq, thus reducing regulation by other
Hfq-dependent sRNA/mRNA systems.

1.6.2

Alternative regulatory mechanisms employed by Hfq

Hfq is known to stabilize sRNAs by protecting them against the action of ribonucleases
(Moller et al., 2002; Sledjeski et al., 2001). Additionally, Hfq has been shown to directly
repress translation of an mRNA by competing with ribosomes for binding the TIR; this
activity is enhanced by sRNAs, which recruit Hfq to the mRNA, but interference can
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occur even without the sRNA partners (Desnoyers and Masse, 2012; Salvail et al., 2013).
One case of such repression by Hfq is the autoregulation of its own mRNA (Vecerek et
al., 2005). Hfq also participates in sRNA-induced mRNA degradation. Hfq is believed to
recruit RNA-degradation machinery to targeted mRNAs, as Hfq interacts with both
sRNAs and RNase E (Ikeda et al., 2011; Masse et al., 2003; Morita et al., 2005). Hfq also
enhances processivity of poly(A) polymerase I (PAPI), increasing turnover of certain
mRNA targets (Folichon et al., 2003; Hajnsdorf and Regnier, 2000; Mohanty et al.,
2004). The diverse mechanisms utilized by Hfq highlight the complexity of Hfq
regulation within a bacterial cell. Interestingly, Hfq has been shown to function in one
cis-encoded antisense system. In the case of GadY, Hfq stabilizes the asRNA, but it was
not determined if Hfq plays any role in antisense pairing (Opdyke et al., 2004). A role for
Hfq in facilitating base pairing in a classical antisense regulatory system (such as the
RNA-IN/RNA-OUT system of Tn10) has not yet been established.

1.7 Bacterial stress-response and transposons
Bacteria can dynamically alter their gene expression profiles in order to survive adverse
and fluctuating conditions in their immediate surroundings. A bacterial cell can react
simultaneously to a wide variety of stresses and the various stress-response systems
interact with each other in a complex global regulatory network. Classic examples
include the SOS response to DNA damage, stringent response to amino acid starvation
(and other forms of stress) and the stationary phase/general stress response.
A transcriptional repressor protein, LexA, negatively regulates the expression of
SOS genes during normal growth by sequestering these specific promoters. When RecA
senses DNA damage, it stimulates autoproteolysis of LexA, leading to activation of SOS
genes. These genes encode proteins for processes like nucleotide excision repair,
recombination and inhibition of cell division, allowing the cell to repair the DNA damage
before continuing with replication (reviewed in Friedberg et al., 2006).
The stringent response is signaled by (p)ppGpp and can modulate the
transcription of up to one third of all genes in the cell, in order to divert cellular resources
away from growth and division and toward amino acid synthesis. Low amino acid
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concentration is sensed by RelA, which synthesizes (p)ppGpp. In conjunction with the
protein DksA, (p)ppGpp regulates its target genes by interfering with transcription by
RNA polymerase (RNAP) until amino acid levels recover, leading to the breakdown of
(p)ppGpp by SpoT (reviewed in Potrykus and Cashel, 2008).
Sigma factors recognize specific promoters, and the promoter-binding activity of
RNAP holoenzyme is determined by which sigma factor is bound to the RNAP core
enzyme. For instance, holoenzyme primarily contains the ‘housekeeping’ sigma factor
(σ70) during normal growth. During the transition to stationary phase or due to various
stresses (including starvation), σ70 becomes sequestered by its ‘anti-sigma factor’, while
levels of the stationary phase sigma factor (σS) increase dramatically. Consequently,
holoenzyme contains primarily σS under such conditions, which alters the promoter
specificity of RNAP and therefore the gene expression profile of the cell (reviewed in
Landini et al., 2014).
Crp (cAMP-response protein) is a well-studied global transcription factor that
enacts a coordinated shift in gene transcription in response to glucose levels. Low glucose
concentration leads to high intra-cellular cyclic AMP (cAMP), which then binds to (and
activates) Crp (Popovych et al., 2009). Crp-cAMP binds to specific promoters, leading
either to transcriptional activation or repression. Activation is typified by the lac operon:
cAMP-Crp binds upstream of the promoter and interacts with RNAP, enhancing
transcription initiation (Hudson et al., 2009). Repression also occurs for many genes (e.g.
glutamine synthetase) (Mallick and Herrlich, 1979; Prusiner et al., 1972); Crp-cAMP
binds in close proximity to the transcription initiation site and/or -10 sequence,
interfering with RNAP binding and transcription initiation. Crp regulates dozens of other
genes, many of which encode local transcription factors. The net effect is a decrease in
expression of genes for utilizing glucose and an increase in expression of genes for using
alternative carbon sources, such as lactose (reviewed in Busby and Ebright, 1999; Kolb et
al., 1993). Interestingly, cAMP-Crp also has a modest repressive effect on Hfq expression
(Lin et al., 2011).
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As previously mentioned, Hfq-dependent sRNAs have emerged as a major
component of bacterial stress-response. An advantage of post-transcriptional regulation is
that it allows very rapid and reversible response to stress, since sRNAs can be quickly
induced and act on existing mRNA, and also experience a more rapid turnover than
protein regulators when the stress is removed (Gottesman and Storz, 2011; Vogel and
Papenfort, 2006). Hfq and its sRNA accomplices are important mediators of several
different cellular stress-response pathways, including oxidative (Zhang et al., 1998),
phosphosugar (Vanderpool and Gottesman, 2004), iron (Masse and Gottesman, 2002),
osmotic (Vytvytska et al., 1998) and low-temperature stress (Hankins et al., 2010; Soper
and Woodson, 2008). In each of these pathways, the stress induces transcription of at
least one Hfq-dependent sRNA. Subsequently, Hfq interacts with the sRNA to mediate
the stress-response by promoting the interaction of the sRNA with its mRNA target(s)
(Gottesman et al., 2006; Vogel and Papenfort, 2006; Vogel and Luisi, 2011; Waters and
Storz, 2009). For example, phosphosugar stress (triggered by the abnormal intracellular
accumulation of glucose-6-phosphate or analogues thereof) induces the sRNA, SgrS.
Levels of this sRNA increase by at least 10-fold under these conditions (Vanderpool and
Gottesman, 2007). SgrS down-regulates glucose import by base pairing to the ptsG
mRNA, repressing translation of the primary glucose transporter; SgrS also encodes a
small peptide (SgrT) which blocks the glucose transporter at the protein level
(Vanderpool and Gottesman, 2004; Wadler and Vanderpool, 2007). Additionally, SgrS
up-regulates expression of a phosphatase (YigL) that de-phosphorylates glucose-6phosphate (Papenfort et al., 2013), which reduces glucose retention in the cell.
Ultimately, the consequence of SgrS-induction is to reduce intra-cellular glucose-6phosphate levels, thus alleviating the stress.
As discussed above, increased transposition could provide an evolutionary
advantage during bacterial stress-response, perhaps explaining why host factors are often
positive regulators of transposition. Interestingly, there is evidence that some transposons
are mobilized by environmental stresses. For example, UV radiation has been shown to
induce IS10 transposition in E. coli, as a component of the SOS DNA-damage response
(Eichenbaum and Livneh, 1998). In human colonic Bacteroides, exposure to tetracycline
increased the rates of excision of the conjugal tetracycline resistance element, CTnDOT,
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from the host chromosome (Shoemaker and Salyers, 1988). Another example is IS1. In
this case, levels of the IS1 transposase mRNA (insA-insB’) increase in E.coli as part of a
cellular response to high levels of divalent metal ions (Brocklehurst and Morby, 2000). In
Pseudomonas putida, entry into stationary phase (where nutrients are growth limiting)
was found to induce transposition of Tn4652 by up-regulating transposase transcription.
This response was found to be dependent on the general stress-responsive sigma factor,
σS, although it was not established if σS bound directly to the transposase promoter under
these growth conditions (Ilves et al., 2001). The phenomenon of stress-induced
mobilization is not limited to bacteria; in the eukaryote Saccharomyces cerevisiae, severe
adenine starvation induces Ty1 transcription and retrotransposition (Todeschini et al.,
2005).
Post-transcriptional regulation of transposition may provide a previously
unrecognized means to link bacterial stress-response to transposon mobilization.

1.8 Topics addressed in this thesis
Despite the wealth of data concerning the chemical steps of excision and joining in
bacterial transposition, and the various host-encoded factors that have been implicated as
regulators of transposition, there are relatively few examples of host factors that influence
transposase expression by a well-defined mechanism. Similarly, there are relatively few
examples where increased transposition has been linked to a specific cellular stressresponse. Furthermore, the host-encoded machinery for post-transcriptional regulation
has not yet been implicated in regulating a transposition system. Chapter 2 describes
experiments aimed at expanding the current understanding of host-imposed regulation of
transposition, using Tn10/IS10 in E. coli as a model system. I determined that Hfq is a
potent repressor of transposase expression at the post-transcriptional level, and that this
regulation was exercised via two pathways, one of which involves the intrinsic antisense
regulator (RNA-OUT). Given that Hfq—or any other components of the sRNA-based
post-transcriptional regulatory network in E. coli—had never before been implicated in
regulation of transposition, I sought to further define the mechanism by which Hfq acts in
the Tn10/IS10 antisense system. In Chapter 3, I show that Hfq plays a role in
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restructuring RNA-IN and RNA-OUT, and generally acts to enhance base pairing in this
antisense system in analogous fashion to a canonical sRNA/mRNA system. Notably, Hfq
had not previously been implicated as a positive regulator of base pairing in cis-antisense
systems. In Chapter 4, I show that a second transposition system (Tn5/IS50) is also
repressed by Hfq. Unlike Tn10, the Tn5 system is regulated by Hfq at the level of
transposase transcription and I provide evidence that this regulation is exercised
indirectly, via Crp. Additionally, I show in Chapter 4 that Tn5 transposition is activated
by nutrient starvation, providing a new example of stress-induction of transposition. In
Chapter 5, I further discuss the implications of post-transcriptional regulation of DNA
transposition, the possible role of Hfq as a general repressor of transposons, and the
interplay between stress response and transposition. I also address the broader impact of
my work, and discuss future directions.
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Chapter 2 1

2

Tn10/IS10 transposition is down-regulated at the level
of transposase expression by the RNA-binding protein
Hfq

2.1 Introduction
Within bacterial populations there is often promiscuous transfer of DNA between species,
a phenomenon referred to as lateral gene transfer (LGT). In bacteria LGT is typically
mediated by natural plasmid transformation, conjugation and/or phage transduction. The
dissemination of transposons between bacterial species is greatly facilitated by insertion
of transposons into the ‘agents’ of LGT (i.e. plasmids and phage). Moreover, since many
transposons encode antibiotic resistance genes, LGT represents a major pathway through
which bacteria become resistant to (multiple) antibiotics (Davies, 1994). Since
transposons are key players in the acquisition of antibiotic resistance genes and are often
tightly regulated by their hosts, it is important to understand mechanisms of host
regulation of bacterial transposition. Interestingly, there is existing evidence that host
regulation of transposition can be tied into cellular stress response pathways, raising the
possibility that certain transposons may be mobilized by environmental stresses
(Eichenbaum and Livneh, 1998; Brocklehurst and Morby, 2000; Todeschini et al., 2005;
Twiss et al., 2005).
Tn10 (and its component insertion sequence IS10 – see Figure 2.1) is an example
of a bacterial transposon that is subject to strong negative and positive regulation by its
host. In Escherichia coli, Dam methylation down-regulates both the expression of the
transposase gene at the transcriptional level and the binding of transposase to the inside
end (defined in Figure 2.1) (Roberts et al., 1985). Integration host factor (IHF) acts as a

1

A version of this chapter has been published: Ross,J.A., Wardle,S.J. and Haniford,D.B. (2010) Tn10/IS10
transposition is downregulated at the level of transposase expression by the RNA-binding protein Hfq.
Molecular microbiology, 78(3), 607-621.
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Figure 2.1. Structure of Tn10/IS10 including a ‘marked’ IS10 and summary of the
major steps in Tn10/IS10 transposition.
 ends, respectively, and include binding sites for the
OE and IE are outside and inside

IS10-encoded transposase protein. For IS10-Kan promoters pIN and pOUT (blue and
black squares respectively) and the corresponding RNA transcripts, RNA-IN and RNAOUT (blue and black lines with arrows), are shown. RNA-OUT is an anti-sense RNA to
RNA-IN (transposase transcript) and pairing of these RNAs blocks ribosome binding to
RNA-IN by sequestering the ribosome binding site (RBS). Translation of RNA-IN
generates the transposase protein, which binds transposon ends to form a transpososome.
Subsequent to transpososome assembly the chemical steps in transposition are initiated.
For details see Kennedy et al. (1998).
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positive regulator of Tn10/IS10 transposition by binding outside end DNA (defined in
Figure 2.1) and promoting transpososome assembly (Sakai et al., 1995). However, the
continued presence of IHF in the transpososome acts to inhibit intermolecular
transposition (Chalmers et al., 1998). The ejection of IHF from the transpososome is
promoted by a second host protein, H-NS (histone-like nucleoid structuring protein)
(Wardle et al., 2005), which also has a more general role in promoting LGT through the
transient down-regulation of laterally acquired genes (Navarre et al., 2007).
Tn10/IS10 transposition is also tightly negatively regulated by an anti-sense RNA
encoded by the transposon itself. The anti-sense RNA (RNA-OUT) is complementary to
the 5′ end of the transposase mRNA (RNA-IN) and pairing between the two RNAs
reduces translation of the transposase message through sequestration of the ribosome
binding site (Simons and Kleckner, 1983; Ma and Simons, 1990). In addition, pairing
increases the sensitivity of RNA-IN to RNase E-mediated degradation (Case et al., 1990).
The anti-sense system plays a particularly important role in limiting Tn10/IS10
transposition when the transposon is present on a multi-copy plasmid. For example,
introduction of IS10 on a multi-copy plasmid actually reduces the frequency of
transposition of a chromosomal copy of Tn10 by about 10-fold and IS10 transposition
itself (present on a multi-copy plasmid) does not increase significantly relative to a
situation where IS10 is present in single copy (Simons and Kleckner, 1983). This
phenomenon is called multi-copy inhibition (mci) and can be reconciled by the fact that
RNA-OUT, which is expressed at a much higher level than RNA-IN (Simons et al.,
1983), is freely diffusible in the cell and thus can act in trans as an inhibitor of
transposase expression. In contrast, the transposase protein is largely cis-acting because it
tends to associate with transposon ends present on the element that encodes it (Morisato
et al., 1983). Thus, increasing the copy number of Tn10/IS10 effectively results in an
increased cellular concentration of the trans-acting inhibitor without altering the
propensity of transposase protein to act on the element that encodes it. To date, host
factor involvement in mci has not been established. Importantly, it should be recognized
that interference with mci has the potential to greatly increase the frequency of
Tn10/IS10 transposition when the transposon is present on a multi-copy plasmid as the
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frequency of Tn10/IS10 transposition is roughly proportional to the amount of
transposase protein synthesized (Morisato et al., 1983).
In the current work we set out to further evaluate the importance of H-NS in the
regulation of Tn10/IS10 transposition. Our initial objective was to determine if
modulating H-NS expression levels had a significant impact on transposition frequencies.
Regulation of H-NS gene expression is complex. H-NS is a potent transcriptional
repressor and transcription of the hns gene is autoregulated by H-NS protein (Williams
and Rimsky, 1997). It follows that simply increasing hns gene copy number may not be
sufficient to increase cellular levels of H-NS protein. However, H-NS expression is also
regulated post-transcriptionally. The small non-coding RNA (sRNA) DsrA binds
segments at the 5′ and 3′ ends of hns mRNA through complementary base-pairing and in
so doing promotes degradation of hns RNA (Lease and Belfort, 2000). Pairing of DsrA
RNA to hns RNA is facilitated by Hfq, an RNA-binding protein (Sledjeski et al., 2001).
Notably, Hfq binds to the majority of the sRNAs encoded by E. coli (of which there are
over 100) and stabilizes these RNAs and/or promotes the pairing of these RNAs with
partner mRNAs possessing partial sequence complementarity (Majdalani et al., 2005;
Storz et al., 2005; Brennan and Link, 2007). Accordingly, we chose to up-regulate H-NS
expression by disrupting the dsrA gene. As a control we also disrupted (in a separate
strain) the hfq gene. We report here that disrupting the hfq gene results in a large increase
in IS10 transposition but disrupting the dsrA gene has essentially no effect on IS10
transposition. Since Hfq is essentially an auxiliary factor in DsrA mediated regulation of
hns gene expression (Sledjeski et al., 2001), these results are consistent with Hfq acting
as a negative regulator of IS10 transposition by a mechanism that is not related to cellular
H-NS levels. Evidence is presented that Hfq negatively regulates Tn10/IS10 transposition
by inhibiting expression of the IS10 transposase protein. Interestingly, while Hfq appears
to contribute to the mci pathway (which inhibits transposase translation), we also provide
evidence that Hfq negatively regulates transposition under conditions where the IS10
anti-sense regulatory system is not functional. Together, these results suggest that Hfq
can inhibit two distinct steps in Tn10/IS10 transposition.
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2.2 Results
2.2.1

Hfq acts as a potent negative regulator of IS10 transposition
independent of its effects on H-NS gene expression

H-NS has previously been shown to act as a positive regulator of Tn10 transposition
(Swingle et al., 2004; Wardle et al., 2005). To examine the possibility that up-regulating
the expression of H-NS influences IS10 transposition we measured the frequency of IS10
transposition in strains of E. coli where genes encoding negative regulators of hns
expression (dsrA and hfq) were disrupted. Disruption strains (hereafter referred to as hfqand dsrA-) were generated by transducing NK5830 (recA- F+) with either hfq-1::Ωcat or
dsrA::Ωcat alleles as previously described (Swingle et al., 2004). We then introduced a
marked IS10 (IS10-Kan – see Figure 2.1) (Bender et al., 1991) on a multi-copy plasmid
into NK5830 and the respective hfq- (DBH16) and dsrA- (DBH23) NK5830 derivatives
and measured the frequency of IS10-Kan transposition via the conjugal mating out assay
(described in Experimental procedures). As shown in Table 2.1, IS10-Kan transposition
was greatly increased (86-fold) in hfq- compared with the wild-type (WT) strain. In
contrast, disrupting dsrA had essentially no effect on the frequency of IS10-Kan
transposition. Notably, the relatively low level of transposition (~3 x 10-4) for multi-copy
IS10 observed in the WT strain is typical for an IS10 element that possesses intact mci
functions (Shen et al., 1987). In fact, the IS10-Kan transposition frequency in hfq+ was
only 20-fold above background for the mating out assay. This was determined using an
IS10-Kan construct (pNK2727) containing an in-frame deletion in transposase that
destroys transposase function (Haniford et al., 1989). Importantly, ‘background’ events
did not go up in hfq- as the transposition frequency of the same in-frame deletion was
slightly reduced in hfq- versus hfq+ (Table 2.1). Thus, the increase in transposition seen
for IS10-Kan (WT transposase) in hfq- versus hfq+ cannot be explained by an increase in
the frequency of background events in the hfq- strain. In addition, the increase in
transposition in hfq- cannot be accounted for by an increase in IS10-Kan plasmid copy
number as there was actually a slight decrease in plasmid copy number in hfq- versus hfq+
(Figure 2.2).

43

Table 2.1. In vivo transposition of IS10-Kan in isogenic WT, hfq- and dsrA- strains.
Strain/Genotype

Transposase
Source

Transposition
frequencya

NK5830 (WT)

pNK1219 (WT)
pNK2727 (Nco∇)

3.3 (±1.5) x10-4
1.8 (±1.3) x10-5

DBH16 (hfq-1::Ωcat)

pNK1219 (WT)
pNK2727 (Nco∇)

2.8 (±1.5) x10-2
6.6 (±2.2) x10-6

DBH23 (dsrA::Ωcat)

pNK1219 (WT)
pNK2727 (Nco∇)

3.9 (±2.2) x10-4
1.3 (±0.1) x10-5

a

Normalized
frequencyb
1.0
0.055
86
0.020
1.2
0.039

Transposition frequency represents an average value obtained from 3 representative
experiments wherein matings with at least 4 different donor transformants were carried
out in each experiment
b
Transposition frequencies were normalized to the level of transposition in the WT strain
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Figure 2.2. The copy number of a plasmid encoding IS10-Kan is decreased in hfq- vs
hfq+ cells.
1 mL aliquots of hfq+/- donor cells transformed with pNK1219 were removed from
cultures to be used for a mating out experiment and mixed with 1 mL aliquots of DH5α
cells containing pBR322; both cultures were at an OD600 of approximately 0.4. Plasmid
DNA was then isolated from each of the mixed cultures using the plasmid mini-prep kit
from Sigma and analyzed on a 1% agarose gel. Lanes 1-7 contain DNA isolated from
separate cultures of NK5830/pNK1219 plus DNA from one culture of DH5α/pBR322
and lanes 8-14 contain DNA isolated from separate cultures of DBH16/pNK1219 plus the
aforementioned culture of DH5α/pBR322.

45

To ensure that the large increase in transposition we observed in hfq- is due
specifically to the loss of Hfq function in the hfq- strain we introduced the hfq gene on a
low-copy plasmid into the hfq- strain (DBH16) and measured IS10-Kan transposition via
the mating out assay. We show in Table 2.2 that under these conditions the frequency of
IS10-Kan transposition was essentially equivalent to that observed in the WT strain. This
indicates that it is the disruption of the hfq gene, as opposed to possible polar effects of
the hfq disruption on downstream genes that is having the large impact on IS10
transposition. We also monitored H-NS protein levels in hfq+/- strains used for mating out
experiments by Western blotting and did not see a significant difference (data not
shown).
Taken together, the results in this section show that disruption of the hfq but not
the dsrA gene greatly increased the frequency of IS10-Kan transposition in E.coli.
Because DsrA RNA is the primary mediator of post-transcriptional regulation of the hns
gene and Hfq is essentially an accessory factor in this pathway, we conclude that the
large increase in IS10-Kan transposition observed in hfq- is indicative of Hfq functioning
as a negative regulator of IS10 transposition independent of its effects on H-NS protein
levels. Below, we present the results of studies aimed at elucidating the mechanism by
which Hfq down-regulates Tn10/IS10 transposition.

2.2.2

Hfq can act independent of the mci pathway to suppress
Tn10/IS10 transposition

The naturally occurring antisense RNA system operating in Tn10/IS10 transposition
mediates mci (see Introduction). Since disruption of mci is known to cause large
increases in Tn10/IS10 transposition when Tn10/IS10 is present on a multi-copy plasmid
(Case et al., 1989) and Hfq is known to promote the pairing of RNA molecules that share
at least partial complementarity, we hypothesized that the large increase in IS10
transposition observed in the hfq- strain reflects a role for Hfq in mci. To test this idea
genetically we compared the transposition frequency of IS10-Kan in hfq-, mci- and hfq- /
mci- backgrounds. Our expectation was that if Hfq acts in the mci pathway, the
transposition frequency of IS10-Kan in the double mutant would be no greater than that
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Table 2.2. Complementation of the hfq- effect on in vivo transposition of IS10-Kan
Strain/Genotype

Plasmid(s)

Transposition
frequencya

NK5830 (WT)

pDH602

1.6 (±0.6) x10-3

DBH16 (hfq-1::Ωcat)

pDH602

8.1 (±5.9) x10-2

NK5830 (WT)

pDH602/
pDH614 (Hfq source)

2.7 (±1.3) x10-3

1.6

DBH16 (hfq-1::Ωcat)

pDH602/
pDH614 (Hfq source)

5.1 (±3.8) x10-4

0.31

a

Normalized
frequencyb
1.0
50

Transposition frequency represents an average value obtained from a representative
experiment wherein matings with at least 4 different donor transformants were carried out
b
Transposition frequencies were normalized to the level of transposition in the WT strain
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in hfq- or mci-. For this experiment an mci- phenotype was conferred by introducing into
cells a plasmid that expressed a high level of truncated RNA-IN. This effectively titrates
out the RNA-OUT produced by IS10-Kan (Jain, 1995). Contrary to our expectation the
results show that combining mci- with hfq- mutations had a synergistic effect, increasing
IS10-Kan transposition approximately 10-fold relative to mci- and hfq- in isolation (Table
2.3). This result implies that Hfq can function outside of the mci pathway to negatively
regulate IS10 transposition. It should be noted that the above synergy does not rule out
the possibility that Hfq also plays a role in the mci pathway.
To estimate the impact of the hfq- phenotype on IS10 transposition independent of
mci, we measured the transposition frequency of a single-copy IS10-Kan located in the
chromosome; notably, when IS10 is present in single copy the anti-sense system has little
effect on transposase expression (Kleckner, 1989). To do this we crossed IS10-Kan from
a plasmid onto bacteriophage λ and subsequently made λ lysogens in isogenic hfq+/strains. We then measured the transposition frequency of the single-copy IS10-Kan as
previously described. As shown in Table 2.4, IS10-Kan transposition increased about
sevenfold in hfq- versus hfq+. While significant, this increase is substantially smaller, at
least 12-fold, compared with what we observed for hfq- in the situation where the same
transposon is present on a multi-copy plasmid.
We also used a papillation assay to follow the transposition frequency of a singlecopy Tn10 derivative from the chromosome of isogenic hfq+/- strains. In this setup the
experimental readout for transposition is a ‘LacZ turn-on’ event that results from
mobilization of a Tn10 derivative encoding a truncated lacZ gene into an expressed gene.
When plated on MacConkey lactose indicator plates, cells having a Tn10 transposition
event that results in LacZ turn-on form red papillae (or outgrowths) on a background of
white (LacZ-) cells (Haniford et al., 1989). The number of LacZ+ papillae formed per
colony is roughly proportional to the frequency of Tn10 transposition within the colony
(Huisman and Kleckner, 1987). To drive transposition we provided a copy of the
transposase gene under the control of a heterologous promoter (pTac) on a multi-copy
plasmid – this construct does not encode functional RNA-OUT. We show in Figure 2.3
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Table 2.3. In vivo transposition of IS10-Kan in hfq+/hfq- strains containing a vector
control or an RNA-OUT ‘titrator’.
Strain/Genotype

Plasmids

NK5830 (WT)

pNK1219/
pACYC184 (vector)

NK5830 (WT)

pNK1219/
pNK2197 (titrator)

1.3 (±0.6) x10-2

28

DBH16 (hfq-1::Ωcat)

pNK1219/
pACYC184 (vector)

1.5 (±0.9) x10-2

31

DBH16 (hfq-1::Ωcat)

pNK1219/
pNK2197 (titrator)

1.7 (±1.1) x10-1

370

a

Transposition
frequencya
4.7 (±2.7) x10-4

Normalized
frequencyb
1.0

Transposition frequency represents an average value obtained from 2 representative
experiments wherein matings with at least 4 different donor transformants were carried
out in each experiment
b
Transposition frequencies were normalized to the level of transposition in the WT strain
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Table 2.4. In vivo transposition of chromosomal IS10-Kan in hfq+/hfq- strains.
Strain/Genotype

Transposase

Transposition
frequencya

DBH99 (WT)

WT

3.7 (±1.3) x10-5

1.0

DBH100 (WT)

Nco∇

< 9 x10-7

< 0.02

DBH93 (hfq-1::Ωcat)

WT

2.5 (±0.87) x10-4

6.9

DBH94 (hfq-1::Ωcat)

Nco∇

< 2 x10-6

< 0.01

a

Normalized
frequencyb

Transposition frequency represents an average value obtained from a representative
experiment wherein matings with at least 4 different donor transformants were carried out
b
Transposition frequencies were normalized to the level of transposition in the WT strain
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Figure 2.3. Papillation assay showing the relative transposition frequency of a Tn10
derivative in hfq+/- strains.
A plasmid (pNK629) encoding IS10 transposase expressed from a pTac promoter and
lacking DNA sequences encoding functional RNA-OUT was transformed into isogenic
hfq+/- strains (NK8044 and DBH15) containing a single chromosomal copy of miniTn10LK; the lacZ gene in mini-Tn10LK is only expressed when the mini-Tn10LK
transposes into a transcriptionally active gene in the correct orientation and reading
frame. Transformants were selected on MacConkey lactose plates containing tetracycline
and grown for 3 days. Representative colonies from the different transformation mixes
plated on different halves of the same MacConkey lactose plate are shown.
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that hfq- transformants formed substantially more papillae than did hfq+ transformants.
For example, after 72 h of growth on the ‘papillation’ plates there were on average 12
papillae on hfq- colonies versus 2 papillae on hfq+ colonies, even though the hfq+ colonies
grew at close to twice the rate of hfq- colonies.
In addition to showing that Tn10 transposition is up-regulated in hfq-, the
papillation experiment shows that Hfq can function totally independent of the naturally
occurring anti-sense system in Tn10/IS10 to inhibit transposition. The papillation assay
result also shows that we can detect an increase in transposition (in this case of a Tn10
derivative) in hfq- versus hfq+ in an assay that does not depend on bacterial conjugation.
This is relevant because it has been shown that Hfq negatively regulates F plasmid
mating efficiency (Will and Frost, 2006), although this is not a factor in our mating out
experiments because all of our mating out data is normalized for mating efficiency.

2.2.3

Hfq down-regulates transposase expression

To further delve into the mechanism by which Hfq down-regulates Tn10/IS10
transposition, we looked at the impact of knocking out Hfq on both steady-state levels of
RNA-IN and on expression of RNA-IN in transcriptional and translational fusions. For
measuring steady-state levels of RNA-IN we performed semi-quantitative RT-PCR.
Using primers (see Table 2.5) designed to amplify a segment at the 3′ end of RNA-IN
and RNA isolated from donor strains grown as in the mating out protocol, we amplified
an RT-PCR product of the expected size (212 bp) for RNA-IN. As a control for the
quality and concentration of RNA prepared from hfq+ and hfq- strains we also amplified a
16S rRNA RT-PCR product in a separate reaction. We show in Figure 2.4 that while
there appeared to be a small increase (1.6-fold) in the steady-state level of RNA-IN in the
Hfq- versus the hfq+ strain, this difference was not statistically significant. Note that we
could not detect RNA-IN by either primer extension or RNase protection in hfq+ or hfqcells transformed with the IS10-Kan plasmid (either pNK1219 or pDH602) and this
precluded us from directly measuring RNA-IN stability under conditions comparable to
our transposition assays.
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Table 2.5. Oligonucleotides used in this study.
Name

Sequence (5’ to 3’)

Use

JR1

TAATACGACTCACTATAGGCGAAAAAT
CAATAATCAGACAACAAG

Forward primer (includes T7 promoter) for in vitro
transcription template (RNA-IN)

JR2

GGGGCAGAATTGGTAAAGAGAGTCG

Reverse primer for above synthesis

JR3

TAATACGACTCACTATAGGCTCGCACAT
CTTGTTGTC

Forward primer (includes T7 promoter) for in vitro
transcription template (RNA-OUT)

JR4

GGATACACATCTTGTCATATGATCA

Reverse primer for above synthesis

JR5

ACAAGGTTGGGACAAGCACTTCCAG

Forward primer for RT-PCR of RNA-IN

JR6

CTGAGAGATCCCCTCATAATT

Reverse primer for RT-PCR of RNA-IN

JR7

CGTGTTGTGAAATGTTGGGTTAAGT

Forward primer for RT-PCR of rrsb (16S rRNA)

JR8

AACCCACTCCCATGGTGTGACGGGC

Reverse primer for RT-PCR of rrsb (16S rRNA)

JR9

GGAAAAGAGCATATGGCTAAGGGGC

Forward primer for cloning hfq onto pDH631; NdeI cut site

JR10

AAAACAGCCCGGATCCTTATTCGGT

Reverse primer for above synthesis; BamHI cut site

JR11

NNNACTAGTNNNTTGAGACGTATCGTG

Forward primer for cloning hfq (with native promoter) onto
pDH614; SpeI cut site

JR12

NNNAAGCTTNNNGCGTATAACCCTCTA

Reverse primer for above synthesis; HindIII cut site
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Figure 2.4. Steady-state RNA-IN levels in hfq+/- strains as determined by RT-PCR.
Isogenic hfq+/- strains (NK5830 and DBH16) transformed with an IS10-Kan containing
plasmid (pNK1219) were grown in LB supplemented with kanamycin as described for
donor strains in the mating out protocol. At the point where donor cells would normally
be mixed with recipient cells, RNA was extracted from donor cells (separate cultures
derived from three independent transformants of each strain) and used for RT-PCR with
primers suitable for amplifying cDNAs from RNA-IN and 16S rRNA, in separate
reactions. (A) Ethidium bromide-stained agarose gels corresponding to separate primer
pairs and control reactions are shown. Lanes 1 and 2: amplification using genomic DNA
(+ and - refers to genomic DNA isolated from DBH16 either containing or not containing
pNK1219 respectively). Lanes 3 and 4: RT-PCR performed in the absence of RNA and in
the presence of RNA but the absence of reverse transcriptase (RT) respectively. Lanes 5
and 6: RT-PCR performed with only the forward (For) or reverse (Rev) primer
respectively. Lanes 7–9: complete RT-PCR reactions performed on RNA isolated from
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hfq+ cells. Lanes 10–12: complete RT-PCR reactions performed on RNA isolated from
hfq- cells. RNA-IN and 16S rRNA amplicons are predicted to be 212 and 355 base pairs
respectively. (B) Quantification of the gel image shown in (A). The band intensity of the
RNA-IN amplicon was divided by the band intensity of the 16S rRNA amplicon for each
of three hfq+ and hfq- isolates and the average value for this ratio for each of the two sets
was calculated. Error bars indicate standard deviation on the mean.
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To look at possible effects of Hfq on transcription and translation of RNA-IN, we
analyzed the expression of transposase–lacZ fusions in hfq+/- cells. We introduced into
hfq+/- cells plasmids encoding a portion of IS10 including pIN and pOUT (pNK774) or
only pIN (pNK772) fused to a promoter-less lacZ gene (Simons et al., 1983). We then
measured β-galactosidase activity in these strains and observed only a very small
difference (less than twofold) in hfq- versus hfq+ (Figure 2.5). This suggests that Hfq does
not influence transcription of RNA-IN. Next we introduced a translational fusion that
encodes pIN, pOUT plus the first 183 nucleotides of RNA-IN into hfq+/- cells and
measured β-galactosidase activity (Figure 2.6A). In one configuration translational
fusions were present on a multi-copy plasmid; the IS10 component was either mci+ or
mci- (Jain, 1995). In this case mci- status was conferred by the R5 mutation, which
destabilizes RNA-OUT (Simons and Kleckner, 1983; Case et al., 1989). We show in
Figure 2.6B that in hfq-, mci- and hfq- mci- β-galactosidase activity increased an average
of 5-, 9- and 51-fold respectively.
In a second configuration the transposase–lacZ translation fusion was present in
single copy on the chromosome and the IS10 segment contained two mutations, HH104
and G8. The HH104 mutation increases the level of transposase transcript (RNA-IN)
relative to WT IS10 (Simons et al., 1983) and the G8 mutation increases the level of
RNA-OUT transcript relative to WT IS10 (Simons and Kleckner, 1983; Case et al.,
1989). Together these mutations allow detection of transposase expression from a singlecopy IS10 derivative and ensure that the system is sensitive to anti-sense RNA regulation
by RNA-OUT (Case et al., 1989). The results were very similar to those observed in the
multi-copy system, as hfq-, mci- and hfq- mci- conferred moderate, strong and very strong
increases in β-galactosidase activity respectively (Figure 2.6C).
The results in this section are consistent with Hfq inhibiting transposase
expression at the post-transcriptional level. In addition, as we observed synergy between
hfq- and mci- mutations in both transposase expression and transposition assays, the data
are entirely consistent with the higher transposition frequencies observed in hfq- strains
being due to increased transposase expression. At this point the data (Figures 2.4 - 2.6)
are also consistent with hfq status influencing transposase translation, but as we have not
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Figure 2.5. β-galactosidase activity for hfq+/- strains containing IS10-lacZ
transcriptional fusions.
(A) Schematic of an IS10-LacZ transcriptional fusion used in this work (present in
pNK774). The first 181 basepairs of IS10 (includes pIN, the first 101 nucleotides of
RNA-IN, pOUT and RNA-OUT) plus the last 265 basepairs of IS10 are fused to a
promoterless lacZ gene with intact lacZ translational sequences (including the ribosome
binding site and start codon – approximate position indicated by red asterisks). A second
transcriptional fusion (present in pNK772) has the first 118 basepairs of IS10 plus the last
265 basepairs of IS10 fused to a promoterless lacZ gene as above. This transcriptional
fusion encodes pIN, the first 38 nucleotides of RNA-IN but does not encode RNA-OUT.
(B) β-galactosidase activity (given in Miller units) for strains containing the
transcriptional fusions described in (A). A plasmid (pNK678) encoding the promoter-less
lacZ gene was used to assess background β-galactosidase activity. The bar graph presents
the results of average values from two independent experiments wherein 4 independent
transformants were tested for each of the indicated strains. The error bars represent the
standard deviation on the mean for each of these sets.
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Figure 2.6. β-Galactosidase activity for hfq+/- strains containing an IS10–lacZ
translational fusion.
(A) Schematic of the IS10–lacZ translational fusion used in this work. The first 291 base
pairs of IS10 (includes pIN, the 5′UTR of RNA-IN, the first 61 codons of transposase,
pOUT and RNA-OUT) was fused to the tenth codon of the lacZ gene. (B) βGalactosidase activity (given in Miller units) for strains containing the IS10–lacZ fusion
on a multi-copy plasmid. Mci- status was conferred by using a version of the IS10–lacZ
fusion containing the R5 mutation; this mutation destabilizes RNA-OUT. (C) βGalactosidase activity for strains containing a single copy of the IS10–lacZ fusion in the
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chromosome. To facilitate detection of β-galactosidase activity above background a
promoter-up mutation was present in pIN (HH104). To maintain antisense control a
promoter-up mutation (G8) was also present in pOUT. Mci- status was conferred by
transforming in a plasmid (pNK2197) that produces high levels of a truncated RNA-IN.
In both (B) and (C) five independent isolates were tested for each of the indicated strains
and the error bars represent the standard deviation on the mean for each of these sets.
Two additional experiments analogous to those shown in each of (B) and (C) were
performed and the general trends presented here were maintained.
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yet directly measured RNA-IN half-life in hfq+/- strains, we cannot rule out the possibility
that Hfq influences RNA-IN stability as well (see Discussion).

2.2.4

Hfq binds both RNA-IN and RNA-OUT and accelerates the
rate of pairing of these species

To this point we have not looked directly at the ability of Hfq to function in the mci
pathway. Attempts to do so genetically are complicated by the finding that Hfq can
inhibit Tn10/IS10 transposition independent of mci (Table 2.4 and Figure 2.3).
Accordingly, we looked at the potential of Hfq to function as a co-factor in the mci
pathway by asking if Hfq affects the pairing of RNA-IN and RNA-OUT in vitro.
Taking advantage of the fact that the RNA-IN:RNA-OUT binary complex has a
reduced mobility on a polyacrylamide gel versus the individual RNA species, we used a
gel shift assay to measure the rate and efficiency of RNA-IN:RNA-OUT pairing. 32Plabeled RNA-OUT was mixed with an excess of unlabeled RNA-IN in the presence and
absence of Hfq for varying amounts of time. Reactions were terminated by treatment with
a phenol/water mixture. Phenol extraction was included to disrupt any Hfq–RNA
complexes formed. This simplified the analysis by ensuring that the paired species in the
different treatment groups had a uniform mobility. Dilution in water was included to
reduce the monovalent cation concentration below the amount optimal for RNAIN:RNA-OUT pairing (Kittle et al., 1989).
We show in Figure 2.7 that Hfq addition had a significant positive effect on the
rate of RNA-IN:RNA-OUT pairing in vitro. In the presence of Hfq, RNA-IN:RNA-OUT
pairing reached half maximal levels (t1/2) at a rate approximately eight times faster than in
the absence of Hfq. Thus, this experiment shows that Hfq is capable of accelerating the
rate of RNA-IN:RNA-OUT pairing and therefore has the potential to act as an accessory
factor in the mci pathway. Notably, at very low concentrations of RNA-IN – that is,
under suboptimal pairing conditions – binary complex formation became almost fully
dependent on Hfq (Figure 2.8). This could be particularly relevant because RNA-IN is
typically expressed at very low levels in vivo (Raleigh and Kleckner, 1986).
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Figure 2.7. Effect of Hfq addition on the rate of RNA-OUT:RNA-IN pairing in vitro.
In vitro transcribed RNA-OUT (3.5 nM) and RNA-IN (54 nM) were mixed where
indicated with purified Hfq (1430 nM); RNA-OUT was 32P-labeled. At the indicated time
points pairing reactions were stopped by treatment with phenol and water. Reactions
were analyzed on a polyacrylamide gel, which was then subject to phosphorimaging
analysis to detect reactants and products. The amount of RNA-OUT:RNA-IN complex
versus the amount of total RNA-OUT was determined for each time point and plotted as
a function of time. The time-course was performed three times; error bars indicate
standard deviation on the mean for each time point. From the above plots we calculated
the half-time (i.e. the time after mixing at which half the maximal RNA-OUT:RNA-IN
complex has formed) for each reaction (see Experimental procedures).
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Figure 2.8. Hfq is required for RNA-IN:RNA-OUT pairing under suboptimal
pairing conditions in vitro.
In vitro transcribed 32P-RNA-OUT (7 nM) and RNA-IN (7 nM) were mixed where
indicated with purified Hfq (1430 nM), except that RNA-IN was diluted such that the
RNA species were present at a 1:1 molar ratio as opposed to a 15:1 ratio (RNA-IN in
excess) as in Figure 2.7. (A) At the indicated time points, pairing reactions were stopped
by treatment with phenol/water and analyzed on a polyacrylamide gel. Upper panel: free
32

P-RNA-OUT (OUT*) and RNA-IN:RNA-OUT binary complex (IN:OUT*) are shown.

Lower panel: over-exposure of the region of the gel containing binary complex. (B) The
gel was subject to phosphorimaging analysis to detect reactants and products. The
amount of RNA-OUT:RNA-IN complex versus the amount of total RNA-OUT was
determined for each time point and plotted as a function of time. In the absence of Hfq,
binary complex was not quantifiable above background. In the presence of Hfq, binary
complex increases from ~ 0.19% of total RNA-OUT at 15 seconds to ~ 0.88% at 8
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minutes after mixing all components. Since the amount of binary complex formed after 8
minutes (-Hfq) is lower than the amount of binary complex formed after 15 seconds
(+Hfq), we conclude that after 8 minutes at least 4.6-fold more binary complex was
formed in the presence versus the absence of Hfq.
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For purposes of comparison the above rate enhancement in RNA pairing is
roughly 3.5-fold less than what has been observed for the pairing of RpoS and DsrA
RNA in the presence of Hfq (Soper andWoodson, 2008). It is also notable that in both
systems Hfq is required in a fairly substantial molar excess relative to at least one of the
RNA species in the pairing reaction to promote pairing; 50-fold in the RpoS:DsrA system
and 400-fold in the Tn10/IS10 system. This presumably reflects the relatively weak
binding of Hfq to one of the RNA species in the respective pairing reactions; for example
the Kd for Hfq binding to RpoS RNA is approximately 280 nM (Soper and Woodson,
2008) and we show below the Hfq binds relatively weakly to RNA-OUT. A more trivial
explanation for the requirement of a large excess of Hfq in our pairing reaction would be
that a significant portion of the Hfq in our preparation is inactive. Note that the RNAOUT used here matches the size and sequence of RNA-OUT formed in vivo (Lee and
Schmidt, 1985). Our choice of using an RNA-IN composed of residues 1–75 of native
RNA-IN was somewhat arbitrary with the exception that the first 36 residues are known
to participate in pairing with RNA-OUT and residues 21–28 constitute a putative Hfq
binding site (Lorenz et al., 2010).
A specific expectation of Hfq producing a rate enhancement in the RNAIN:RNA-OUT pairing reaction is that Hfq will bind one or both of the RNA species
involved. We performed mobility shift assays with 32P-labeled RNA-OUT and RNA-IN
preparations and purified Hfq to test this. In the binding experiments approximately
equivalent amounts of RNA-IN and RNA-OUT were used. We show in Figure 2.9A that
RNA-IN and RNA-OUT both bind Hfq as in both reactions distinct bands with reduced
mobility were observed upon addition of Hfq (lanes 5–6 and lanes 8–12). We presume
the supershifted bands designated Hfq:OUT cpx 2 (lane 6) and Hfq:IN cpx 2 (lane 12)
contain molecules of the respective RNA species with more hexamers of Hfq protein than
are present in the corresponding cpx 1 species. From these titrations it is also apparent
that RNA-IN binds Hfq with a higher affinity than does RNA-OUT as about 98% of
RNA-IN exhibited a reduced mobility at 89 nM Hfq (14.8 nM Hfq6) whereas
approximately 50% of RNA-OUT had a reduced mobility at an eightfold higher Hfq
concentration.
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Figure 2.9. Hfq binds both RNA-IN and RNA-OUT and forms a ternary complex.
(A) 32P-labeled RNA-IN (75 nt) or RNA-OUT (69 nt) was mixed with varying amounts
of purified Hfq protein and reactions were subject to EMSA as described in Experimental
procedures. RNA-IN and RNA-OUT were present at approximately 10 nM in each
binding reaction. (B) 32P-labeled RNA-OUT (2 nM) was incubated with Hfq (lanes 6–10)
or Hfq storage buffer (lanes 1–5) for 10 min as in (A). Subsequently, varying
concentrations of unlabeled RNA-IN were added (where indicated) and incubation was
continued for an additional 10 min. Reactions were then subjected to EMSA. Positions of
RNA-OUT (OUT*); RNA-OUT:RNA-IN binary complex (IN:OUT*); Hfq:RNA-OUT
binary complex (Hfq:OUT*); Hfq:RNA-IN binary complex (Hfq:IN*) and Hfq:RNAIN:RNA-OUT ternary complex (Hfq:IN:OUT*) are indicated in (A) and (B). The asterisk
(*) denotes 32P-label.
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We also used a mobility shift assay to show that a ternary complex (Hfq:RNAIN:RNA-OUT) is formed in reactions containing Hfq, RNA-IN and RNA-OUT. We preincubated Hfq and 32P-labeled RNA-OUT and then added varying amounts of RNA-IN
(lanes 6–10). In a control set of reactions only 32P-labeled RNA-OUT and unlabeled
RNA-IN were mixed (lanes 1–5). Addition of unlabeled RNA-IN to a reaction containing
preformed RNA-OUT:Hfq binary complex resulted in the formation of a super-shifted
species (relative to RNA-OUT:RNA-IN and RNA-OUT:Hfq binary complexes), the level
of which increased as a function of increasing RNA-IN concentration (Figure 2.9B).
Based on this and the requirement for all three species (Hfq, RNA-IN and RNA-OUT) to
be added to generate the super-shifted complex, we infer that this species is an Hfq:RNAIN:RNA-OUT ternary complex.

2.3 Discussion
We have shown that disruption of the hfq gene in E. coli markedly increased the
frequency of IS10 and Tn10 transposition. This is consistent with Hfq being a potent
negative regulator of Tn10/IS10 transposition. Notably, Hfq has not previously been
implicated as a regulator of transposition reactions, so this is a new role for this global
regulator of gene expression that also is central to several stress response pathways
(Waters and Storz, 2009). Evidence is presented that is consistent with Hfq downregulating Tn10/IS10 transposition by acting both as an accessory factor in the mci
pathway (inhibits initiation of RNA-IN translation) and as a negative regulator of another
step in Tn10/IS10 transposition. To date the only other host factor shown to negatively
regulate IS10 transposition to an extent comparable to what we report here for Hfq is
DNA adenine methylase. In this case inhibition of transposition results from the
combined effect of DNA adenine methylase down-regulating transposase transcription as
well as transposase binding to the inside end of IS10 (Roberts et al., 1985).

2.3.1

Hfq down-regulates IS10 transposase expression

We observed an increase in β-galactosidase activity in hfq- versus hfq+ in transposase–
lacZ translational fusions, demonstrating that Hfq down-regulates transposase expression.
Importantly, when we looked at steady-state levels of RNA-IN in hfq- versus hfq+ we saw
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no significant difference in the two strains. This is consistent with our finding that hfq
status did not influence RNA-IN expression in a transcriptional fusion. Taken together
these results are most consistent with Hfq primarily regulating RNA-IN translation.
However, as we have not directly measured RNA-IN stability in hfq+/- strains we cannot
rule out an effect of Hfq on RNA-IN turnover.
The observation that Hfq accelerates the rate of RNA-IN:RNA-OUT pairing in
vitro is consistent with Hfq acting as an accessory factor in the mci pathway to limit the
initiation of RNA-IN translation. However, it is difficult to know if this rate enhancement
is meaningful in a biological context; we presume it would be if the rate of RNAIN:RNA-OUT pairing is a limiting factor for a robust mci response. This appears to be
the case as it has previously been shown that mutations in either RNA-IN or RNA-OUT
that reduce the rate of pairing in vitro also reduce, in a roughly proportional manner, the
effectiveness of the mci system (Kittle et al., 1989). We have also shown that disruption
of the hfq gene resulted in a moderate increase in Tn10/IS10 transposition under
conditions where mci does not function (Figure 2.3 and Table 2.4). This means that Hfq
does not function exclusively through the mci pathway to inhibit transposition. In
agreement with this we observed synergy between mci- and hfq- mutations. Synergy
between these mutations is not expected in a situation where both mutations act
exclusively at the same step in transposition. Importantly, this synergy was manifested
both in transposition and transposase expression assays leading us to speculate that Hfq
acts at (at least) two different steps in RNA-IN expression to limit transposase synthesis.
An alternative explanation for the observed synergy might be that neither the mci- nor the
hfq- mutations fully disrupt the mci pathway, but together the mutations fully block mci.
To this point we have not carried out any molecular characterization of the mci-independent pathway for up-regulation of Tn10/IS10 transposition in hfq-. The effect may
be indirect, resulting from altered regulation of a gene product that is itself a regulator of
Tn10/IS10 transposition. In this regard, Hfq has been shown to regulate the expression of
hundreds of genes in Salmonella (Ansong et al., 2009). Alternatively, the absence of Hfq
might increase the stability of RNA-IN as Hfq is known to influence mRNA stability
(Aiba, 2007). With regard to the latter possibility, a straightforward scenario that could
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explain the large difference in the magnitude of the increase in Tn10/IS10 transposition
in single- versus multi-copy in hfq- would be the following: In multi-copy the absence of
Hfq would both increase the stability of RNA-IN and the efficiency with which RNA-IN
is translated (the latter because of the weakening of the mci response). In single-copy
there would only be the positive effect of stabilizing RNA-IN.

2.3.2

Hfq interactions with RNA-IN and RNA-OUT

We have shown that Hfq binds both RNA-IN and RNA-OUT and forms a ternary
complex when a preformed RNA-OUT:Hfq binary complex is incubated with RNA-IN.
However, we do not know how Hfq promotes RNA-IN:RNA-OUT pairing. In the case of
DsrA-directed regulation of rpoS translation, two A-rich sequences present in the rpoS
leader sequence raise the affinity of Hfq for this RNA (Soper and Woodson, 2008).
Similarly a U-rich sequence in DsrA is an important Hfq binding determinant for this
RNA (Brescia et al., 2003). As Hfq is thought to have distinct binding sites for A- and Urich RNA sequences (Mikulecky et al., 2004; Sun and Wartell, 2006), it is likely that Hfq
facilitates rpoS:DsrA complex formation at least in part by bringing binding partners into
close proximity. Consistent with this, it has been shown that rpoS:DsrA:Hfq complex
formation is greatly reduced by mutations in one A-rich sequence (5′-AACAA-3′) in rpoS
RNA (Soper and Woodson, 2008). More recently it has been shown through genomic
SELEX using Hfq as bait that the above Hfq binding site in rpoS RNA makes up a
portion of an RNA motif (5′-AAYAAYAA-3′) that can confer low nanomolar binding
affinity to Hfq (Lorenz et al., 2010).
At present it is difficult to use a genetic approach to determine if Hfq functions in
mci because we have already shown that disrupting the hfq gene causes an increase in
Tn10/IS10 transposition through a mechanism that does not involve the mci pathway.
However, if we could define specific Hfq binding sites in RNA-IN and/or RNA-OUT that
are important for RNA-IN:RNA-OUT pairing in vitro, mutagenesis of such sites could
allow us to disrupt Hfq function in mci without altering its function in other steps in
transposition. Interestingly, residues 21–28 of RNA-IN (5′-CACAACAA) constitute
close to a perfect match to the consensus binding-site for Hfq (only the 5′-C does not
match the consensus sequence).
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2.3.3

Hfq could link Tn10/IS10 transposition to cellular stress
response pathways

Hfq is a mediator of several different cellular stress response pathways, including
oxidative (Zhang et al., 1998), phosphosugar (Vanderpool and Gottesman, 2004), iron
(Masse and Gottesman, 2002), osmotic (Vytvytska et al., 1998) and likely cold stress
(Hankins et al. 2010). Hfq also regulates the expression of the stress response
transcription factor σs (Sledjeski et al., 2001). In each of the aforementioned pathways
the stress induces transcription of at least one Hfq-dependent sRNA. Subsequently, Hfq
interacts with the sRNA to mediate the stress response by promoting the interaction of the
sRNA with an mRNA that shares partial complementarity with the sRNA (see Figure
2.10) (Majdalani et al., 2005; Waters and Storz, 2009). In the case of SgrS, for example,
phosphosugar stress causes up-regulation of this sRNA by at least 10-fold (Vanderpool
and Gottesman, 2007). As Hfq acts stoichiometrically (not catalytically) with sRNAs to
promote pairing reactions, the possibility exists that stress induction would significantly
impact on the number of Hfq molecules in the cell available to interact with other
substrates. Given the negative regulatory role we have documented here for Hfq in
Tn10/IS10 transposition, a reduction in the available Hfq concentration could activate
Tn10/IS10 transposition, thereby linking transposition to a stress response pathway
(Figure 2.10). One caveat here is that Hfq is a highly expressed protein. It is estimated
that there are approximately 10,000 Hfq hexamers per cell (Ali Azam et al., 1999).
However, there are many Hfq binding partners in E. coli including the nucleoid and
ribosomes, thus it is difficult to predict if the fractional saturation of a given target would
be low under a specific stress condition. However, this idea is easily testable as one could
look for changes in the frequency of Tn10/IS10 transposition under conditions where a
given sRNA is artificially overexpressed.
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Figure 2.10. Model for linking Tn10/IS10 transposition to Hfq-mediated stress
response pathways.
(Left) Growth of E. coli at suboptimal temperatures induces transcription of DsrA RNA
(sRNA) (Repoila and Gottesman, 2001; Sledjeski et al., 2001); indicated by upwardpointing arrow. Note that blue is used to indicate a stress or response to a stress condition
whereas red is used to indicate a non-stress or response to a non-stress condition. DsrA
RNA basepairs with rpoS mRNA to promote translation in an Hfq-dependent manner
(Hfq is shown binding to both DsrA and rpoS RNAs) (Soper and Woodson, 2008).
Additionally, DsrA enhances turnover of hns mRNA leading to reduced levels of H-NS
protein (downward-pointing arrow) (Lease and Belfort, 2000). (Right) Other cellular
stresses (see text) also induce expression of Hfq-dependent sRNAs; these inhibit
translation and/or promote turnover of their respective target mRNAs leading to a stress
response. (Middle) Hfq is shown binding RNA-IN (mRNA) and RNA-OUT (antisense
RNA). This leads to reduced expression of Tn10/IS10 transposase protein by mechanisms
that have not yet been fully defined (this work). Red and blue lines linking the left and
right panels to the middle panel relate stress/non-stress conditions, cellular levels of
unbound Hfq protein and the potential of Hfq to function in the Tn10/IS10 system. It is
hypothesized that under non-stress conditions there would be ample unbound Hfq to bind
RNA-IN and RNA-OUT and inhibit transposase expression and thus transposition. In
contrast, under cellular stress conditions Hfq would be titrated by overexpression of one
or more sRNAs resulting in insufficient levels of unbound Hfq to inhibit transposase
expression. Accordingly, transposase expression and Tn10/IS10 transposition would
increase in response to the cellular stress.
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2.3.4

Summary

We have shown that the Hfq protein is a potent negative regulator of Tn10/IS10
transposition and provided evidence that Hfq inhibits transposition both by participating
in the mci pathway, which limits ribosome loading onto RNA-IN, and by inhibiting
another as yet undefined step in transposition. While mci is a phenomenon peculiar to
Tn10/IS10 (and presumably its close relatives), the observation that Hfq negatively
regulates a step in Tn10/IS10 transposition that is distinct from the function of mci raises
the likelihood that Hfq could act as a negative regulator of many different bacterial
transposition systems. Regulation of Tn10/IS10 and possibly other transposition reactions
by Hfq could also provide a means of linking transposition reactions with cellular stress
response pathways if the cellular pool of Hfq available to bind ligands is significantly
reduced during elicitation of an Hfq-mediated stress response.

2.4 Experimental procedures
2.4.1

Strains, bacteriophage and plasmids

All E. coli strains, plasmids and bacteriophage used in this study are listed in Table 2.6.
All gene disruption strains were constructed by generalized transduction using phage P1
as described in Swingle et al. (2004). Integration of transduced DNA into recA- strains
was made possible by supplying RecA in trans from a temperature-sensitive replicon,
pET001 (gift of K. Derbyshire). After selection of transductants using appropriate
antibiotics, growth at 37°C in the absence of selection for pET001 permitted isolation of
recA- transductants. pDH602 and pDH607 are pACYC184 derivatives encoding IS10Kan WT transposase and Nco deletion transposase respectively. They were constructed
by cloning an SpeI–EcoRV fragment from pNK1219 and pNK2727 (Bender et al., 1991)
into EcoRV/XbaI cut pACYC184 (CmR; KanR). Single-copy IS10-Kan strains were
constructed by crossing IS10-Kan WT transposase (pNK1219) and IS10-Kan Nco
deletion transposase (pNK2727) onto λNK1039 as previously described (Haniford et al.,
1989). KanR phages were isolated and used to lysogenize NK5830 to generate DBH99
and DBH100, and DBH16 to generate DBH93 and DBH94. For the latter, DBH16 (hfq-)
was first transformed with pDH633, a derivative of pET001 encoding the hfq gene. This
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Table 2.6. Strains of E. coli and plasmids used in this study.
Strain or Plasmid

Relevant genotype

Source or reference

E.coli
HB101
NK5830
GS081
DBH17
DBH16
DBH23
DBH93
DBH94
DBH99
DBH100
NK8044
DBH15
DBH90
DBH92
DH5α
BL21Δhns

F- leu- ; StrR (mating out recipient)
recA- arg- / F’ pro+ (mating out donor)
MC4100 hfq-1::Ωcat; CmR
C600 dsrA::Ωcat; CmR
NK5830 hfq-1::Ωcat; CmR (mating out donor)
NK5830 dsrA::Ωcat; CmR (mating out donor)
DBH16 / λIS10-Kan (WT t’ase); KanR (mating out donor)
DBH16 / λIS10-Kan (Nco∇ t’ase); KanR (mating out donor)
NK5830 / λIS10-Kan (WT t’ase); KanR (mating out donor)
NK5830 / λIS10-Kan (Nco∇ t’ase); KanR (mating out donor)
recA- lac - / λNK1276 ; KanR (papillation assay)
NK8044 hfq-1::Ωcat; CmR (papillation assay)
Chromosomal IS10-lacZ translational fusion; KanR
DBH90 hfq-1::Ωcat; KanRCmR
recA- (plasmid propagation)
recA- hns- / DE3 T7 RNA polymerase; KanR (Hfq over-expression)

Bolivar (1979)
Foster (1981)
Zhang (2002)
Sledjeski (1996)
This study
This study
This study
This study
This study
This study
Haniford (1989)
This study
Case (1989)
This study
Invitrogen
Zhang (1996)

pBR322-derived; HisG1::IS10-Kan (WT t’ase); ApRKanR
pNK1219 (Nco∇ t’ase); ApRKanR
pACYC184-derived; IS10-Kan (WT t’ase); TetSCmRKanR
pDH602 (R5-mutated t’ase); TetSCmRKanR
pSC101-derived; low copy-number ori; ApR
pWKS30-hfq; ApR
pACYC184 derived; IS10 (bp 1-350); ‘RNA-OUT titrator’; CmSTetR
pNK2974-derived; IS10-lacZ translational fusion (WT); ApSKanR
pNK2227-derived; IS10-lacZ translational fusion (R5); ApSKanR
pACYC184-derived; pTac-t’ase; TetR
pRR10-ts97-derived; encodes recA; temperature-sensitive ori
(permissive temp=30°C); ApR
pRR10-ts97 derived; encodes hfq; temperature-sensitive ori (permissive
temp=30°C); ApR
pET3a derived; Hfq over-expression (IPTG-induced); ApR
IS10-lacZ transcriptional fusion (WT pIN; WT pOUT); ApR
IS10-lacZ transcriptional fusion (pIN only); ApR
Promoterless lacZ (no pIN or pOUT); ‘Background control’; ApR

Bender (1991)
Bender (1991)
This study
This study
Wang (1991)
This study
Jain (1995)
Jain (1995)
Jain (1995)
Huisman (1987)
Coros (2005)

Plasmids
pNK1219
pNK2727
pDH602
pDH609
pWKS30
pDH614
pNK2197
pDH611
pDH606
pNK629
pET001
pDH633
pDH631
pNK774
pNK772
pNK678

This study
This study
Simons (1983)
Simons (1983)
Simons (1983)
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was necessary because λ cannot form lysogens on an hfq- host. Subsequently, pDH633
was segregated out of DBH93 and DBH94 by passage at 37°C. pDH633 was generated in
the following way. pET001 was cut with Acc561 and BamHI to drop out the recA gene.
After re-circularizing the plasmid by blunt end ligation of filled-in ends, the resulting
plasmid (pDH399) was digested with HindIII and XbaI and ligated to HindIII/SpeIdigested PCR product containing the hfq gene that was generated with primers JR11 and
JR12. pDH614 is a low-copy-number plasmid containing the hfq gene and was
constructed by cloning the filled-in HindIII/SpeI-cut PCR product generated with primers
JR11 and JR12 into SmaI cut pWKS30 (Wang and Kushner, 1991). pDH631 encodes the
hfq gene fused to the T7 promoter in pET3a and was constructed by cloning the
BamHI/NdeI digested PCR product formed with primers JR9 and JR10 into NdeI/BamHI
cut pET3a. pDH606 and pDH611 are pNK2227 and pNK2974 (Jain, 1995), respectively,
with the KanR gene from IS903 cloned on a filled-in HindIII fragment into the ScaI site
of the ampicillin resistance gene of a pUC119 derivative (KanR;ApS).

2.4.2

Mating out assay

Mating out assays used NK5830 and derivatives as donors and HB101 as recipient.
Plasmids encoding IS10-Kan were transformed into donor strains and transformants were
selected on M9-Glucose plates supplemented with arginine, thiamine and kanamycin.
Donors were grown overnight to saturation in LB Kan and subcultured the following day
in LB without antibiotic. Subculturing involved an initial 2 h of growth for hfq+ and 4 h
of growth for hfq- at ‘fast roll’, followed by an additional 2 h of growth for hfq+ and 4 h
of growth for hfq- at ‘slow roll’. The extra time allotted for growth of Hfq cells ensured
that donor strains were at roughly the same cell density prior to mixing with the recipient.
Recipient cells grown in LB to an OD600 of 0.4–0.6 were then mixed with donors and
cultures were grown at ‘slow roll’ for 1 h. Cultures were then vortexed vigorously, 1 ml
of mating mix was removed and cells were pelleted and then resuspended in 1 ml of
0.85% saline. Cells were then plated on M9-Glucose plates supplemented with leucine
and streptomycin for determining the number of exconjugants and leucine, streptomycin
and kanamycin for measuring transposition events. The transposition frequency was
obtained by dividing the number of KanR SmR colonies (hops) by the number of SmR
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colonies (total exconjugants). We routinely monitored the copy number of IS10-Kancontaining plasmids to determine if the hfq status of the donor strain influenced plasmid
copy number. We did this by removing 1 ml of donor culture prior to addition of
recipient and mixing these cells with 1 ml of DH5α cells containing pBR322.
Subsequently, we performed plasmid mini-preps and analyzed the samples on a 1%
agarose gel (Figure 2.2). DH5α/pBR322 was included to provide a control for plasmid
DNA recovery. For measuring transposition frequency with IS10-Kan lysogens we first
diluted donors (from independent colonies obtained from glycerol stocks) to
approximately one cell per culture and then propagated this culture to saturation before
subculturing (as above) on the day of the mating. This was done to avoid starting with
mixtures of donor cells that included cells that had already had a transposition event into
the F plasmid during strain preparation.

2.4.3

Papillation assay

Escherichia coli NK8044 and DBH15 (NK8044 transduced to hfq-), which contain miniTn10LK, were transformed with either pNK629 (pTac-transposase) or pACYC184 (no
transposase control). Both NK8044 and pNK629 are described in (Haniford et al., 1989).
Transformants were selected on MacConkey lactose plates supplemented with
tetracycline (15 µg ml-1). After three days of growth individual colonies were imaged on
an hp scanjet 3670 scanner and the number of LacZ+ papillae was counted by visual
inspection of images.

2.4.4

Semi-quantitative RT-PCR

Steady-state transposase mRNA levels were determined by extracting RNA from hfq+
and hfq- donor strains harboring pNK1219 (Table 2.1) and performing RT-PCR. RNA
was isolated using the RNeasy minikit (Qiagen) and treated with RQ1 RNase-free DNase
(Promega) as per the manufacturer’s instructions. RNA was quantified spectroscopically
and RNA purity and quality were assessed by determining the OD260/280 ratio and by
visualizing small and large ribosomal RNA subunits on a 1% agarose gel respectively.
RT-PCR was carried out as described in Gibb and Edgell (2007) using M-MuLV reverse
transcriptase (NEB), Taq DNA polymerase (Promega), 3 µg of cellular RNA and primer
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pairs JR5 and JR6 for RNA-IN and JR7 and JR8 for 16S rRNA. The PCR cycle for RNAIN was: 98°C, 30 s; 65.8°C, 45 s; 72°C, 60 s and 22 cycles were run. The PCR cycle for
16S rRNA was as above except that the annealing temperature was 61.5°C and eight
cycles were run. We checked that we were within the linear range of amplification for
both sets of RT-PCR reactions by repeating the analysis using two- and fourfold dilutions
of the input RNA and found that the band intensities of the PCR products decreased
linearly (Figure 2.11).

2.4.5

β-Galactosidase assay

Isogenic hfq+/- strains of E. coli containing transposase-β-galactosidase transcriptional or
translational fusions were grown as described for the mating out assay. After reaching
mid-log-phase cells were placed on ice for 20 min, pelleted and resuspended in minA
medium. β-Galactosidase activity in cell extracts was determined as described in Jain and
Kleckner (1993). At least four different transformants of each strain was tested and mean
values plus standard deviation on the mean were calculated.

2.4.6

Protein purification

Hfq protein was purified from E. coli BL21(DE3) cells transformed with pDH631.
Briefly, cultures were grown to an OD600 = 0.6 at 37°C. Hfq expression was induced by
addition of 1 mM IPTG. After 2 additional hours of growth at 37°C cells were harvested
by centrifugation and resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 1 mM EDTA,
50 mM NH4Cl, 5% glycerol). Cells were lysed by passage through a French press and
cellular debris was removed by centrifugation. All subsequent steps in the purification
were carried out as described in Brescia et al. (2003). Hfq protein purity was assessed by
SDS-PAGE and found to be > 99% pure. Hfq protein concentration was determined
spectroscopically using a molar extinction coefficient of 3840 M-1 cm-1 (Lease and
Woodson, 2004).

2.4.7

In vitro transcription and RNA labeling

Linear DNA templates for run-off transcription of RNA-IN (nucleotides 1–75) and RNAOUT (nucleotides 1–69) were synthesized by PCR using primers JR1/JR2 and JR3/JR4
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Figure 2.11. Linear dependence of RT-PCR signal intensity on the concentration of
input RNA.
RNA extracted from 3 independent isolates (either hfq+ or hfq-) was subjected to 2- and
4-fold dilutions prior to RT-PCR amplification of RNA-IN or 16S rRNA (rrsB) as in
Figure 2.4, and the resulting amplicons quantified by densitometry on an AlphaImager.
The amount of input RNA (0.75, 1.50 or 3.00 µg) was plotted on the x-axis and the
average area of each amplicon (in AlphaImager units) was plotted on the y-axis. (A) and
(B): average area of the RNA-IN or 16S rRNA amplicons (respectively) from hfq+
isolates; (C) and (D): average area of the RNA-IN or 16S rRNA amplicons (respectively)
from hfq- isolates. Error bars represent the standard deviation on the mean. Lines were
obtained by linear regression (Prism).
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respectively; note that in each primer pair the ‘forward’ primer included a T7 promoter.
The amplicons were gel purified and used as templates for in vitro transcription using T7
RNA polymerase (NEB). For in vitro transcription approximately 1 µg of template DNA
was mixed with 0.5 mM of each rNTP, 50 mM DTT, 0.5 ml of RNasin (Promega), 50
units of T7 RNA polymerase in supplied reaction buffer (NEB) in a total volume of 20
ml. The mixture was incubated at 37°C for 2 h before adding 1 unit of RQ1 RNase free
DNase (Promega) and continuing incubation for 0.5 h. The mixture was then ethanol
precipitated and resuspended in 20 ml of Hfq binding buffer; 50 mM Tris-HCl (pH7.5), 1
mM EDTA, 250 mM NH4Cl, 10% glycerol. In vitro transcribed RNA was 32P-labeled
either by including [α-32P]-CTP in the transcription reaction (RNA-IN) or by treating
phosphatased transcript with T4 polynucleotide kinase and [γ-32P]-ATP (RNA-OUT).
RNAs were subject to denaturing PAGE and purified from gel slices. Eluates containing
RNA were run through a Biospin 6 column (Bio-Rad) and then concentrated by ethanol
precipitation. RNA was resuspended in Hfq binding buffer and the concentration was
determined spectroscopically using a NanoSpectrophotometer (IMPLEN).

2.4.8
32

Gel retardation assay

P-labeled RNA-IN or RNA-OUT was incubated at 95°C for 2 min and then placed on

ice before being mixed with Hfq protein in Hfq binding buffer. The final concentration of
RNA-IN or RNA-OUT per binding reaction was 10 nM. Hfq concentrations ranged from
0.089 mM to 1.43 mM and the total volume per binding reaction was 10 ml. Binding
reactions were incubated at 25°C for 10 min before being mixed with load dye (20 mM
Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% glycerol; 0.05% w/v bromophenol
blue) and loaded onto a 6% native polyacrylamide gel. Electrophoresis took place in 1x
TAE buffer and was carried out at 200 V for 1 h. Following electrophoresis the gel was
dried and analyzed using a Phosphorimager. For detection of the ternary complex, Hfq
protein and 32P-labeled RNA-OUT were first incubated together for 10 min and then
varying concentrations of RNA-IN were added. Reactions were subjected to PAGE and
analyzed as described above.
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2.4.9

Kinetic analysis of RNA-IN:RNA-OUT pairing

Ternary or binary complexes were formed as described above with 32P-labeled RNAOUT in a total reaction volume of 80 ml. At the indicated time intervals 10 µl aliquots
were removed from the reaction and added to tubes containing 50 µl of phenol and 40 µl
of water. After vortexing and centrifugation, 16 µl of aqueous phase was removed, mixed
with 4 µl of load dye mix and subject to electrophoresis on a 6% PAGE as previously
described. Observed rate constants for RNA-IN:RNA-OUT pairing were calculated by
plotting the number of counts in the RNA-IN:RNA-OUT band on the y-axis and time on
the x-axis. The resulting curves were fit by non-linear regression to the equation:
RNA-IN:RNA-OUTt = RNA-IN:RNA-OUTmax (1 – e-

kobs

),

where RNA-IN:RNA-OUTt is the amount of binary complex at time t. t1/2 values were
calculated using the equation:
t1/2 = ln2 / kobs
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Chapter 3 2

3

Hfq restructures RNA-IN and RNA-OUT and facilitates
antisense pairing in the Tn10/IS10 system

3.1 Introduction
Small RNAs (sRNAs) have emerged as important components of gene expression
regulatory networks in bacteria. sRNAs generally function by base-pairing to mRNAs
with which they share at least partial sequence complementarity. Base-pairing between
sRNAs and mRNAs typically influences translation and/or stability of the mRNA (for
reviews, see Gottesman and Storz 2011; Vogel and Luisi 2011). sRNAs are categorized
as either trans- or cis-encoded. Trans-encoded sRNAs are expressed from distinct loci
relative to the transcripts they regulate, whereas cis-encoded sRNAs are expressed from
the strand opposite their target mRNA and, consequently, are perfectly complementary to
at least a portion of their target RNA (Figure 3.1A). Cis-encoded sRNAs are also referred
to as antisense RNAs (or asRNA). The regulation imposed by many trans-encoded
sRNAs is dependent on the protein Hfq, an Sm-family protein that is present in many
bacterial species. With regard to sRNA-based regulation, Hfq functions by promoting the
pairing of sRNAs to their target mRNAs (Moller et al. 2002; Zhang et al. 2002; Vogel
and Luisi 2011). The expression of many trans-encoded sRNAs is up-regulated by
environmental stress, and typically this imposes a biological response to stress through
Hfq-mediated pairing of sRNAs and their target mRNAs (Altuvia et al. 1997; Vogel and
Papenfort 2006).
asRNAs were originally found on extra-chromosomal DNAs, such as plasmids
and transposons. Chromosomally encoded asRNAs have since been identified, although a
subset of these is imbedded within mobile DNA elements that have recently been

2
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Figure 3.1. Small regulatory RNAs (sRNAs) and the Tn10/IS10 antisense system.

Figure 1

(A) Cis- vs. trans-encoded sRNAs. Transcribed strands of three different genes and their
corresponding RNAs (color coded) are shown. Pairing of a trans-sRNA (gold) and an
mRNA (green) and of a cis-sRNA (pink) and an mRNA (cyan) is shown. Hfq (blue
hexamer) catalyzes pairing in the former case where there is partial sequence
complementarity between partners, but it is unclear if it also catalyzes pairing in the latter
case where there is perfect sequence complementarity between partners. Asterisks (*)
define the translation initiation region (TIR) of the mRNAs. (B) Structure of Tn10 and
IS10-Kan. Tn10 is a 9147-bp composite transposon that confers tetracycline resistance
(TetR). Tn10 is comprised of IS10-Left and IS10-Right, the latter of which encodes a
functional transposase protein that catalyzes DNA cleavage and joining events involving
the “outside” (OE) and “inside” (IE) ends. The transposase mRNA (RNA-IN) is encoded
from the promoter pIN (blue squares). A second promoter (pOUT–black squares) within
IS10-Right encodes a cis-sRNA (also referred to as an antisense RNA), RNA-OUT. To
follow transposition of IS10-Right in E. coli, a KanR gene cassette was cloned into IS10Right, creating IS10-Kan. RNA-OUT is depicted as a stable stem–loop structure (black)
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and RNA-IN is depicted as a blue line with asterisks defining the TIR. RNA-OUT is
known to pair with RNA-IN, and this inhibits translation of RNA-IN, thereby downregulating transposition. Hfq can enhance the rate of RNA-IN:OUT pairing in vitro, but it
is not known if Hfq plays a role in this antisense system in vivo.
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acquired (e.g., pathogenicity islands). The general perception is that, due to the perfect
complementarity between asRNAs and their targets, the regulatory function of asRNAs
will not be dependent on Hfq (Waters and Storz 2009).
Tn10/IS10 (Figure 3.1B) encodes a 69-nt asRNA (RNA-OUT) that regulates
transposase expression by pairing with the transposase mRNA (RNA-IN). This pairing
down-regulates transposase translation by sequestering the 5′ translational initiation
region (TIR) from the ribosome, thereby limiting transposase translation (Simons and
Kleckner 1983; Ma and Simons 1990). We recently demonstrated that the frequency of
Tn10/IS10 transposition from a multi-copy plasmid is greatly increased in an hfq- strain
of Escherichia coli, thereby implicating Hfq as a potent negative regulator of Tn10/IS10
transposition (Ross et al. 2010). The Hfq-effect was much less robust in a system with
reduced RNA-OUT levels, suggesting that Hfq functions, in part, through antisense
regulation. Transposase expression from a translational fusion was also found to increase
in the hfq- background, consistent with a post-transcriptional role for Hfq in transposase
regulation. Furthermore, studies in vitro demonstrated that Hfq bound both RNA-IN and
RNA-OUT and increased the rate at which these molecules pair. Taken together, these
results are consistent with Hfq playing an important role in translational regulation
mediated by an asRNA (Ross et al. 2010).
The finding that Hfq participates in a regulatory system involving an asRNA
raises questions regarding the mechanism through which Hfq acts in this system and
invites comparisons to its mechanism of action in trans-sRNA regulated systems. Hfq
readily forms a hexamer, and the hexameric unit possesses at least two RNA binding
sites. These sites, referred to as the proximal and distal binding sites, are located on
opposing surfaces of the toroidal structure of the hexamer. Structure-based design of
mutations in the proximal and distal binding sites has been important in defining the
RNA binding specificities of these sites. The proximal site mutation K56A blocks Hfq
binding to U-rich trans-sRNAs, thereby implicating the proximal site as the trans-sRNA
binding site. In contrast, the Y25A mutation impairs Hfq binding to A-rich RNAs as well
as mRNAs, thereby implicating the distal site in mRNA binding	
  (Mikulecky et al. 2004;
Brennan and Link 2007; Olejniczak 2011).
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In the current work, we have further evaluated the interactions between E.coli Hfq
and Tn10/IS10-encoded RNA-IN and RNA-OUT and have begun to evaluate the
importance of these interactions with respect to the function of the asRNA system of this
transposon.

3.2 Results
3.2.1

Hfq binds RNA-IN approximately 80-fold more tightly than
RNA-OUT

In previous work, we demonstrated using EMSA that E.coli Hfq binds RNA-IN and
RNA-OUT (Ross et al. 2010). Our initial objective in the current work was to quantify
the binding strength of these interactions to facilitate comparison with previously defined
trans-sRNA/mRNA partners whose pairing is catalyzed by Hfq. Toward this end, we
prepared 32P-labeled RNA-OUT (69 nt + 2 extra nucleotides encoded by the expression
construct) and a truncated form of RNA-IN (the first 160 nt) by in vitro transcription and
individually mixed each of these RNAs (∼ 0.1 nM) with purified Hfq over a broad range
of Hfq concentrations. Binding reactions were then analyzed on a 6% polyacrylamide gel.
We show in Figure 3.2A that two distinct Hfq-bound RNA-OUT complexes were
generated in our “Hfq titration.” Just under 50% of the input RNA was shifted to a
reduced mobility (Hfq:OUT-1) at an Hfq concentration of 14 nM (lane 3). At 38 nM Hfq
(lane 9), a second complex (Hfq:OUT-2) was detected, and at 48 nM, Hfq:OUT-2 and
Hfq:OUT-1 were present at close to a 1:1 ratio. Apparent dissociation constants KD1 and
KD2, for Hfq:OUT-1 and Hfq:OUT-2, respectively, are 19.6 and 44.8 nM, calculated per
Hfq hexamer (Figure 3.2B; Table 3.1).
We show in Figure 3.2C that Hfq also formed multiple complexes (four distinct
species) with RNA-IN-160. Hfq:IN-1 formed at the lowest Hfq concentration in the
titration. The apparent KD for this complex is ~0.24 nM per hexamer (Figure 3.2D; Table
3.1). This represents an 81-fold higher affinity relative to Hfq binding to RNA-OUT. At
higher Hfq concentrations, additional Hfq:IN complexes were formed (Hfq:IN-2; Hfq:IN3 and Hfq:IN-4). It appears as though Hfq:IN-2 was generated from Hfq:IN-1, Hfq:IN-3
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Figure 3.2. Hfq binds with high and moderate affinities to RNA-IN and RNA-OUT
in vitro.
32

P-labeled RNA-OUT (A) or RNA-IN (C) was mixed with varying concentrations

(reported per hexamer) of purified Hfq protein, and reactions were subject to EMSA as
described in Materials and Methods. Band intensities were quantified (ImageQuant), and
the percent of each shifted species (relative to total labeled RNA) was plotted vs. Hfq6
concentration (B, D). RNA-OUT formed two complexes with Hfq, Hfq:OUT*1, and
Hfq:OUT*2. RNA-IN formed four complexes with Hfq, Hfq:IN*1, Hfq:IN*2, Hfq:IN*3,
and Hfq:IN*4. Apparent dissociation constants (KD) are indicated; see Table 3.1 for a
summary of KD values and Hill coefficients determined in this study. RNA-OUT and
RNA-IN were present at a final concentration of ~0.1 nM. Error bars represent standard
error from two experiments. KD is reported ± standard error.
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Table 3.1. In vitro bindinga of RNA-OUT or RNA-IN to WT, distal- or proximalimpaired Hfq mutants.
RNA Species

Hfq variant

KD1 (nM)

KD2 (nM)

h

RNA-OUT

HfqWT
his6-HfqWT
his6-HfqY25A
his6-HfqK56A

19.6 ± 0.94
75.6 ± 6.98
94.3 ± 6.50
--

44.8 ± 2.57
179 ± 18.5
202 ± 2.50
389 ± 14.1

3.45 ± 0.49
2.20 ± 0.36
2.42 ± 0.32
--

RNA-IN

HfqWT
his6-HfqWT
his6-HfqY25A
his6-HfqK56A

0.24 ± 0.01
0.99 ± 0.13
1.69 ± 0.23
3.10 ± 0.40

1.18 ± 0.12
2.29 ± 0.31
11.1 ± 2.92
15.1 ± 1.01

2.44 ± 0.27
2.09 ± 0.55
1.32 ± 0.20
1.00 ± 0.10

a

Binding oberved by EMSA. The percentages of RNA bound by Hfq were
plotted versus Hfq6 concentration (in nM) and the data were fit to a binding
curve to determine apparent KD values and Hill Slopes (h), expressed ±
Standard Error. Binding assays were performed twice.
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was generated from Hfq:IN-2, and Hfq:IN-4 was generated from Hfq:IN-3, as the
appearance of each of these species coincided with the reduction in the amount of the
species with the next highest gel mobility. The apparent KD and Hill coefficient for each
Hfq:RNA complex is summarized in Table 3.1.
Supershifting in the above experiments can most easily be explained by each of
the RNAs having multiple Hfq binding sites with different affinities. Detection of
supershifting over a narrower Hfq concentration range for RNA-OUT vs. RNA-IN
(reflected in the higher Hill coefficient) is consistent with a higher degree of
cooperativity in the former.

3.2.2

RNase and hydroxyl radical footprinting of RNA-IN, RNAOUT, and Hfq:RNA complexes

To further characterize Hfq:RNA-IN and Hfq:RNA-OUT interactions in vitro, we used a
combination of hydroxyl radical and ribonuclease (RNase) footprinting. Hydroxyl radical
and RNase footprinting have both been used to identify Hfq binding sites within target
mRNA and sRNAs (Brescia et al. 2003; Lease and Woodson 2004; Vecerek et al. 2005;
Rolle et al. 2006). RNase footprinting also provides insight into the structure of the RNA
as well as structural changes in the RNA upon protein binding. Structure-probing
techniques have not previously been applied to RNA-IN and RNA-OUT, although a
model for RNA-OUT (Model I) was proposed based on predictions from in silico RNA
folding programs and genetic data (see Figure 3.3B; Case et al. 1989; Kittle et al. 1989).
For RNase structure probing/footprinting, 5′ end-labeled RNA-OUT was treated
with either RNase A, T1, or V1 in the presence or absence of purified Hfq protein. RNase
A and T1 cleave RNA following single-stranded C/U and G, respectively, while RNase
V1 cleaves 3′ of paired nucleotides.
RNase probing of RNA-OUT yielded a predicted structure similar to what has
been previously proposed (Figure 3.3B). However, our data support some modifications
to this model (see Figure 3.3A,B; note that ribonuclease-sensitive residues in Model II
are colored red for A or T1 and blue for V1). U33, which was previously predicted to be
in the unpaired loop, exhibited moderate sensitivity to V1 and relatively low sensitivity to
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Figure 3.3. Structure-probe analysis of RNA-OUT and Hfq:RNA-OUT complex.

Figure
3
(A) 32P-labeled
RNA-OUT (65 nM) was incubated with or without Hfq as indicated
before hydroxyl radical (lanes 4–7) or ribonuclease (A, T1, or V1; lanes 8–19)
treatments. Reactions, including untreated RNA (lanes 2,3) and a G-ladder (lane 1), were
analyzed on a 10% denaturing polyacrylamide gel. Nucleotide labeling is relative to the
RNA-OUT in vitro transcriptional start site, which includes two extra nucleotides
introduced by T7 RNA polymerase at the 5′ end of the RNA. Where Hfq was included, it
was present at 1460, 2190, and 4380 nM. (B) A previous model of RNA-OUT (Model I)

93

is compared to the model derived from the current work (Model II). Colored letters
represent RNase-sensitive positions in RNA-OUT observed in the absence of Hfq. Red
indicates cleavage by either RNase A or T1, while blue indicates cleavage by RNase V1.
Symbols (triangles and asterisks) are defined in the text. [This Figure and the work it
represents was contributed by M. Ellis.]
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A, suggesting that this residue is base-paired, presumably to A39. C42 and C43 were
both strongly sensitive to A, and this is consistent with a 2-nt bulge (bulge 1) in the 3′
side of the stem, immediately adjacent to the loop. Also, in Model II, bulge 2 is larger
than in Model I, consisting of six as opposed to three unpaired residues. This is supported
by sensitivity of U24, A25, U26, and U27 to A and low sensitivity	
  of G48 to T1.
Additionally, for 14 of the 23 bp in the predicted stem, at least 1 nt in the pair showed
sensitivity to V1, and only 2 bp had 1 nt that was sensitive to A. The V1-sensitive
residues appeared in all four segments of the stem that are separated by bulges. In
contrast, no residues in the loop or bulges exhibited V1 sensitivity.
Addition of Hfq to RNA-OUT caused some significant changes in the RNase
cleavage profile (indicated by upward and downward pointing triangles in Figure 3.3A,
B). In this experiment, Hfq was added to RNA-OUT at concentrations sufficient (based
on EMSA data) (Figure 3.4A) to give >90% Hfq:OUT-1 (1460 nM) and >90%
Hfq:OUT-2 (2190 and 4380 nM). Based on similarities of sample loading and total
reactivity relative to the “no Hfq” control, results for the “intermediate” Hfq
concentration (2190 nM—lanes 10, 14, and 18) were the easiest to analyze and are
discussed in detail below.
Hfq binding appears to destabilize the base-paired stem of RNA-OUT. All four of
the stem regions contained residues that increased in sensitivity to single-strand-specific
ribonuclease (upward facing red triangles), and the lower stem also contained residues
that exhibited reduced sensitivity to double-strand-specific ribonuclease (downward
facing blue triangles). Destabilization of the stem by Hfq could be functionally
significant because the 5′ portion of the stem, including residues 6–33, is expected to pair
with RNA-IN in the antisense response.
Interestingly, of the predicted 15 unpaired residues in RNA-OUT, eight exhibited
increased reactivity to single-strand-specific ribonucleases. While it is not obvious how to
interpret this result, perhaps the simplest explanation is that Hfq binding to RNA-OUT
prevents conversion of loops and/or bulges to structures that include base-paired regions.
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Figure 3.4. RNA footprinting EMSAs.
Figure S1. RNA fooprinting EMSAs. Following binding reactions (see Materials and Methods) for
RNA-OUT (A) and RNA-IN (B) footprinting experiments (shown in Figures 3 and 4 respectively), a
Following binding
reactions (see Materials and Methods) for RNA-OUT (A) and RNAsample was run on a 6% polyacrylamide gel to monitor RNA:Hfq complex formation. The final
concentration of RNA-OUT was 65 nM, RNA-IN was 45 nM, and Hfq concentrations are reported
IN (B) footprinting
experiments (shown in Figures 3.3 and 3.5 respectively), a sample
per hexamer.

was run on a 6% polyacrylamide gel to monitor RNA:Hfq complex formation. The final
concentration of RNA-OUT was 65 nM, RNA-IN was 45 nM, and Hfq concentrations are
reported per hexamer. [This Figure and the work it represents was contributed by M.
Ellis.]
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Finally, a stretch of five consecutive residues in bulge 2 (nucleotides 23–27)
exhibited a decrease in sensitivity to all three RNases (green asterisks). This suppression
could result from Hfq binding to this segment. Notably, this is a very U-rich sequence (5′
UUAUUG 3′) that is predicted to be in single-stranded form. E. coli Hfq has been shown
to preferentially bind U-rich single-stranded sequences in sRNAs through its proximal
binding site (Ishikawa et al. 2012), and we provide evidence below that Hfq engages
RNA-OUT exclusively through its proximal binding site (Figure 3.8). Using data from
our RNase probing of RNA-OUT in the presence of Hfq, we determined a single
structure of an RNA-OUT:Hfq complex (Figure 3.6). This predicted structure is largely
single stranded, with the exception of 5 bp forming between nucleotides 29–33 and 59–
63. Of the 35 nt that are predicted to base-pair with RNA-IN, 30 are in single-stranded
regions after Hfq addition.
We also performed hydroxyl radical footprinting on Hfq:RNA-OUT complexes to
further investigate the position(s) of Hfq binding (Figure 3.3A, lanes 4–7) but were
unable to see clear and reproducible patterns of protection. The hydroxyl radical cleavage
pattern was, however, useful in assigning cleavage products produced in the RNase
structure-probe experiments.
We next probed the structure of the first 160 nt of RNA-IN with RNases as
described for RNA-OUT. In the absence of Hfq, there was a significant amount of
reactivity to V1 nuclease (lanes 2 and 11 in Figure 3.5A), which is indicative of this RNA
forming base-paired segments. Two regions in which V1-reactive residues clustered
(residues 17–35 and 45–60) (indicated by a solid blue line in Figure 3.5A) also showed
minimal reactivity to single-strand-specific ribonucleases. Hard constraints from the
nuclease data (circled letters in Figure 3.5B) were input into the Mfold program to
generate a model of RNA-IN-160 structure. Notably, addition of these hard constraints
resulted in the output of a single structure. The model predicts one substantial stem that
includes 11 bp and two bulges. The stem includes residues 25–36 on one strand and
residues 45–60 on the other strand. At least 1 nt in each of the 11 predicted base pairs
showed reactivity to V1. We note that our model for RNA-IN-160 includes some
secondary structure involving the first 20 nt. However, the single base pair between
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Figure3.5.
4 RNase footprinting of RNA-IN.
(A) 32P-labeled RNA-IN-160 (45 nM) was incubated with or without Hfq as indicated
before treatment with ribonuclease A, T1, or V1 (lanes 5–13). Reactions, including RNA
not treated with RNase (lanes 2–4) and a G-ladder (lane 1), were analyzed on a 10%
denaturing polyacrylamide gel. Nucleotide labeling is relative to the RNA-IN in vitro
transcriptional start site, which is nucleotide 1. Blue bars highlight clusters of V1
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sensitivity observed in the absence of Hfq. (B) A model is shown for the secondary
structure of RNA-IN-160. The model was produced using Mfold with hard constraints
(circled positions) obtained from two independent RNase structure-probe experiments
(part A and Appendix A). RNase A/T1 cleavage is indicated with red letters, while V1
cleavage is indicated with blue letters. Symbols (triangles and asterisks) are defined in the
text. [This Figure and the work it represents was contributed by M. Ellis.]
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Figure S3. Structure of RNA-OUT and RNA-IN in the presence of Hfq. 5’ end-labeled RNA-OUT (A) and
RNA-IN
was probed of
withRNA-OUT
RNase A/T1/V1
in the
presence of
Figures 3 of
andHfq.
4). Nucleotides
Figure
3.6.(B)Structure
and
RNA-IN
inHfq
the(see
presence
indicated in red and blue represent mFold constraints for ssRNA and dsRNA, respectively. These structures
formed at 37oC in the presence of 10 mM MgCl2. Putative Hfq-binding sites were entered as single-stranded
constraints.

5’ end-labeled RNA-OUT (A) and RNA-IN (B) was probed with RNase A/T1/V1 in the
presence of Hfq (see Figures 3.3 and 3.5). Nucleotides indicated in red and blue represent
mFold constraints for ssRNA and dsRNA, respectively. These structures formed at 37°C
in the presence of 10 mM MgCl2. Putative Hfq-binding sites were entered as singlestranded constraints. [This Figure was contributed by M. Ellis.]
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position 6 and 149 is unlikely to maintain the most 5′ and 3′ portions of the RNA in a
stable secondary structure. The absence of stable secondary structure within the first 8 nt
of RNA-IN suggests that there is no structural impediment to initiating pairing with
RNA-OUT. Of the first 35 nt of RNA-IN-160 that are complementary to RNA-OUT,
residues 25–35 are sequestered in a stem that may interfere with the antisense response.
Addition of Hfq to RNA-IN-160 had substantial effects on RNA structure. Much
of the V1 sensitivity in the predicted stem was lost (indicated by downward pointing blue
triangles in Figure 3.5A,B). Strikingly, starting at position 104 and continuing to position
149, there was a large increase in V1 sensitivity with the addition of Hfq. As there were
few residues within the 104–149 segment that showed substantial increases in either A or
T1 sensitivity upon Hfq addition, it appears likely that some intra-molecular base-pairing
is occurring in this region. There were also a few regions that showed a decrease in
reactivity to both single- and double-strand-specific ribonucleases. This includes
segments 3–13, 17–25, 38–40, and 71–92 (denoted by green asterisks). These regions
could define Hfq binding sites. Notably, at the highest concentration of Hfq used in this
experiment, we anticipate, based on EMSA data (Figure 3.4), that there could be as many
as three distinct Hfq binding sites in RNA-IN-160. A predicted structure of RNA-IN-160
in the presence of Hfq is presented in Figure 3.6. Consistent with the RNase footprinting
data, the first 98 nt of RNA-IN are mostly single-stranded, with two small hairpins
formed at nucleotides 34–56 and 66–79. An extensive stem–loop structure is predicted to
form from nucleotides 99–160. We note that 33 out of 35 nt of RNA-IN that are expected
to base-pair with RNA-OUT are single-stranded in the presence of Hfq.
Note that RNase data for RNA-IN-160 footprinting comes from two independent
experiments (Figure 3.5A; Appendix A). All reactivities were reproducible except at
positions C72–C75, where we saw Hfq-dependent protection of these residues only in the
experiment shown in Appendix A.
To further probe the location of Hfq binding sites in RNA-IN-160, we performed
hydroxyl radical footprinting on 5′ end-labeled RNA-IN-160 using multiple Hfq
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Figure 3.7. Hydroxyl radical footprinting of RNA-IN.
(A) 32P-labeled RNA-IN-160 (45 nM) was incubated with increasing concentrations of
Hfq (lanes 3–10) and then subject to hydroxyl radical treatment (lanes 2–10). Lane 1
contains RNA not treated with hydroxyl radicals. Samples were analyzed as in Figure
3.5. Nucleotides are numbered as in Figure 3.5. Green asterisks identify positions
protected from hydroxyl radical cleavage in the presence of Hfq, while purple asterisks
identify positions where Hfq induced hypersensitivity to hydroxyl radical cleavage. (B)
Quantification of band intensities from selected lanes of the gel image in part A is shown.
Reactivity is presented in arbitrary units (AU). [This Figure and the work it represents
was contributed by M. Ellis.]
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concentrations (Figure 3.7). Quantitation of portions of the gel image showing the
greatest differences in band intensity for “no Hfq” (lane 2) and selected “plus Hfq”
samples (lanes 3, 6, and 10) is also presented. A region spanning residues 29 to 46
showed protection against hydroxyl radical cleavage at both 149 nM and 347 nM Hfq. At
the higher Hfq concentration, additional zones of protection were observed as indicated
beside the gel image (green asterisks). Due to discontinuities in the patterns of protection
it is difficult to infer the boundaries of individual binding sites and, therefore, the total
number of sites. However, based on the density of protected residues in the 29–46
segment and the fact that there was uniform protection in this cluster at an intermediate
Hfq concentration, we suggest that this cluster defines a single Hfq binding site. The
region spanning residues 84 to 94 includes the second highest density of protected
residues and could represent a second Hfq binding site. This second site would be a lower
affinity site relative to the site within the nucleotide 29–46 segment, as protections in this
site were only observed at the highest Hfq concentrations. Unfortunately, we were not
able to obtain high-quality hydroxyl radical footprinting data for the most 5′ portion of
RNA-IN-160 to further test the possibility raised by RNase footprinting that this segment
also contains an Hfq binding site. We do note that five residues (38, 39, 40, 45, and 46)
within segment 29–46 showed a general suppression of cleavage by RNases (Figure
3.5A), as did residues 80, 82, and 86, which are close to or within segment 84–94,
supporting the possibility that these segments include Hfq binding sites.

3.2.3

RNA-binding sites in Hfq that interact with RNA-IN and RNAOUT

Hfq has at least two distinct RNA-binding surfaces, enabling it to simultaneously bind
multiple RNAs and catalyze trans-sRNA/mRNA pairing reactions. To gain insight into
how Hfq interacts with RNA-IN and RNA-OUT, we performed experiments designed to
define the surfaces in Hfq that interact with these RNAs. It should be recognized that Hfq
binding determinants for an asRNA have not previously been reported. Two
complementary approaches were used. In one approach, we performed binding assays
with RNA-IN-160 or RNA-OUT and Hfq mutants that are defective in either proximal
site (HfqK56A) or distal site (HfqY25A) RNA binding. In the second approach, we
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performed binding assays with HfqWT and RNA-IN-160 or RNA-OUT in the presence of
competitor RNAs that exhibit high affinities for either the proximal (DsrA) or distal (A18)
RNA-binding surfaces of Hfq.
For binding experiments with Y25A and K56A mutant forms of Hfq, it was
necessary to use Hfq bearing a C-terminal his6 epitope tag (hereafter referred to as “his6Hfq”). This is because, unlike HfqWT, the two mutant forms of Hfq are not heat-stable
and therefore cannot be purified in the same way as untagged HfqWT (Mikulecky et al.
2004). However, all three forms of the his6-tagged Hfq can be purified using nickel
affinity chromatography. We show in Figure 3.8A and Table 3.1 that WT and Y25A
forms of his6-Hfq bound RNA-OUT with similar affinities (KD1 ~76 nM and 94 nM,
respectively). In contrast, his6-HfqK56A bound very poorly to RNA-OUT at Hfq
concentrations up to 309 nM. At the high end of the HfqK56A titration (upwards of 464
nM Hfq6), essentially all of RNA-OUT was bound by HfqK56A, forming Hfq:OUT- 2 with
an apparent KD ~389 nM. This represents a fivefold reduction in the affinity of his6HfqK56A vs. his6-HfqWT for RNA-OUT.
The above results are consistent with Hfq binding RNA-OUT through its
proximal site, which is typical of how Hfq binds trans-sRNAs. If this is correct, then it is
expected that an sRNA, but not a distal-specific RNA, would act as a competitor for
RNA-OUT binding to untagged HfqWT. We show in Figure 3.8B that this is the case.
When we pre-incubated Hfq with DsrA (an sRNA) or A18 (a distal-specific RNA) and
then added 32P-labeled RNA-OUT, only DsrA inhibited Hfq:OUT-1 complex formation;
IC50 values (Table 3.2; Figure 3.9) are ~7 nM and >4000 nM for DsrA and A18,
respectively. In fact, there was evidence of ternary complex formation at A18
concentrations above 31 nM (see lanes 18–24 in Figure 3.8B). Overall, we conclude that
RNA-OUT behaves like a trans-sRNA in its interaction with Hfq.
In titrations with RNA-IN-160 and his6-tagged Hfq proteins (WT, K56A, and
Y25A), there was a moderate reduction in binding affinity. This is reflected by changes in
KD1 of 1.7- and 3-fold, respectively, for HfqY25A and HfqK56A vs. HfqWT (see Figure
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Figure 3.8. RNA-OUT interacts specifically with the proximal RNA-binding surface
of Hfq.
(A) EMSAs with 32P-labeled RNA-OUT (~0.4 nM) and either WT or mutant forms of
Hfq. HfqY25A is defective in RNA-binding at the distal site, and HfqK56A is defective in
RNA-binding at the proximal site. The corresponding binding curves are presented below
each gel image. Error bars represent standard error from two experiments. Note that all
forms of Hfq used in this experiment possess a his6 epitope tag at their C termini. Species
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are labeled as in Figure 3.2. (B) EMSAs performed in the presence of competitor RNAs.
HfqWT (untagged) was first mixed with various concentrations of DsrA or A18 RNA for 5
min, and 32P-labeled RNA-OUT (0.4 nM) was added. After an additional 15 min,
reactions were subjected to polyacrylamide gel electrophoresis. A species expected to
represent a ternary complex is labeled A18:Hfq:OUT*. IC50 values were calculated from
curves shown in Figure 3.9 and are reported in Table 3.2.
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A

B

C

D

E

Figure 3.9. IC50 determinations for A18 and/or DsrA competition experiments.
The percentage inhibition of Hfq:IN-1 (A-C) and Hfq:OUT-1 (D-E) complex formation
by competitor RNAs (DsrA, A18 or DsrA+A18) is plotted as a function of competitor
concentration. The data is derived from experiments in Figures 3.8 and 3.10 plus
additional experiments not shown. Data were fit to sigmoidal curves to obtain the IC50
values (reported in Table 3.2).
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Table 3.2. In vitro competitiona by DsrA or A18 for binding of HfqWT to RNA-IN or
RNA-OUT.
RNA Species

DsrA IC50 (nM)

A18 IC50 (nM)

DsrA+A18 IC50 (nM)c

RNA-OUT

6.77 ± 0.317

> 4000b

N.D.

RNA-IN

52.7 ± 14.1

10.6 ± 1.18

8.93 ± 2.12

a

IC50 values (± Standard Error) were measured by EMSA. Percentage of
competition was plotted versus competitor concentration and IC50 values were
obtained from the resulting curves (shown in Figure 3.9). Competition assays were
performed twice.
b
Instead of competition, a ternary complex was formed.
c
Reported for each competitor in the mix.
N.D., not determined.
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3.10A; Table 3.1). These results are consistent with RNA-IN-160 binding to both the
proximal and distal sites. Competition experiments support this inference, as both DsrA
and A18 gave some inhibition of Hfq:IN-1 formation when each of these RNAs was preincubated with Hfq prior to addition of RNA-IN-160. More specifically, we observed
strong inhibition of Hfq:IN-1 formation at concentrations above the KD for A18:Hfq
complex formation, which is ~10 nM (Figure 3.10B, lanes 11–15; IC50 ~11 nM, Table
3.2; Figure 3.9; Sun and Wartell 2006). In contrast, we observed weak inhibition of
Hfq:IN-1 formation at DsrA concentrations above the KD for DsrA:Hfq complex
formation, which is ~21 nM (Figure 3.10B, lanes 6–8; IC50 ~53 nM, Table 3.2; Figure
3.9; Mikulecky et al. 2004). At A18 concentrations above its KD for Hfq (lanes 11–15),
primarily the proximal site is expected to be available for RNA-IN-160 binding, and at
DsrA concentrations above its KD for Hfq (lanes 5–7), primarily the distal site is expected
to be available for RNA-IN-160 binding. Accordingly, the stronger inhibition observed
for A18 is consistent with the distal site of Hfq being the higher affinity site for RNA-IN160 binding. This is typical of Hfq binding to mRNAs (Mikulecky et al. 2004; Soper et
al. 2011).
We also performed a competition experiment where both competitors were mixed
with Hfq simultaneously and then RNA-IN-160 was added (Figure 3.10B, lanes 16–26).
Very strong inhibition of Hfq:IN-1 formation was only observed when the concentrations
of both A18 and DsrA were close to or above their respective KD values for Hfq complex
formation (lanes 23–26). These results suggest that an additional RNA-binding site in
Hfq does not contribute significantly to the formation of a stable Hfq:RNA-IN-160
complex.

3.2.4

HfqK56A exhibits a reduced rate of RNA-IN:OUT pairing in
vitro

The results in the previous section show that RNA-IN can contact both the distal and
proximal sites in Hfq and that RNA-OUT binds only to the proximal site. One or more of
these interactions is likely important for the acceleration in the rate of RNA-IN:OUT
pairing directed by Hfq that we previously documented (Ross et al. 2010). The proximal
site is likely of particular importance, as both RNA species could conceivably bind here
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Figure 3.10. RNA-IN interacts with the distal and proximal RNA-binding surfaces
of Hfq.
(A) EMSAs with 32P-labeled RNA-IN (0.17 nM) and either WT or mutant forms of his6tagged Hfq. Species are labeled as in Figure 3.2. Binding curves are shown below the
corresponding EMSA, and apparent KD values are reported in Table 3.1. Error bars
represent standard error from two experiments. (B) EMSAs performed in the presence of
competitor RNAs. Competitor experiments were performed as described in Figure 3.8B
except that RNA-IN was present at a concentration of 0.17 nM. For lanes 18–26, a 1:1
mix of DsrA and A18 was serially diluted to the indicated concentrations before
competition. IC50 values were calculated from curves shown in Figure 3.9 and are
reported in Table 3.2.
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and begin to pair. Accordingly, we asked if an intact proximal RNA-binding site is
necessary for Hfq to accelerate the rate of RNA-IN:OUT pairing. Note that we developed
an alternative means to purify untagged HfqWT and HfqK56A (see Materials and Methods),
as the his6-tagged forms gave inconsistent pairing results. We mixed Hfq (WT or K56A),
32

P-labeled RNA-OUT, and 32P-labeled RNA-IN-160 and incubated them for the

indicated times before processing and analysis on a native polyacrylamide gel. Processing
involved phenol extraction (mixing, centrifugation, and recovery took ~15 sec) and then
immediately loading the samples on a native polyacrylamide gel. This step was included
to remove Hfq from the paired product so that identification of this species was
unambiguous. The ratio of RNA-OUT to RNA-IN was fixed (10:1) to roughly reflect the
ratio of these RNAs in vivo. The Hfq concentration used (45 nM) was set from a
preliminary experiment where we determined the minimum concentration of Hfq that
yielded an enhancement in RNA-IN:OUT pairing (relative to the absence of Hfq) at the
above ratio of RNA-OUT to RNA-IN (see Figure 3.11).
We show in Figure 3.12 that addition of 45 nM HfqWT increased the rate (kobs) of
RNA-IN:OUT pairing approximately 19-fold relative to no Hfq addition (kobs = 1.51
min-1 for HfqWT vs. 0.080 min-1 in the absence of Hfq). By comparison, the rate
enhancement was less than twofold when HfqK56A was used (kobs = 0.14 min-1). These
results indicate that the K56A mutation negatively impacts RNA-IN:OUT pairing under
these specific conditions, consistent with the proximal surface playing an important role
in the enhancement of antisense pairing in vitro.

3.2.5

IS10-Kan transposition is derepressed in strains expressing
Y25A and K56A forms of Hfq

While Hfq increases the rate of RNA-IN:OUT pairing substantially in vitro, it is difficult
to know if effective antisense inhibition of transposase expression requires this
enhancement in the RNA pairing rate in vivo. To address this issue, we asked if untagged
HfqK56A (which is impaired in its ability to promote IN:OUT pairing in vitro) is also less
effective than wild-type Hfq at repressing IS10 transposition. We also assessed the ability
of the distal-impaired HfqY25A to repress transposition of IS10. We used a “mating out”
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Figure 3.11. Measurement of RNA-OUT:RNA-IN pairing as a function of Hfq
concentration.
RNA-IN:RNA-OUT pairing reactions were performed in the presence of the indicated
concentrations of Hfq (WT or K56A) as described in Figure 3.12 for a 2 minute reaction.
As 45 nM gave an enhancement in RNA-IN:OUT pairing, this concentration of Hfq was
used in the experiments summarized in Figure 3.12.
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No Hfq
Time (min)
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HfqWT

10 60 0.5 0.75 1

HfqK56A
10 60 0.5 0.75 1
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OUT:IN*
IN*

OUT*
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9

10

11 12 13 14 15

B
kobs (min-1)
HfqWT

1.512 ± 0.142

HfqK56A

0.143 ± 0.020

No Hfq

0.080 ± 0.004

Figure 3.12. RNA-IN:RNA-OUT pairing reactions.
(A) 32P-labeled RNA-IN-160 (0.85 nM) was mixed with excess 32P-labeled RNA-OUT
(8.5 nM) and, where indicated, untagged WT or K56A Hfq (45 nM). Note that RNAOUT had a lower specific activity than RNA-IN. At the indicated time points, pairing
reactions were stopped by treatment with a phenol/water mix and immediately loaded
onto a 6% native polyacrylamide gel. (B) The amount of RNA-OUT:RNA-IN* complex
(OUT:IN*) was determined as a percentage of total RNA-IN* for each time point and
plotted as a function of time. Error bars represent the standard error from three
experiments. The observed rate constant (kobs) is indicated for each reaction. These values
were derived from curves corresponding to the equation describing the rate of
exponential association, presented in Materials and Methods.
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assay to measure the frequency of IS10-Kan transposition from a multi-copy plasmid in
different genetic backgrounds. In this assay, the frequency of transposition of IS10-Kan
from a multi-copy plasmid to the F plasmid in the donor strain is measured (see Materials
and Methods). For the mating out experiments, the Hfq status was manipulated by
transforming the donor strain (DBH16; hfq-) with a plasmid expressing untagged WT,
Y25A, or K56A forms of Hfq from a native hfq promoter. As controls, we also measured
the frequency of IS10-Kan transposition in hfq+ (DBH33; full repression) and hfq- (no
repression) strains.
The results of the mating out analysis are presented in Figure 3.13, where we
report the fold change in transposition frequency relative to the average transposition
frequency calculated for hfq+. In both the hfqK56A and hfqY25A strains, IS10-Kan
transposition was derepressed to about the same level as in hfq-. Importantly, these
deficiencies cannot be attributed to differential levels of Hfq expression in the different
strains, as Western blotting confirmed that plasmid-encoded WT, Y25A, and K56A
forms of Hfq were present at comparable levels in the respective donor strains (Appendix
B). These results show that Hfq mutants that are partially defective in binding RNA at
specific surfaces, one of which (K56A) is impaired in its ability to catalyze RNAIN:OUT pairing in vitro, are unable to repress IS10 transposition in vivo.
Hfq is also known to stabilize trans-encoded sRNAs (for review, see Vogel and
Luisi 2011), and such an activity could influence the effectiveness of RNA-OUT in the
Tn10/IS10 antisense system. We performed a rifampicin time-course experiment to look
at this possibility. We show in Figure 3.14 that the half-life of RNA-OUT actually
decreased by about 2.5-fold in an hfq+ relative to an hfq- strain. Accordingly, we can rule
out the possibility that Hfq contributes to the antisense system by stabilizing RNA-OUT.

3.3 Discussion
Tn10/IS10 transposition is negatively regulated by an asRNA (RNA-OUT) that pairs
with the 5′ TIR of the transposase mRNA (RNA-IN) to inhibit transposase expression.
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Figure 3.13. IS10-Kan transposition is derepressed in E. coli encoding Y25A and
K56A forms of Hfq.
E. coli cells (hfq+ or hfq-) were co-transformed with pDH602 (encodes IS10-Kan) and a
compatible plasmid encoding untagged Hfq (WT, K56A, or Y25A) or the corresponding
“empty vector” control. Relative transposition frequencies were measured using the
conjugal mating out assay (see Materials and Methods for details). An average
transposition frequency (4.03 x 10-4 events per mL of mating mixture) was calculated for
the hfq+ strain (hfq+/emp.vect.) from 15 independent “donor” colonies across four
independent experiments, and this value was set at 1. All other transposition values are
expressed relative to this value where Hfq-directed repression of transposition is at its
maximal level. Bars indicate the mean; the error bars indicate standard error on the mean.
From left to right, the n value for each treatment group is 15, 15, 14, 16, and 11—these
were compiled from at least two (and up to four) independent experiments. An asterisk
(*) indicates that means were significantly different from the hfq+ control group; P values
are indicated above the corresponding bars.
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A

hfq-

hfq+
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0
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OUT (+69)*

OUT (primer)*

B
t1/2 = 21 min
t1/2 = 52 min

Figure 3.14. RNA-OUT half-life analysis in isogenic hfq+/- backgrounds.
Rifampicin-sensitive strains DBH116 (hfq+) and DBH117 (hfq-) were transformed with
plasmid pDH502 (ApRKanR, source of IS10-Kan; Ross et al., 2010). Cells were grown to
mid-log phase in 20 mL LB supplemented with 25 µg/mL kanamycin. (A) Two ‘time 0’
samples (600 µL) were removed to tubes containing 300 µL ‘Stop solution’ (1.5% [w/v]
SDS, 300 mM Sodium Acetate, 30 mM EDTA), boiled for 1 minute and stored on ice.
Rifampicin was immediately added to the remaining cells (final concentration: 200
µg/mL), and 600 µL samples were removed at the indicated time and processed as above.
After all samples were collected on ice, total RNA was extracted by the ‘hot phenol’
method, treated with Turbo DNase (Ambion) and ethanol precipitated. Samples were
resuspended in nuclease-free water and quantified by spectroscopy. RNA-OUT levels
were assessed by primer extension with 32P-labeled JR4; cDNA was fractionated by
denaturing PAGE. OUT (+69)* indicates full-length primer extension product; OUT
(primer)* indicates unextended primer. Note that the top panel is an over-exposure of the
region of the gel where +69* migrated. (B) The area of the bands corresponding to fulllength RNA-OUT and unextended primer were quantified (ImageQuant) and RNA-OUT
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(+69) was divided by unextended primer for each lane; these values were normalized to
time 0 in the hfq+ strain and plotted on the y-axis, with Time (after rifampicin addition)
on the x-axis. To obtain half-lives, the resulting curves were fit by non-linear regression
to the equation describing exponential decay (Prism); note that the plateau was set to zero
RNA-OUT remaining:
P = Span•e-k t
•

Where P is the proportion of RNA-OUT remaining, Span is 1.0, t is time (in minutes) and
k is the rate of decay in units of min-1. The half-life (t1/2) is equal to 0.6932/k.
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Hfq is also a negative regulator of Tn10/IS10 transposition that down-regulates
transposase expression in vivo. The effect of disrupting hfq on Tn10/IS10 transposition is
diminished in a system with reduced RNA-OUT expression. In vitro, Hfq binds RNA-IN
and RNA-OUT, forms a ternary complex with these RNAs, and increases the rate of
RNA-IN:OUT pairing. Taken together, these observations are consistent with Hfq
regulating Tn10/IS10 by operating on the antisense mechanism. In the current work, we
have further characterized the interactions between Hfq, RNA-IN, and RNA-OUT with
regard to binding affinity, binding sites within Hfq that govern these RNA contacts, and
the impact mutating one of these binding sites has on RNA-IN:OUT pairing. We have
also begun to define Hfq binding sites within each RNA, as well as the impact Hfq
binding has on the structure of these RNAs.

3.3.1

RNA-IN and RNA-OUT bind Hfq like a prototypical sRNAmRNA pair

The Hfq binding affinities we have measured for RNA-IN and RNA-OUT are consistent
with what is typically seen for canonical trans-encoded sRNA-mRNA pairs. For
example, KD1 for RNA-OUT is 19.6 nM and KD1 for Hfq binding to DsrA is 21 nM
(Mikulecky et al. 2004). Hfq binds RNA-IN with sub-nanomolar affinity (apparent KD1
0.24 nM), which is comparable to the tightest Hfq-mRNA interactions described to date
(OmpC 0.9 nM, Fender et al. 2010; SodB 0.3 nM, Geissmann and Touati 2004; RpsO 90
pM, Folichon et al. 2003).
We also investigated determinants in Hfq responsible for RNA-IN and RNA-OUT
binding. Hfq possesses at least two distinct RNA-binding surfaces; the distal site
generally binds A-rich RNA/mRNA while the proximal site binds U-rich sRNAs
(Mikulecky et al. 2004; Soper et al. 2011; Ishikawa et al. 2012). Both competition and
binding experiments (with Hfq variants) revealed that Hfq binds RNA-OUT exclusively
through its proximal RNA-binding surface. For RNA-IN, both the distal and proximal
binding sites in Hfq contribute to RNA-IN binding, although the distal site is the higher
affinity site. In canonical sRNA-mRNA systems, there is competition between sRNA and
mRNA binding at the proximal site, and this appears to be required for the formation of
the paired species (Hwang et al. 2011). Competition is ensured by the individual RNAs
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having similar binding affinities for the proximal site, and in general, these affinities are
much weaker than those for the distal site. The high affinity interaction for the mRNA
with the distal site effectively tethers the mRNA to Hfq, allowing other parts of the
mRNA to interact relatively weakly with the proximal site, and this increases the
probability that the mRNA and sRNA can occupy the proximal site at the same time
(Hopkins et al. 2011). As discussed above, the Hfq:RNA interactions in the IS10 system
are consistent with this general model. A recent study defined a third RNA-binding site in
Hfq (the lateral surface) that may be important in allowing the mRNA to simultaneously
bind distal and proximal sites (Sauer et al. 2012). Our competition studies indicate that
the lateral surface alone is not sufficient for binding RNA-IN or RNA-OUT.
We have not defined the number of Hfq hexamers present in any of the Hfq:RNAIN or Hfq:RNA-OUT complexes. The KD values discussed above relate only to the
complexes formed at the lowest Hfq concentrations in each titration. For RNA-IN, at
least four distinct Hfq complexes were detected, raising the possibility that at least four
Hfq hexamers may be accommodated within the first 160 nt of RNA-IN. Results from
hydroxyl radical footprinting support the existence of multiple Hfq binding sites in RNAIN. One such site may extend from position 29 to 46 and appears to be the highest
affinity site identified by hydroxyl radical footprinting, as it was occupied at a lower Hfq
concentration relative to the other sites. For RNA-OUT, two distinct Hfq-bound species
were detected. Results from RNase footprinting revealed only one strong candidate for an
Hfq binding site within RNA-OUT. This site is located within the U-rich segment of
bulge 2. We don’t yet know which Hfq binding site(s) in RNA-IN or OUT are
biologically relevant. Work in other systems is consistent with the idea that maximal
pairing of an mRNA:sRNA pair can require the mRNA to bind multiple Hfq hexamers
(Soper and Woodson 2008; Salim and Feig 2010). Mutagenesis of potential Hfq binding
sites in RNA-IN and RNA-OUT is currently under way to test the importance of
individual sites in IS10 transposition.
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3.3.2

A proximal site mutation impacts on RNA-IN:OUT pairing
and IS10 transposition

The rate of RNA-IN:OUT pairing was substantially enhanced by HfqWT but not HfqK56A.
A limitation of this analysis was that we measured kobs under one specific set of
parameters as opposed to measuring a second-order rate constant. We used excess RNAOUT relative to RNA-IN (10:1) and a small excess of Hfq relative to both (less than
fivefold). As “available” Hfq is thought to be limiting in the cell (Hussein and Lim 2011;
Moon and Gottesman 2011), we feel this is a reasonable approximation of in vivo
conditions. Under these conditions, the kobs value was 10.6-fold lower for HfqK56A vs.
HfqWT.
We also measured the impact of the Hfq proximal and distal site mutations on
IS10 transposition. IS10 transposition was derepressed in both hfqK56A and hfqY25A strains
relative to hfqWT. RNA-IN:OUT pairing in vitro was enhanced ~19-fold by HfqWT relative
to no Hfq, and the magnitude of derepression of IS10 transposition in hfq- relative to hfq+
was ~10–15-fold. Furthermore, in vitro pairing was ~10-fold faster in the presence of
HfqWT relative to HfqK56A, and in vivo transposition was derepressed ~12-fold for hfqK56A
relative to plasmid-borne hfq+. Taken together, these results are consistent with Hfq
playing a significant role in the pairing component of the IS10 antisense system. Another
way in which Hfq might facilitate the IS10 antisense system is through the stabilization
of RNA-OUT. However, this possibility is not supported by our observation that RNAOUT stability is actually reduced in an hfq+ compared to an hfq- strain. Finally, Hfq
might directly interfere with IS10 transposase translation. We think this is unlikely
because, as previously noted, the large increase in Tn10/IS10 transposition from a multicopy plasmid in hfq- is tightly linked to the expression of RNA-OUT.

3.3.3

How might Hfq promote pairing in the IS10 antisense
system?

The simplest scenario for how Hfq promotes RNA pairing in the IS10 antisense system is
that, through simultaneous binding of RNA-IN and RNA-OUT, Hfq acts as a pairing
catalyst by increasing the local concentration of these two RNAs. In addition to providing
a single surface to which both RNAs bind, Hfq might actively alter the structure of RNA-
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Figure 3.15. Model for RNA-IN:OUT antisense pairing in the presence vs. absence
of Hfq.
The Hfq-independent pairing pathway is shown on the left-hand side (structures i, iv, and
vii) and the Hfq-dependent pathway is shown on the right-hand side (structures iii, vi, and
viii). In structures (ii) and (v) Hfq is shown bound to RNA-OUT and RNA-IN,
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respectively, but conformational changes in the RNAs have not yet taken place. Other
structures are described in the text. Hfq hexamers are indicated by green circles. The start
codon (AUG) and Shine-Dalgarno sequence (SD) of RNA-IN are indicated by asterisks
(*) at the first nucleotide of each sequence. Intramolecular base pairs in RNA-OUT/IN
are indicated by blue and red, respectively. Intermolecular base pairs between RNA-OUT
and RNA-IN are in gray. [This Figure was prepared primarily by M. Ellis, with input
from J. Ross.]
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IN and RNA-OUT to promote pairing. In fact, our structure-probing data support an Hfqdependent restructuring model (Figure 3.15). On the left-hand side of Figure 3.15, we
show how RNA-IN and RNA-OUT might interact in the absence of Hfq. Structureprobing experiments with RNA-IN and RNA-OUT revealed that the pairing region of
both RNAs is at least partly sequestered in secondary structure. In this pathway, a total of
8 bp between RNA-IN and RNA-OUT could readily form without any RNA restructuring
(structure vii). In the right-hand panel, we show how pairing could occur with RNAs
(structures iii and vi) that have been restructured by Hfq. In the presence of Hfq, the
pairing region of both RNAs is largely single-stranded, leading to the formation of a
paired species (structure viii) that contains 30 bp between RNA-IN and OUT. Notably,
only in structure viii is the TIR sequestered through base-pairing with RNA-OUT. We
anticipate that upon Hfq dissociation, RNA-OUT will adopt its native structure (transition
from structure iii to structure i). However, the capacity of the 3′ end of RNA-IN to form a
stable secondary structure in the presence of Hfq may prevent Hfq-bound RNA-IN
(structure vi) from converting back to structure iv upon Hfq release. As Hfq rapidly
cycles on and off of RNAs (Fender et al. 2010), the formation of the 3′ stem-loop
structure could maintain RNA-IN in a “pairing competent” state after Hfq release.
Consistent with genetic data, the “Hfq pairing pathway” includes pairing of the 5′
terminus of RNA-IN with the hairpin loop of RNA-OUT. Also, the internal loop of RNAOUT has been shown to be important for the antisense response (Case et al. 1989; Kittle
et al. 1989; Jain 1995). In the Hfq-independent pathway, nucleotides within this loop can
directly pair with RNA-IN, facilitating further propagation of pairing. In the Hfq
pathway, we suggest that internal loop residues directly participate in Hfq binding and
are, therefore, important in the restructuring of RNA-OUT.
An active remodeling role for Hfq has been well documented in other systems.
Hfq alters the structure of RpoS mRNA such that the sequence that base-pairs with DsrA
becomes single stranded (Soper et al. 2011). The pairing region within SodB mRNA is
also sequestered in a stem-loop structure; Hfq binding is required to disrupt this stemloop, resulting in formation of a large loop that is then competent to pair with the sRNA,
RyhB (Geissmann and Touati 2004).
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In other systems, the presence of base-pairing discontinuities in structured regions
of asRNAs has also been shown to be critical for antisense regulation (see Wagner et al.
2002). At this point, it is unclear if these discontinuities are sufficient for a robust
antisense response in vivo, and in this regard, it will be interesting to see if the
effectiveness of other antisense systems shows any reliance on Hfq.
In the current work, we have provided additional insight into how Hfq interacts
with the RNA components of the IS10 antisense system and provided further evidence
that these interactions ultimately influence this system. To date, only one other antisense
system is known to be Hfq-regulated. Hfq regulates the expression of the chromosomally
encoded gadX gene, which is involved in acid tolerance in E. coli. An sRNA called GadY
is antisense to the 3′ UTR of GadX, and it has been shown that GadY expression
increases the stability of the GadX transcript. Importantly, Hfq binds to the GadY
transcript and stabilizes it (Opdyke et al. 2004). However, it has not been established if
Hfq plays a direct role in promoting pairing of GadY and GadX RNAs. With regard to
other transposons, it should be noted that antisense RNAs to the transposase have been
identified, including IS30 (Arini et al. 1997) and IS200 (Sittka et al. 2008). Additionally,
a recent study identified five transcripts in Mycobacterium smegmatus that bind Hfq and
are antisense to transposase mRNAs (Li et al. 2012). It will be interesting to see if any of
these transposons are regulated by Hfq. Notably, Hfq regulation of other transposons
might not be limited to systems encoding asRNAs. Trans-encoded sRNAs frequently
target more than just one mRNA (for review, see Repoila et al. 2003), and as such, there
is the potential for “off-target” effects wherein a trans-encoded sRNA might fortuitously
target a transposase mRNA. This could provide the host with a previously unrecognized
pathway to either down- or up-regulate transposon mobilization. Furthermore, as the
induction of the transcription of sRNA genes is often linked to various cellular stresses
(Repoila et al. 2003), and this induction can temporarily limit the availability of Hfq in
the cell (Hussein and Lim 2011; Moon and Gottesman 2011), there is the potential to
indirectly regulate transposition reactions through stress response pathways.
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Table 3.3. List of E.coli strains and plasmids used in this study.
Strain or
Plasmid

Relevant genotype

Use

Source or
reference

E.coli
HB101
DBH33
DBH16
DH5α
BL21

F- leu- ; StrR
NK5830; recA- arg- / F’ pro+
NK5830 hfq-1::Ωcat; CmR
recArecA- / DE3 T7 RNA polymerase

Mating out recipient
Mating out donor
Mating out donor
Plasmid propagation
Hfq over-expression

Bolivar (1979)
Ross (2010)
Ross (2010)
Invitrogen
Studier (1986)

Plasmids
pDH602
pDH631
pWKS30

pACYC184-derived; IS10-Kan ; CmRKanR
pET3a derived; T7-hfq ; ApR
pSC101-derived; low copy-number ori ; ApR

Mating out assays
Hfq over-expression
‘Empty vector’ for
Hfq expression
HfqWT expression
HfqK56A expression
HfqY25A expression
HfqWT overexpression
HfqK56A overexpression
HfqY25A overexpression

Ross (2010)
Ross (2010)
Wang (1991)

pDH700
pDH701
pDH713
pDH686
pDH688
pDH697

pWKS30-P3-hfqWT ; ApR
pWKS30-P3-hfqK56A ; ApR
pWKS30-P3-hfqY25A ; ApR
pET28a-derived; C-terminal his6-tagged
HfqWT; kanR
pET28a-derived; C-terminal his6-tagged
HfqK56A; kanR
pET28a-derived; C-terminal his6-tagged
HfqY25A; kanR

This study
This study
This study
Mikulecky
(2004)
Mikulecky
(2004)
Mikulecky
(2004)
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Table 3.4. List of oligonucleotides used in this study.
Name

Sequence (5’ to 3’)

Use

JR1

TAATACGACTCACTATAGGCGAAAAAT
CAATAATCAGACAACAAG
CAAGTTCGGTAAGAGTGAGAG
GAATTGTAATACGACTCACTATAGGGCT
CGCACATCTTGTTGTC
GGATACACATCTTGTCATATGATCA
NNTCTAGANNCAGGTTGTTGGTGCTATC
NNAAGCTTNNTTATTCGGTTTCTTCGCT
AGCCAGATGGTTTACGCGCACGCGATTT
CTACT
AGTAGAAATCGCGTGCGCGTAAACCAT
CTGGCT
GTTCCAGTTTCTATTGCTTTGGTGAATG
GTATTAAG
CTTAATACCATTCACCAAAGCAATAGAA
ACTGGAAC
TAATACGACTCACTATAGGCAACACATC
AGATTTCCTGGTGTAACGAATT
AAATCCCGACCCTGAGGGGGTCGGGAT

Forward primer (includes T7 promoter) for in
vitro transcription template (RNA-IN)
Reverse primer for above (RNA-IN-160)
Forward primer (includes T7 promoter) for in
vitro transcription template (RNA-OUT)
Reverse primer for above
Forward primer for pDH700 construction
Reverse primer for above
Forward primer for K56A quikchange
mutagenesis
Reverse primer for above

JR2-2
JR3
JR4
JR15
JR16
JR17
JR18
JR19
JR20
JR21
JR22

Forward primer for Y25A quikchange
mutagenesis
Reverse primer for above
Forward primer (includes T7 promoter) for in
vitro transcription template (DsrA)
Reverse primer for above
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3.4 Materials and Methods
3.4.1

Strains, plasmids, and primers

All E. coli strains and plasmids used in this study are listed in Table 3.3. Oligonucleotides
used are listed in Table 3.4. To express Hfq in vivo, we cloned a fragment that included
the hfq gene with its P3 promoter into the low-copy cloning vector pWKS30 (Wang and
Kushner 1991). The aforementioned fragment was generated by PCR using genomic
DNA from DBH33 and primers JR15 and JR16, which include XbaI and HindIII sites,
respectively. After digestion of the PCR product with XbaI-HindIII, the “hfq” fragment
was ligated into XbaI-HindIII-digested pWKS30, creating pDH700. We then used
pDH700 as a template for site-directed mutagenesis to create pDH701 and pDH713,
which encode HfqK56A and HfqY25A, respectively. For purification of C-terminal his6tagged Hfq (WT, HfqY25A, and HfqK56A), the hfq gene was cloned into pET28a as
described in Mikulecky et al. (2004).

3.4.2

Hfq purification and quantitation

Untagged Hfq was purified as described in Ross et al. (2010) but included a treatment of
the lysate with DNase I (100 units) and RNase A (100 µg) for 1 h on ice before heat
treatment of the lysate at 85°C. His6-Hfq proteins were purified as described in
Mikulecky et al. (2004). Untagged HfqWT and HfqK56A for the experiments presented in
Figure 3.12 were expressed from pDH700 and pDH701 and purified on a TALON Cobalt
column as described in Soper et al. (2010), followed by further purification on a polyA
column as described in Ross et al. (2010). Purified Hfq was dialyzed against Hfq
storage/binding buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 250 mM NH4Cl, 10% (v/v)
glycerol). SDS-PAGE revealed that the Hfq was ~95% pure (Appendix B). Hfq
concentration was determined by Bradford assay.

3.4.3

In vitro transcription and RNA purification

Linear DNA templates for run-off transcription of RNA-IN (nucleotides 1–160) or RNAOUT (nucleotides 1–69) were amplified from pDH602 (Ross et al. 2010) by PCR with
primers JR1/JR2-2 or JR3/JR4, respectively; note that, for each primer pair, the forward
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primer includes the T7 core promoter. The same approach was used to make templates
for in vitro transcription of DsrA (primers JR21/JR22). Our standard in vitro transcription
reaction for generating unlabeled RNA was performed in a 30-µL volume with 200 ng
DNA template, 2.5 mM rNTPs, 10 mM DTT, 1x T7 RNA polymerase reaction buffer
(NEB), 100 units RNasin (Promega), 2.5 units yeast inorganic pyrophosphatase (NEB),
and 100 units T7 RNA polymerase (NEB). For preparing 32P-labeled RNA, in vitro
transcription was performed in a 20-µL volume as above except that UTP was added to
only 50 nM, and 2.5 µCi [α-32P]UTP was added. Reaction mixtures were incubated at
37°C for 1 h before adding 0.1 units of Turbo DNase (Ambion) per µL of reaction and
continuing incubation for 20 min. RNAs were purified using denaturing PAGE and, after
elution from gel slices, were concentrated by ethanol precipitation and finally
resuspended in Hfq storage/binding buffer. RNA concentrations were determined using a
NanoSpectrophotometer (IMPLEN). Purity of in vitro transcribed RNA was assessed by
high-resolution denaturing PAGE. A18 was purchased from Sigma-Aldrich and dissolved
in Hfq storage/binding buffer.

3.4.4

Hfq-RNA binding assays

In our standard Hfq-RNA binding reaction, we mixed 32P-labeled RNA (0.1–0.4 nM)
with Hfq (0.05–1856 nM) in Hfq storage/binding buffer (total reaction volume 10 µL) for
15 min at 37°C. In the case of “competitor” experiments, unlabeled competitor RNAs
(0.5–4000 nM) were mixed with Hfq for 5 min as described above, and then either 32Plabeled RNA-IN (0.17 nM) or RNA-OUT (0.4 nM) was added. Incubation was continued
at 37°C for an additional 15 min. Prior to mixing RNA with Hfq, the various RNA
species were incubated at 95°C for 2 min, placed on ice for 2 min, and equilibrated to
37°C. At the reaction end points, samples were mixed with 0.3 volumes of gel load dye
(21 mM Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% (v/v) glycerol, 0.05% (w/v)
bromophenol blue) and applied to a 6% native polyacrylamide gel. Electrophoresis was
carried out at 14 V/cm for 70 min, whereupon the gel was dried and exposed to a
phosphorimager screen. Gel images were obtained using the STORM phosphorimager.
For measuring the equilibrium dissociation constant (KD) in binding reactions,
bands representing shifted and unshifted RNA species were quantified (ImageQuant
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software), and the percentage of counts for a given shifted species (relative to total counts
for all bands in the lane) was plotted on the y-axis and Hfq concentration on the x-axis
(Prism software). The resulting curve was fit by nonlinear regression to the equation:
P: L =

P: L!"# ∙ [P]!
K ! ! + [P]!

where P and L are Hfq and RNA, respectively, P:L is the percentage of RNA shifted by
Hfq, [P] is the concentration of Hfq6 in nM, KD is the equilibrium dissociation constant,
and h is the Hill coefficient. To calculate KD1, the percentages of all shifted species were
summed to yield the appropriate curve (e.g., the curve marked “total” in Figure 3.2B or
D). To calculate KD2 for RNA-OUT, the percentages of all species representing complex
2 were plotted (e.g., the curve marked “Hfq:OUT*2” in Figure 3.2B). To calculate KD2
for RNA-IN-160, the total percentages of all species other than free RNA-IN-160 or
Hfq:IN*1 were plotted (i.e., the curve marked “Hfq:IN*2” in Figure 3.2D). To calculate
KD3 for RNA-IN-160, the total percentages of all species other than free RNA-IN-160,
Hfq:IN*1 or Hfq:IN*2 were plotted (i.e., the curve marked “Hfq:IN*3” in Figure 3.2D).
For calculating IC50 values (i.e., the concentration of competitor RNA that
inhibited Hfq:RNA-IN or Hfq:RNA-OUT complex formation by 50%), bands
representing Hfq:RNA* complexes (* denotes radiolabeled RNA-IN or RNA-OUT) and
unshifted RNA* were quantified, and the percentage of Hfq-shifted RNA* at 0 nM
competitor was set at 0% competition. The percentage of Hfq-shifted RNA* remaining at
increasing concentrations of competitor was subtracted from 100% to give the percent
competition (0% shifted complex = 100% competition). Percent competition was plotted
on the y-axis and competitor concentration on the x-axis (Prism). The resulting curve was
fit by nonlinear regression to the equation:

PC =

PC!"# ∙ [C]
IC!" + [C]
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where PC is percent competition, [C] is the concentration of competitor RNA in nM, and
IC50 is the concentration of competitor RNA giving 50% competition.

3.4.5

RNA structure-probing and footprinting

In vitro-transcribed RNA-IN and RNA-OUT were gel-purified, treated with Antarctic
Phosphatase (NEB) and 5′ end-labeled with [γ-32P]ATP (Perkin Elmer) and OptiKinase
(USB). 5′-labeled RNA was gel-purified, ethanol-precipitated, and finally resuspended in
RNA Storage Buffer (20 mM MES pH 7.0, 150 mM NaCl, 1 mM EDTA). RNA
concentrations were determined using a NanoSpectrophotometer (IMPLEN). RNA and
Hfq were mixed in RNA Structure Buffer (20 mM MES pH 7.0, 150 mM NaCl, 1 mM
EDTA, 10 mM MgCl2) to a final volume of 9 µL. Binding reactions took place at 37°C
for 15 min. For RNase footprinting, 1 µL of dilute RNAse A, T1, or V1 (Ambion) was
added to each binding reaction. For RNA-OUT, 0.04 ng RNase A, 0.03 units or 0.04
units of RNAse T1 (− or + Hfq, respectively), and 0.00005 units or 0.0001 units of
RNase V1 (− or + Hfq, respectively) were added. For RNA-IN, 0.004 or 0.01 ng of
RNase A (− or + Hfq, respectively), 0.01 units of RNase T1, and 0.00005 units or 0.0001
units of RNase V1 (− or + Hfq, respectively) were added. G-lanes were produced by T1
digestion of RNA following the manufacturer’s directions (Ambion). RNase reactions
proceeded for 15 min at 25°C before RNA was ethanol-precipitated and resuspended in 7
µL formamide load dye (97.5% deionized formamide (v/v), 10 mM EDTA, 0.5 x TBE,
3% xylene cyanol [w/v]), and ~2 µL was loaded onto a high-resolution 10%
polyacrylamide denaturing gel. Hydroxyl radical footprinting was performed as
previously described (Jain and Tullius 2008). Briefly, following binding reactions, 1 µL
of freshly prepared H2O2 (2.5% [v/v]), Fe(II)EDTA (32 mM ferrous ammonium sulphate,
88 mM EDTA; Bio Basic), and sodium ascorbate (60 mM; Bio Basic) were added to each
9 µL binding reaction. The final concentrations of hydroxyl radical reagents in each 12µL reaction were as follows: H2O2, 0.21% (v/v); Fe(II), 2.67 mM; EDTA, 7.33 mM;
sodium ascorbate, 5 mM. Following incubation at 25°C for 10 min, samples were
processed as described above for RNase treatment. For footprinting reactions, RNA-OUT
was at a final concentration of 65 nM, RNA-IN at 45 nM, and Hfq6 at a final
concentration of 99–4380 nM. Gels were dried and imaged with a phosphorimager (GE
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Healthcare). A sample of each binding reaction (RNA-IN and RNA-OUT, each Hfq
concentration) was run on a 6% polyacrylamide gel to monitor complex formation under
the conditions used (Figure 3.4). Quantitation of RNA-IN hydroxyl radical footprinting
was performed using ImageQuant software.

3.4.6

Determination of RNA-OUT:RNA-IN pairing rates

RNA-IN:OUT pairing reactions were carried out by spotting 3.5 µL of 32P-labeled RNAIN and RNA-OUT onto separate faces of an Eppendorf tube, mixing them with 24.5 µL
of Hfq storage/binding buffer, and immediately removing 9 µL to separate tubes
containing 1 µL of Hfq (or Hfq storage buffer), as indicated. Mixing was achieved by
rapid pipetting. Final concentrations of reactants were: RNA-IN*, 0.85 nM; RNA-OUT*,
8.5 nM; Hfq, 45 nM. Incubation was at 37°C, and after the indicated times, each 10-µL
reaction was added to tubes containing 30 µL H2O and 40 µL phenol:chloroform:isoamyl
alcohol. These were immediately vortexed (8 sec) and centrifuged (3-sec pulse-spin)
before removing 10 µL of the aqueous phase and loading it directly on a 6% native
polyacrylamide gel at 7 V/cm. After the last sample was loaded, electrophoresis was
continued at 13 V/cm for 45 min. Gels were dried and imaged as described above. Bands
representing RNA-OUT:IN paired species or free RNA-IN were quantified
(ImageQuant). The percentage of paired species (relative to total RNA-IN counts) was
plotted on the y-axis and time on the x-axis (Prism). The resulting curves were fit by
nonlinear regression to the equation:
A: B! = A: B!"# (1 − ! !!!"# ∙! )
where A:Bt is the percentage of binary complex at time t and kobs is the observed rate
constant.

3.4.7

Mating out assay

Mating out experiments were carried out with DBH33 (hfq+) and DBH16 (hfq-) as donor
strains and HB101 as the recipient strain. Plasmids encoding IS10-Kan (pDH602) and
Hfq (pDH700, 701, 713, and pWKS30 as the “empty vector” control) were cotransformed into donor strains, and transformants were selected on M9-Glucose plates
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supplemented with arginine, kanamycin (50 µg/mL), and ampicillin (50 µg/mL). Donors
and recipient strains were grown in liquid media as previously described in Ross et al.
(2010), and mating was allowed to proceed for 1 h, whereupon mating mixes were
pelleted and resuspended in 0.85% saline. Resuspended mating mixes were then plated
on M9 media supplemented with glucose, leucine, and streptomycin (150 µg/mL) or
streptomycin plus kanamycin (50 µg/mL). Plating on the former gave the mating
frequency and plating on the latter gave the number of transposition events. Relative
transposition frequencies were calculated by dividing the number of colonies present on
streptomycin/kanomycin plates by the number of colonies on streptomycin plates. For
statistical analysis, we first carried out an F-test to demonstrate that the variances
between the hfq+ control group and the other treatments were not equal (hfq+ vs. hfq/hfqWT, P = 0.001; hfq+ vs. all other treatments, P < 0.0001). We then conducted a twotailed t-test with Welch’s correction (does not assume equal variances) to compare the
various treatments to the hfq+ control group. All statistical analyses were carried out in
Prism. Sample numbers and P values for the t-test are reported in Figure 3.13.
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Chapter 4

4

Tn5 transposition in Escherichia coli is repressed by
Hfq and activated by nutrient stress3

4.1 Introduction
Transposase proteins catalyze the chemical steps in bacterial transposition
reactions. It follows that the regulation of expression of these genes is a critical feature in
dictating the transposition frequency of most transposons. In many instances, including
Tn10/IS10 and Tn5/IS50, transposase gene promoters are inherently weak. In addition,
Dam methylase limits initiation of IS10 and IS50 transposase gene transcription by
methylating promoter elements (Roberts et al, 1985; Yin et al, 1988). These factors
together make transcription initiation a limiting step in Tn10/IS10 and Tn5/IS50
transposition reactions (Krebs & Reznikoff, 1986; Raleigh & Kleckner, 1986). There are
also examples where translation of transposase transcripts is subject to both intrinsic and
host levels of regulation. In the case of IS10 transposase, the ribosome binding site is
inherently weak and the transposon encodes an antisense RNA that binds the translation
initiation region (TIR), blocking ribosome binding (Ma & Simons, 1990; Simons &
Kleckner, 1983). There is also evidence that the ‘host’ protein Hfq helps mediate the
pairing interaction between the antisense RNA and the IS10 transposase transcript (Ross
et al, 2013; Ross et al, 2010).
Hfq is a global regulator of gene expression in bacteria. It typically functions at
the post-transcriptional level by influencing translation initiation and/or transcript
stability by various mechanisms (reviewed in (Vogel & Luisi, 2011)). In contrast to the
many examples of Hfq acting in a post-transcriptional capacity to impact gene
expression, there is (to our knowledge) only one example in the literature of Hfq acting at
the level of transcription to influence gene expression. In the case of ribosomal proteins

3

A version of this chapter has been submitted for publication: Ross,J.A., Trussler,R.S., Black,M.D.,
McLellan,C.R. and Haniford,D.B. (2014) Tn5 transposition in Escherichia coli is repressed by Hfq and
activated by nutrient stress. RNA.
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rpsO, rpsT and rpsB-tsf, Hfq was shown to increase transcript levels without influencing
transcript stability. It was suggested that this is accomplished through Hfq binding to
secondary structure elements in the respective transcripts that form early in the elongation
phase of transcription and that this interaction reduces RNA polymerase pausing (Le
Derout et al, 2010).
As noted above, Hfq has been implicated in the regulation of Tn10/IS10
transposition. Under conditions of hfq deficiency, a large increase in both Tn10/IS10
transposition (up to 80-fold) and transposase expression (up to 7-fold) were observed.
The existing evidence is consistent with Hfq acting as a negative regulator of IS10
transposase expression by both antisense dependent and independent pathways. In
support of the latter, it was found that hfq deficiency had a significant impact on Tn10
transposition even when the level of antisense RNA was insufficient to impact on
transposase expression (i.e. when Tn10 is present in single copy in the bacterial
chromosome). In addition, there was a synergistic increase in transposase expression
when both hfq and the antisense RNA were knocked out, implying that Hfq does not
function exclusively in the same pathway as the antisense RNA (Ross et al, 2010).
Taking the above results into account, and considering that most bacterial
transposition systems are not regulated by antisense RNAs, we wondered if Hfq might
play a more general role in regulating transposition systems. In the current work we
tested this hypothesis by asking if Tn5 transposition is also regulated by Hfq. Like Tn10,
Tn5 is a composite transposon (Figure 4.1). The two transposons are closely related but
Tn5 lacks an antisense RNA regulatory system (Bhasin et al, 1999; Kennedy et al, 1998;
Mahillon & Chandler, 1998). Instead, it encodes an inhibitor protein that limits Tn5/IS50
transposition by dimerizing with the transposase protein, forming an inactive complex.
Transposase and the inhibitor protein are expressed from overlapping promoters, P1 and
P2 (color coded in Figure 4.1), with the inhibitor transcript (T2) being expressed at a
much higher level than the transposase transcript (T1). T1 expression is down-regulated
by Dam methylase (reviewed in (Reznikoff, 2008)). There is some evidence that P1 is
also negatively regulated by LexA, an SOS-inducible transcriptional repressor
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Figure 4.1. Tn5/IS50 structure and gene expression.
The structure of Tn5 is shown along with transcription units within IS50-Right. There are
two distinct promoters defined by -35/-10 regions that control transposase (black) and
inhibitor (blue) expression. T1 is the transposase (t’ase) transcript and T2 is the inhibitor
transcript. The Shine-Dalgarno sequence of T1 is also shown. Expression of T1 but not
T2 is regulated by Dam methylation at two GATC sequences (red) and potentially LexA
binding (dotted line defines a putative LexA binding site). Mutations in the Dam sites
used in this work are shown. After translation, transposase protein binds transposon ends
(outside ends [OE] for Tn5 transposition and an OE and an inside end [IE] for IS50
transposition) and forms a transpososome (t’some). The inhibitor protein (Inh) blocks this
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step by forming a mixed dimer with transposase. All of the chemical steps in
transposition take place in the context of the t’some. KanR, BleR and StrR are kanamycin,
bleomycin and streptomycin resistance genes, respectively.
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(Kuan & Tessman, 1991). However, there is little else known with regard to host proteins
that influence either transposase transcription or translation.
In the current work, we show that both Tn5 transposition and IS50 transposase
expression increase significantly in E. coli under conditions of hfq deficiency. However,
unlike the situation in Tn10/IS10 transposition, the up-regulation of IS50 transposase
expression is mainly due to an increase in transposase gene transcription. As Hfq does
not typically function directly in transcription, we looked at the possibility that Hfq
regulates IS50 transposase expression by controlling the expression of a transcription
factor. Towards this end, we provide evidence that Hfq acts in a regulatory network with
Crp (cyclic AMP receptor protein) to down-regulate IS50 transposase transcription.
Finally, we demonstrate that over-expression of the sRNA SgrS activates expression of
the IS50 transposase gene specifically when cells are grown with glucose as the sole
carbon source. Evidence is presented that this up-regulation is a consequence of nutrient
starvation, demonstrating that the IS50 transposase promoter (and Tn5 transposition) is
responsive to the nutrient status of the cell.

4.2 Results
4.2.1

Hfq is a potent negative regulator of Tn5 transposition

We asked if Hfq regulates Tn5 transposition in E. coli by measuring the frequency of Tn5
transposition under conditions of hfq deficiency (hfq-). Two different transposition assays
were used, mating out and papillation, each employing a WT strain and an isogenic strain
in which the hfq gene was disrupted.
In the mating out assay we measured transposition of ‘native’ Tn5 from the
chromosome into an F factor. In this assay, an F+ donor strain harboring Tn5 was mated
to an F- recipient strain and the mating efficiency and number of transposition events
were measured by plating mating mixes on the appropriate selective media (see Materials
and Methods). We chose to follow the response of native Tn5 (as opposed to a
genetically manipulated Tn5 derivative) to hfq deficiency because we didn’t want to bias
the results by disabling any of the natural Tn5 regulatory pathways. Also, by using a
donor strain with Tn5 in the chromosome, as opposed to in a multi-copy plasmid, we
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hoped to reduce the ‘background’ that sometimes occurs in mating out assays due to
fortuitous donor plasmid transfer. This can be particularly problematic when measuring
low frequency transposition events, as is expected for the native Tn5 element; Tn5 has
been reported to transpose at a frequency of less than 1 event per 105 cells per generation
(Reznikoff, 2002).
We show in Figure 4.2A that in one donor strain background (DBH179) Tn5
transposition, as measured by the mating out assay, increased by close to 75-fold under
conditions of hfq deficiency. By comparison, when the parent strain was transduced to
dam- instead of hfq-, transposition increased about 7.5-fold. This increase in transposition
in dam- was expected based on previous work in the Tn5 system and served as a positive
control for our experimental system (Yin et al, 1988). Note that we did not have a
defective copy of Tn5 to act as a negative control in this experiment. In lieu of this, we
carried out physical mapping on a sampling of colonies present on ‘hop’ plates to ensure
that bona fide transposition events were being measured in both hfq+ and hfq- strains
(Appendix C).
We also performed a complementation assay in the DBH179 strain background to
further test that the increase in transposition reported above in hfq- was actually due to the
absence of Hfq, as opposed to possible polar effects of the hfq disruption allele. Towards
this end, we introduced hfq on a low-copy plasmid (pDH700) into the hfq- strain and
measured Tn5 transposition as above. We observed nearly complete complementation by
plasmid-borne hfq, as transposition was reduced approximately 45-fold relative to when
no hfq was present (Figure 4.2A). Furthermore, plasmid-encoded variants of Hfq,
including K56A and Y25A, which are impaired for RNA-binding at the ‘proximal’ and
‘distal’ surface, respectively, failed to complement hfq deficiency (Mikulecky et al,
2004). This confirms that specific functions of Hfq, namely interaction with RNA via
known RNA-binding surfaces, are required for effective repression of Tn5 transposition.
We also tested the impact of hfq deficiency on Tn5 transposition in a second
donor strain background (DBH261) via the mating out assay (Figure 4.2B). In this
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Figure 4.2. Frequencies of Tn5 transposition in hfq- versus hfq+ strains of E. coli.
(A) Tn5 transposition from the chromosome of DBH179 and derivatives (hfq- and dam-)
was measured by the conjugal ‘mating out’ assay as described in Materials and Methods.
For purposes of trans-complementation, strains contained an empty vector or a low-copy
plasmid encoding either wild type hfq or mutant forms of hfq (K56A or Y25A) expressed
from the hfq P3 promoter. The data was compiled from 4 independent experiments, each
with at least three isolates of each strain. The average transposition frequency was 8.33 x
10-5 events per mL of mating mix for the WT strain (no ‘hfq plasmid’) and for purposes
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of comparison this value was set at 1 and all other values normalized to this. (B) Tn5
transposition from the chromosome of DBH261 and derivatives (hfq- and dam-) was
measured as in (A). The data shown is from one experiment with 5 independent isolates
of each strain. The average transposition frequency for the WT strain was 2.57 x 10-6
events per mL of mating mix. In (A) and (B) the error bars indicate standard error on the
mean.
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experiment hfq- also caused an increase in Tn5 transposition, although the magnitude of
the effect was smaller (~ 9-fold) than reported for the DBH179 strain background.
The papillation assay provided an independent means of assessing the impact of
hfq deficiency on Tn5 transposition. In this assay, transposition of a single-copy Tn5derivative (miniTn5LT) present on an F’ plasmid was measured. MiniTn5LT contains a
promoter-less LacZ gene flanked by Tn5 outside end sequences and as such the LacZ
gene is not expressed. However, transposition of miniTn5LT into an actively expressed
transcription unit can result in LacZ expression from read-through transcription into the
LacZ gene (Krebs & Reznikoff, 1988). Transposition events are scored as the
development of LacZ+ papillae on a background of LacZ- cells. In the experiment
presented below, transposase was provided from a plasmid containing the IS50
transposase gene under the control of its native promoter. Accordingly, it was trivial to
introduce mutations into the transposase gene to provide appropriate controls.
We transformed 3 different transposase plasmids into WT and hfq- versions of the
papillation strain, including WT, a catalytically inactive transposase mutant (cat-) and
WT under the control of a Dam methylase-insensitive promoter mutant (Daminsensitive). Transformants were grown up to six days on MacConkey-lactose plates and
the number of papillae formed was counted over this period. We show in Figure 4.3 that
hfq deficiency caused an increase in Tn5 transposition, as at the end of six days there
were on average 2.5-fold more papillae per colony in transformants expressing WT
transposase in hfq- versus hfq+. As expected, papillae were not detected in either hfq+ or
hfq- when the source of transposase included the cat- mutation. Also, the frequency of
papillae formation increased about 50-fold in hfq+ when WT transposase was expressed
from the Dam-insensitive promoter compared to the Dam-sensitive promoter.
We also transformed the Dam-insensitive transposase into hfq- to ask if the
mutations exhibited synergy. The average number of papillae per colony for the double
mutant strain did not differ substantially from that observed in the hfq+ strain containing
the Dam-insensitive transposase promoter, indicating a lack of synergy between the
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Figure 4.3. Papillation assay for Tn5 derivatives in hfq+/- strains.
Isogenic hfq+/- strains (DBH55 and DBH124) containing mini-Tn5 lac tetR
(‘miniTn5LT’) were transformed with plasmids encoding either WT transposase (WT
t’ase), a catalytically defective transposase (Cat- t’ase) or WT t’ase in which the
transposase promoter was mutated to be insensitive to Dam methylase (Dam-Ins). Note
that all versions of transposase, including ‘WT’, encode the M56A mutation to prevent
translation of the inhibitor protein. Transformants were grown on MacConkey-lactose
plates containing Ampicillin (100 µg/mL) for up to 6 days. Images of representative
colonies for each of the strains at different stages are shown. The dark spots are LacZ+
papillae. The total number of papillae counted for the indicated number of colonies at day
6 is tabulated on the right-hand side. Note that the Tn5 transposition frequency is
expected to be roughly proportional to the number of papillae formed (Krebs &
Reznikoff, 1988).
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mutations. This result is consistent with Hfq and Dam methylase affecting the same step
in transposition (see below).

4.2.2

Hfq negatively regulates expression of Tn5 transposase

We next asked if Hfq inhibits Tn5 transposition by down-regulating transposase
expression. In one approach, we measured transposase expression by constructing IS50lacZ transcriptional and translational fusions (‘TCF’ and ‘TLF’, respectively; see Figure
4.4A for schematics), integrating these reporters into the chromosome of a lac- strain
(DBH107), and then performing β-galactosidase assays. This was done for each reporter
in isogenic strains that were either WT, dam- or hfq-. As expected for a promoter that is
Dam-sensitive, transposase expression increased in the context of both transcriptional and
translational fusions in the dam- strain relative to WT (~19- and 25-fold, respectively;
Figure 4.4B). The increase in transposase expression for both constructs in dam- is
indicative of expression coming predominantly from the P1 promoter (Yin et al, 1988).
Transposase expression in TCF and TLF constructs also increased in hfq- cells (11-fold
and 7.4-fold, respectively), indicating that Hfq represses Tn5 transposase expression. As
the TCF encodes only 15 nucleotides of the transposase transcript (T1), the strong upregulation of expression in hfq- is consistent with Hfq acting primarily at the
transcriptional level to down-regulate transposase expression, although we cannot rule
out that a small component of the up-regulation of transposase expression in the TLF
construct is post-transcriptional.
The above reporter constructs were also put into one of the mating out strains
(DBH33 background) so that the impact of hfq deficiency on Tn5 transposition and
transposase expression could be studied in the same genetic background. Consistent with
the results in the DBH107 background, transposase expression increased approximately
14-fold for both reporters under conditions of hfq deficiency (Appendix D).
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Figure 4.4. Transposase-lacZ translational and transcriptional fusion reporter
assays in WT, dam- and hfq- strains.
(A) Schematic of the IS50-lacZ transcriptional fusion (TCF; upper) and translational
fusion (TLF; lower) reporters used in this study. The TCF reporter encodes the first 80 bp
of IS50-Right (white rectangle) fused to lacZ (light blue rectangle). This fusion encodes
only the first 15 nucleotides of the transposase (T1) transcript, which is expressed from
the native promoter; the -35/-10 elements are shown in black. The inhibitor transcript is
not expressed as the promoter for the inhibitor is missing its -10 region. The TLF encodes
the first 128 bp of IS50-Right. This includes up to the 12th codon of T1, which is fused
in-frame to the 10th codon of lacZ (purple rectangle). T1 and T2 and their respective
promoter elements (-35/-10 sequences) are color-coded. Note that the start codon for the
inhibitor protein has been mutated so that only transposase expression will give rise to βgalactosidase activity. Also note that the transposase promoter in both the TCF and the
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TLF is sensitive to Dam methylation. (B) β-Galactosidase activity (given in Miller Units)
for isogenic strains (WT, dam- or hfq-) harboring either the TCF or TLF in single-copy in
the chromosome of E. coli. For each fusion, the activity was normalized to that of the WT
strain. The data sets shown for the TCF and TLF were compiled from 2 and 3
independent experiments, respectively, with each experiment including at least 3
replicates. Mean and standard error values are shown.
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4.2.3

Hfq impacts steady-state levels of full-length IS50
transposase mRNA

To further assess the impact of Hfq on transposase gene expression, we looked at both the
steady-state level and the stability of the transposase transcript (T1) under conditions of
hfq deficiency. For the steady-state analysis, total RNA was isolated from various strains
(DBH33 background) containing a multi-copy plasmid encoding the full-length
transposase gene under the control of its native promoter. Primer extension was used to
detect both T1 and T2 transcripts. Of the two transcripts, the steady-state level of T1
increased the most in hfq- (60-fold versus 6.6-fold for T2; Figure 4.5A,B). By
comparison, the T1 level increased 9.6-fold when P1 was Dam-insensitive. As in the
papillation assay, we failed to see evidence of synergy between Dam-insensitivity and hfq
deficiency, as T1 increased to the same level in the double mutant compared to hfqalone. These results are fully consistent with the inference from the previous section that
Hfq represses IS50 transposase transcription.
To directly test if a component of Hfq-directed repression of IS50 transposase
expression is post-transcriptional, we compared the stability of the IS50 transposase
mRNA (T1) in isogenic WT and hfq- strains. Total RNA was isolated from a pair of
rifampicin-sensitive strains (TM338 and TM618) containing a plasmid encoding IS50
transposase (pDH533) before and after rifampicin treatment as shown in Figure 4.5C.
Transposase mRNA was detected by primer extension as in Figure 4.5A. The results
presented in Figure 4.5C show that hfq deficiency increased the half-life of the T1
transcript by ~ 1.7-fold. This is consistent with Hfq having a small but significant
destabilizing effect on the transposase transcript.

4.2.4

Regulation of Tn5 transposase expression by global
transcriptional regulators

As the primary impact of hfq deficiency on IS50 transposase expression is at the level of
transcription and Hfq does not typically function directly in transcription, it is likely that
Hfq suppression of transposase expression is indirect. In an attempt to define a regulon
that impinges on IS50 transposase expression, and might be affected by hfq-, we surveyed
2 global transcription factors, Crp and Lrp (Martinez-Antonio & Collado-Vides, 2003),
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Figure 4.5.
Steady-state
levels and half-life of IS50 transposase mRNA in hfq+/- cells.
Figure
5.
(A) Primer extension analysis of steady-state transposase mRNA levels. Isogenic hfq+/derivatives of DBH33 were transformed with a high-copy plasmid encoding either WT
T’ase expressed from its native promoter (pDH533) or Dam-Ins T’ase (pDH752) and
grown to mid-log phase before harvesting total RNA. Primer extension reactions were
carried out using 32P-labeled primers complimentary to IS50 transposase (primer
oDH230) or lpp (primer oDH231) mRNA; the latter served as an internal control. The
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corresponding cDNAs were analyzed on denaturing polyacrylamide gels. Transposase
RNA, T1; Inhibitor RNA, T2. (B) Quantification of primer extension analysis. T1 levels
from two independent isolates for each of the indicated strains are plotted after
normalization to the amount of lpp transcript expression, the latter of which is known to
be insensitive to hfq status (Le Derout et al, 2010). Mean and standard error values of
duplicate experiments are shown. (C) Transposase mRNA half-life analysis. Strains
TM338 (hfq+) and TM618 (hfq-) were transformed with transposase encoding plasmid
pDH533 and total RNA was isolated either before or after the addition of rifampicin (at
the indicated time points). Transposase RNA was detected as described in (A). The bands
were quantified (ImageQuant) and T1 normalized to un-extended primer before plotting
the proportion of RNA remaining after rifampicin addition (time zero=1.0). The data was
fit to a one-phase exponential decay curve by non-linear regression (Prism) to determine
the half-life (t1/2). The data shown is a compilation from two independent experiments.
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for effects on IS50 transposase gene expression. Towards this end, we constructed strains
that contained the IS50 TCF described in Figure 4.4 (in single copy) and disruptions of
either the crp or lrp genes and measured transposase expression under a variety of growth
conditions. We show in Figure 4.6A that crp- but not lrp- had a substantial impact on
transposase expression. For example, in cells grown to exponential phase in LB, both crp
and hfq deficiency caused a ~ 4-fold up-regulation of transposase expression, while lrpgave a ~ 1.2-fold reduction. The impact of crp- on transposase expression was slightly
weaker (2.2-fold versus WT) when cells were grown in M9-glucose. We also performed
semi-quantitative RT-PCR and show in Figure 4.6B that crp and hfq deficiency caused an
increase in transposase-lacZ transcript level of a comparable magnitude (Figure 4.6B and
Appendix E).
Given that hfq and crp deficiency increased transposase-lacZ levels to a similar
degree (in at least some growth conditions), we wondered if both Crp and Hfq might
impinge on the same pathway in order to repress IS50 transposase expression. To this
end, we performed a Western blot with an anti-Crp antibody on cell lysates from the WT,
hfq- and crp- strains used in Figure 4.6A. We show in Figure 4.6C that Crp protein levels
decreased ~ 2.5-fold in hfq- relative to hfq+, consistent with the possibility that Hfq
influences transposase expression, at least in part, by up-regulating Crp expression.
Notably, it has been shown that Hfq positively regulates Crp expression ~ 5-fold in
Yersinia pestis (Lathem et al, 2014).

4.2.5

IS50 transposase expression and Tn5 transposition are upregulated by nutrient starvation

Over-expression of sRNAs can alter Hfq-regulated networks by limiting the availability
of Hfq (Hussein & Lim, 2011; Moon & Gottesman, 2011). Given our findings that Tn5
transposition and transposase gene expression are regulated by Hfq, we asked if IS50
transposase expression might similarly be sensitive to Hfq-titration. Towards this end, we
measured transposase expression from the TLF under conditions where a single sRNA
was over-expressed from an inducible promoter (pLlacO) in DBH33. Our initial screen
included four different Hfq-dependent sRNAs, including RybB, RyeB, MicC and SgrS,
all of which are expected to tightly bind Hfq in vivo; apparent equilibrium dissociation
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Figure 4.6. Transposase-lacZ transcriptional fusion reporter assays in strains
harboring disruptions of global transcriptional regulators.
(A) β-Galactosidase activity (given in Miller Units) for isogenic strains (WT, hfq-, crpand lrp-) harboring the TCF in single-copy in the chromosome (DBH303 and
derivatives). Cells were grown to mid-log phase either in M9-Glucose or LB (white and
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blue bars, respectively). WT, crp- and lrp- cells were also grown to saturation in M9Glucose (purple bars). For each growth condition, the activity was normalized to that of
the WT strain. Mean and standard error values of duplicate experiments, each of which
included at least 3 replicates, are shown. (B) Summary of the analysis of IS50-lacZ
transcript levels. Total RNA was extracted from cells described in panel (A), and
subjected to RT-PCR as detailed in Appendix E. (C) Western blot analysis of Crp levels
in cellular extracts from hfq+/- cells grown in LB as described for panel (A). Crp levels
were normalized to GroES, which is known to be insensitive to hfq status (Guisbert et al,
2007). Mean and standard error values from at least three independent isolates are shown.
A representative image is inset. As a negative control, crp- cells were also analyzed.
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constants of ~ 3.3 nM and < 20 nM have been measured for MicC and SgrS, respectively
(Fender et al, 2010; Ishikawa et al, 2012; Wassarman et al, 2001). Importantly, cells were
grown in M9-glucose. We show in Figure 4.7A that only one of the sRNAs tested, SgrS,
has a large impact on transposase expression. Induction of SgrS increased transposase
expression close to 4-fold. Given the comparable Hfq binding affinities of these sRNAs,
it seemed unlikely that SgrS expression was increasing transposase expression through an
Hfq-titration mechanism.
Knowing that SgrS down-regulates expression of the glucose transporter ptsG
(Vanderpool & Gottesman, 2004) and given that the experiment was carried out in M9glucose media, we considered the possibility that up-regulation of transposase expression
reported in Figure 4.7A was a response to nutrient starvation. We show in Appendix F
that induction of SgrS in M9-glucose resulted in a substantial slowing of bacterial growth
as would be expected if nutrients had become growth-rate limiting. To further test the
nutrient starvation hypothesis, we performed a similar experiment (in this case using a
TCF in the DBH107 background) in rich media (LB) and in M9-glucose supplemented
with glycerol, a carbon source whose import is not dependent on glucose transporters
(Agre et al, 1998). We also tested the response of the reporter to over-expression of an
sgrS mutant, sgrS1, that is incapable of down-regulating glucose import (Rice &
Vanderpool, 2011). We show in Figure 4.7B that SgrSWT induced close to a 5-fold
increase in reporter expression relative to a ‘vector’ control, when cells were grown in
M9-glucose. In contrast, SgrS1 was incapable of up-regulating reporter expression,
suggesting that SgrS must be able to down-regulate glucose import in order to increase
transposase transcription. When cells were grown in M9-glucose supplemented with
glycerol, expression of SgrSWT caused only a ~ 2-fold increase in transposase expression,
indicating that glycerol addition was sufficient to overcome much of the starvation
phenotype. Importantly, the reduced effects of SgrS on transposase expression under
‘glycerol’ conditions cannot be explained by differential expression of the respective
sRNAs as levels of SgrSWT and SgrS1 were similar in M9-glucose with or without
glycerol (Figure 4.7C). Also, we failed to see significant transposase induction when
SgrS was over-expressed in LB media where there are multiple carbon sources. Finally,
consistent with the nutrient starvation hypothesis, we also show in Figure 4.7B that
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Figure 4.7. Transposase-lacZ expression assays in cells over-expressing sRNAs.
(A) Transposase expression from a TLF present on a low-copy plasmid (pDH798) was
measured in the presence of a compatible plasmid expressing one of the indicated sRNAs
from the inducible pLlacO promoter in DBH33. Cells were grown in M9 glucose and 0.1
mM IPTG was added to subcultures to induce sRNA expression. Transposase expression
was measured 6 hours after IPTG addition. Expression levels were normalized to the
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strain with the vector only control. (B) The impact of different growth conditions on
SgrS-induced up-regulation of transposase expression was evaluated using a single-copy
TCF fusion present in the chromosome of DBH265. Note that the sgrS1 allele of SgrS
contains a two-nucleotide mutation that inhibits its ability to down-regulate expression of
the ptsG glucose transporter. Subcultures were grown in either M9 glucose, M9 glucose +
glycerol, or LB, as indicated. Transposase expression was measured approximately 4 to 6
hours after subcultures were started or when cells reached an OD600 of ~ 0.6. In (A) and
(B) mean and standard error values of duplicate experiments, each of which included at
least 3 replicates, are shown. (C) Northern blot of RNA isolated from cells in (B). RNA
was extracted from cells immediately before starting the Miller assay and visualized with
32

P-labeled RNA probes complementary to either SgrS or the 5S rRNA (internal control).
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increased transposase expression resulting from SgrS expression in M9-glucose is the
only condition that inhibited cell growth.
Given that transposition frequency is expected to be roughly proportional to
transposase expression, we also asked if glucose starvation had an impact on Tn5
transposition. Cells encoding a chromosomal copy of Tn5 were transformed with an
SgrS-expressing plasmid (or vector only control) and the frequency of Tn5 transposition
was measured using the mating out assay. Note that cells were grown in M9-glucose
media and SgrS expression was induced only when donor strains were subcultured on the
day of mating. We show in Figure 4.8 that induction specifically of SgrSWT resulted in a
5-fold increase in Tn5 transposition relative to the vector only control. Notably, when
cells were grown in M9 supplemented with glucose and glycerol, induction of SgrSWT did
not result in a significant increase in Tn5 transposition. Also, we observed a reduced
growth rate only in cultures where SgrSWT was induced in M9-glucose media (data not
shown). The results of the mating out analysis are thus entirely consistent with the gene
expression experiments presented in Figure 4.7.
Taken together, the results in this section are consistent with nutrient starvation
leading to both increased transposase transcription and Tn5 transposition.

4.3 Discussion
Hfq is a global regulator of gene expression in bacteria. However, until recently Hfq had
not been linked to the control of transposable elements. Work in the Tn10/IS10 system
provided the first example of Hfq playing a protective role against a mobile DNA
element (Ross et al, 2010). In the current work, we asked if a second transposon,
Tn5/IS50, is also regulated by Hfq. We show that Hfq strongly down-regulates Tn5
transposition and present evidence that the primary mechanism of regulation is through
the inhibition of transposase transcription. Additional genetic analysis identified: (i) Crp
as a negative regulator of IS50 transposase transcription and (ii) Hfq as a positive
regulator of Crp expression. Taken together, these results are consistent with Hfq and Crp
working in the same pathway to limit IS50 transposase expression. We also show that
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Figure 4.8. Impact of SgrS expression on Tn5 transposition.
Transposition of a chromosomal copy of Tn5 was measured in DBH179 using the mating
out assay. DBH179 containing one of the indicated plasmids was grown overnight in M9Glucose and then sub-cultured in either M9-Glucose or M9-Glucose plus Glycerol as
described in Materials and Methods before mating with the recipient strain and plating on
selective media as described in Figure 2. IPTG was added to the subculture (to 0.1 mM)
to induce SgrS expression, except where indicated (-IPTG). The average transposition
frequency for the ‘no SgrS’ control was 5.52 x 10-5 events per mL of mating mix. All
other transposition frequencies were normalized to this value. Mean and standard error
values of duplicate experiments, each of which included at least 5 replicates for each
experimental group, are shown.
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IS50 transposase transcription is induced by nutrient starvation, providing this mobile
element with a means of responding to environmental stress.

4.3.1

Hfq negatively regulates Tn5 transposition

Two different transposition assays were used to determine if hfq deficiency impacts on
Tn5 transposition. The results of both mating out and papillation experiments were
consistent with Hfq acting as a negative regulator of this transposon. Importantly, the two
assays employ different outputs for measuring transposition. As such, we can be
confident that the observed increases in transposition frequency are not systematic errors
in the assays linked to the elimination of a pleiotropic regulator. It should also be
recognized that the two assays measure transposition under different growth conditions.
In the papillation assay, prolonged growth on plates results in nutrient limitation and the
majority of cells in a colony grow essentially under anaerobic conditions (Twiss et al,
2005). In contrast, most of the growth in the mating out assay is performed without
nutrient limitation and with good aeration. These factors can significantly affect the
magnitude a mutation has on transposition frequency (Swingle et al, 2004). In the results
presented in this work, we found that hfq deficiency caused a much greater increase in
Tn5 transposition in the mating out compared to the papillation assay. At present we have
no clear explanation for this result. One trivial possibility is that hfq- colonies in the
papillation assay appear to have stopped growing relatively early in the 6 day time course
and this could have limited papillae formation relative to the hfq+ strain. An alternative
possibility relating to σS expression is discussed below.
We also found that the magnitude of the Tn5 transposition increase was
dramatically different for hfq- in two different strain backgrounds. Both DBH179 and
DBH261 are K12-derived strains, but like many laboratory strains of E. coli their
histories are quite different. We routinely found that hfq- had a greater negative impact on
growth rate in the DBH261 strain background and this may have increased the likelihood
of picking up partial suppressors of hfq deficiency. If this were the case, the impact of
hfq- on Tn5 transposition could be dampened. However, it may be useful in the future to
perform expression profiling on the two strains in an attempt to define genes that modify
the impact of hfq deficiency on Tn5 transposition.
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Another feature of the transposition assays worth pointing out is that hfq- caused a
larger increase in Tn5 transposition versus dam- (mating out assay), but a smaller increase
versus mutations that made the transposase promoter Dam methylase-insensitive
(papillation assay). A possible explanation for this observation is that the two basepair
mutations that confer Dam methylase-insensitivity have secondary effects (positive in
nature) on the transposase promoter. In this regard, the net effect of both mutations is to
increase the A-T content in the -10 region of the transposase promoter and this could
increase promoter strength. Alternatively, dam deficiency could have additional effects
on the transposase promoter that indirectly counteract the positive effects of relieving
promoter methylation. For example, the expression of a repressor that acts on the
transposase promoter might be increased in dam- cells.
Two final aspects of the transposition assays worth mentioning relate to the transcomplementation results. First, detecting trans-complementation with HfqWT established
that the observed increase in Tn5 transposition was in fact due to hfq deficiency as
opposed to possible polar effects of the hfq-disruption allele used in this work. Second,
the failure of RNA binding face mutants of Hfq to provide trans-complementation
suggests that Hfq-directed inhibition of Tn5 transposition relies on functions of Hfq
required in canonical Hfq-directed regulatory pathways (Mikulecky et al, 2004). That is,
Hfq must retain the ability to bind both mRNAs and sRNAs to influence Tn5
transposition. Genetic analysis in the Tn10/IS10 system led to the same conclusion (Ross
et al, 2013).

4.3.2

Hfq and IS50 transposase gene expression

Evidence that Hfq down-regulates IS50 transposase expression came from two types of
experiments. First, the expression of transposase-lacZ reporter genes in both
transcriptional and translational fusion constructs increased significantly under conditions
of hfq deficiency. Second, the steady-state level of the native transposase transcript also
increased significantly in hfq deficiency. Importantly, the large increase in steady-state
transcript level coincided with only a minor increase in transposase stability. Taken
together, these results provide strong evidence that Hfq predominantly suppresses IS50
transposase transcription, with only minor post-transcriptional effects.
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As Hfq does not typically act directly in gene transcription, we think it likely that
it acts indirectly on the IS50 transposase promoter. In addition to Dam methylase, only
one other factor, LexA, has been implicated as a regulator of transposase transcription.
LexA is a transcriptional repressor and part of the SOS-response regulon (Walker, 1984).
There is a weak LexA-binding site in the transposase promoter (Figure 4.1), however,
lexA deficiency was shown to increase transposase transcription only 2 to 3-fold (Kuan &
Tessman, 1991). As we have seen increases in transposase expression of up to 14-fold in
hfq deficiency, it seems unlikely that Hfq would be working through LexA. We also do
not think that hfq deficiency impacts Dam methylase expression. This comes from a
previous observation where we assessed the impact of hfq- on IS10 transposase
expression in a TCF. If hfq deficiency reduced Dam methylase levels or activity, then it
would be expected that IS10 transposase expression in this fusion would also increase. In
fact, no increase in transposase transcription was observed, although hfq deficiency did
increase IS10 transposase expression in a TLF (Ross et al, 2010).
We searched for a potential Hfq target by looking at the impact of gene
disruptions of two global transcription factors, Crp and Lrp, on IS50 transposase
expression using our TCF construct. While lrp deficiency had almost no impact, crp
deficiency increased transposase expression to approximately the same level as hfq
deficiency when cells were grown in rich media. Given the similar magnitude of upregulation observed for hfq- and crp-, we considered the possibility that Hfq might be
working through Crp. Preliminary evidence supporting this possibility was provided
when we looked at the impact of hfq deficiency on Crp protein levels. This experiment
revealed that the steady-state Crp protein level decreased approximately 2.5-fold in hfqcells grown in rich media. This finding is consistent with Hfq acting as a positive
regulator of Crp expression. Notably, in recent work it was shown in Yersinia pestis that
Hfq positively regulates Crp (~ 5-fold) at the post-transcriptional level (Lathem et al,
2014). There is also an example in the literature of Crp down-regulating the transcription
of a transposase gene. In the case of IS2, crp deficiency increased transposase
transcription close to 200-fold. It was also shown through protein-DNA footprinting that
Crp binds directly to the IS2 transposase promoter (Hu et al, 1998). We have not yet
looked at the possibility that Crp binds directly to the IS50 transposase promoter.
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In addition to defining new negative regulators of IS50 transposase transcription
(and transposition), we also identified in this work a stress condition that activates
transposase expression and Tn5 transposition. Glucose starvation, induced by overexpression of the sRNA SgrS in M9-glucose media, induced transposase expression and
transposition ~ 4- to 5-fold. This response has not yet been characterized in detail but as
glucose starvation is known to induce expression of the stationary phase sigma factor (σS)
(Mandel & Silhavy, 2005), we suggest that an imbalance of σS to σ70 could be driving
this up-regulation. Notably, both σS and σ70 recognize similar promoter sequences, but σS
is more tolerant of sequence variations from the consensus (Landini et al, 2014). The
IS50 transposase promoter matches somewhat poorly to the consensus sequence of σ70
and σS, so it is possible that certain deviations would be better tolerated by σS. In
particular, the IS50 promoter matches poorly to the -35 consensus sequence, which is an
important determinant of σ70 but not σS recognition. Additionally, a guanine at the -14
position (where the first nucleotide of the -10 hexamer is arbitrarily designated -12) is a
distinguishing feature of σS promoters (Landini et al, 2014) and there is a guanine at this
position in the IS50 transposase promoter. It follows that if the IS50 transposase promoter
is better suited for σS-bound RNA polymerase (RNAP), an imbalance in σS to σ70 would
increase expression from this promoter.

4.3.3

Working model for regulation of the IS50 transposase gene

Based on results provided in this work, we present a working model for how IS50
transposase transcription is regulated (Figure 4.9). In this model, Hfq and Crp are
components of a self-regulating (feed-back) loop wherein Crp, or a protein controlled by
Crp, directly binds the transposase promoter to inhibit transcription. Hfq positively
regulates Crp to maintain a repressed state, but under conditions of low glucose, Crp (in
its cAMP-bound form) would limit Hfq expression (Lin et al, 2011), thereby permitting
up-regulation of transposase transcription. Under conditions of severe glucose limitation,
induction of σS expression would further activate the transposase promoter by
outcompeting σ70 for RNAP holoenzyme formation and conferring the holoenzyme with
a higher intrinsic binding affinity for the transposase promoter compared to RNAP-σ70.
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Post-transcriptional?
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Figure 4.9. Working model for Hfq-directed regulation of IS50 transposase
expression.
The basic model is described in the text. The pathway on the far right (dashed red line)
indicates that Hfq has a minor impact on IS50 transposase expression at the posttranscriptional level. The dashed green line indicates that possibility that Crp may not act
directly on the transposase promoter to inhibit transcription.

Figure 9.
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The system would of course be sensitive to other factors that influence Crp and cAMPCrp levels. For example, the global transcription factor Fis is an important negative
regulator of Crp expression (Ninnemann et al, 1992) and accordingly would be expected
to act in opposition to Hfq to promote transposase expression. In fact, Fis is a positive
regulator of Tn5 transposition, although a mechanism for how it promotes Tn5
transposition was never established (Weinreich & Reznikoff, 1992).
Our working model can explain the observation that hfq deficiency caused a
smaller increase in transposition in the papillation versus mating out assays. As
previously noted, growth conditions in the papillation assay are expected to be more akin
to stationary phase growth. It follows that transcription of transposase (and thus
transposition) would be dependent on σS in the papillation assay. Importantly, Hfq is
required for efficient translation of σS (Soper & Woodson, 2008). While the large
increase in transposition in the mating out assay reflects the absence of inhibition by hfq,
the smaller increase in the papillation assay could reflect a balance between the loss of
Hfq-imposed repression and reduced expression of σS.
With regard to the possibility that σS is a key factor in up-regulating IS50
transposase expression under glucose starvation conditions, it has previously been shown
that entry into stationary phase (where nutrients are growth limiting) induced
transposition of Tn4652 in Pseudomonas putida by up-regulating transposase
transcription. This response was found to be dependent on σS, although it was not
established if σS bound directly to the transposase promoter under these growth
conditions (Ilves et al, 2001). To further test the idea that σS plays a key role in induction
of the IS50 transposase transcript under glucose starvation conditions, it will be important
to determine if this response is abrogated in a strain containing an rpoS disruption. As
well, to further test the idea that Crp is a central player in the IS50 transposase regulatory
network, it will be important to test the possibility that Crp binds directly to the
transposase promoter.
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4.3.4

Hfq and genome defense

It is now clear that, like eukaryotes and archaea, bacteria have evolved self-defense
systems that utilize small non-coding RNAs to provide protection against foreign DNA,
including transposons. This includes the CRISPR and the newly discovered Argonautbased surveillance systems (Olovnikov et al, 2013; Wiedenheft et al, 2012). In this
context, we find it striking that Hfq, a mediator of non-coding RNA response pathways,
strongly down-regulates two different transposition systems. If additional transposition
systems are likewise down-regulated by Hfq, this would be suggestive of a general role
for Hfq in host defense against transposons. Considering that transposons have drastically
influenced the evolutionary trajectory of their hosts, including contributing to the
assembly and modulation of RNA-based gene expression networks (Feschotte, 2008), it
is possible that Hfq-dependent small RNA regulatory networks actually evolved from
Hfq-directed host defense mechanisms. In this regard it is relevant that repression of both
IS50 and IS10 transposase expression does require that Hfq possess functional mRNAand sRNA-binding surfaces. Conversely, linking transposon mobilization with Hfq could
enable transposons to mobilize in response to various stress signals that ultimately reduce
the concentration of available Hfq in cells.

4.4 Materials and Methods
4.4.1

Plasmids, bacteriophage and strains

Plasmids used in the papillation assay (pDH533, WT; pDH828, cat-; pDH752, DamInsen) are derivatives of pRZ9905, which encodes M56A transposase under the control
of the native IS50 promoter (P1). The IS50 translational fusion plasmid (pDH798) is a
pWKS30-derivative containing basepairs 1-431 of IS50 (nucleotides 1-366 of T1) fused
to codon 10 (Agrawal et al, 1998) of the E. coli lacZ gene. The IS50 transcriptional
fusion plasmid (pDH682) is a pUC18-derivative containing basepairs 1-80 of IS50
(nucleotides 1-15 of T1) fused to nucleotide -16 (relative to the translational start codon)
of lacZ. Plasmids encoding sRNAs (pDH764, sgrS; pDH766, rybB; pDH768, micC;
pDH772, ryeB) and the corresponding empty vector control (pDH763) were kindly
provided by S. Gottesman. The plasmid encoding sgrS1 (pDH895) was kindly provided
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by C. Vanderpool. Plasmids encoding Hfq (pDH700, WT) and mutant derivatives
(pDH701, K56A; pDH713, Y25A) are described in Ross et al (2013). Details of plasmid
constructions are provided in Appendix G (Supplemental Methods). A list of
oligonucleotides is provided in Appendix H.
Lambda phages encoding IS50 transcriptional (λDBH849 and λDBH888) and
translational (λDBH812) reporters were generated by cloning IS50 expression cassettes
marked with an antibiotic resistance gene (either kanR or cmR) into the his operon of
pNK81 and then infecting a strain harboring one of these plasmids with λNK1039, which
also contains the his operon. Antibiotic resistant lysogens from the above crosses were
selected by replica plating and subsequently phage released from the lysogens were
purified, giving rise to λDBH849 (IS50-lacZ-kanR TCF), λDBH888 (IS50-lacZ-CmR
TCF) and λDBH812 (IS50-lacZ-KanR TLF).
E. coli strains for the mating out assay were constructed by P1 transduction of
Tn5 from ER2507 (NEB) into DBH33 and DBH259. Strains containing chromosomal
IS50-lacZ fusions were generated by lysogenizing DBH107 with λDBH849 (DBH265),
λDBH888 (DBH303) or λDBH812 (DBH281). Mutant derivatives of these strains were
generated by P1 transduction. A list of all of the strains, plasmids and bacteriophage used
in this work is presented in Table 4.1.

4.4.2

Mating out assay

Conjugal mating out experiments were performed essentially as described for single-copy
chromosomal transposons in Ross et al (2010), except that donor growth was carried out
in M9 glucose media supplemented with kanamycin (25 mg/mL) and amino acids,
instead of LB. DBH13 was used as the recipient. Total exconjugants and transposition
events with DBH179 and derivatives were scored by plating mating mixes on M9
Glucose plates supplemented with leucine, thiamine and streptomycin (150 mg/mL) or
streptomycin and kanamycin (25 mg/mL), respectively. Total exconjugants and
transposition events with DBH261 and derivatives were scored by plating mating mixes
on M9 Glucose plates supplemented with leucine, thiamine, streptomycin (150 mg/mL)
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and gentamycin (12.5 mg/mL) or streptomycin, gentamycin and kanamycin (25 mg/mL),
respectively.
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Table 4.1. List of E. coli strains, plasmids and phage used in this study.
Strain or
Plasmid

Relevant genotype

Use

Source or reference

HB101 [F- leu- pro-]; StrR

Mating out recipient
Source of zjc::Tn5
Mating out donor
Mating out donor
Mating out donor
Source of pOX38Gen
Parent strain

DBH259
DBH261
DBH271
DBH272
DBH55

zjc::Tn5; KanR
NK5830 [recA- arg- / F’ lacpro+] zjc::Tn5; KanR
DBH179 hfq-1::Ωcat; KanRCmR
DBH179 dam::Tn9cat; KanRCmR
RZ211/pOX38Gen
HW-5 [phoA4(Am) his-45 recA1 rpsL99 met-54 F-];
StrR
DBH233 / pOX38Gen; StrRGenR
DBH259 zjc::Tn5; StrRGenRKanR
DBH261 hfq-1::Ωcat; StrRGenRKanRCmR
DBH261 dam::Tn9cat; StrRGenRKanRCmR
DH10B / pOX38Gen miniTn5lactetR; TetR

DBH124
DBH107
DBH265
DBH267
DBH268
DBH281
DBH283
DBH285
DBH303
DBH306
DBH307
DBH315
DBH33
DBH16
DBH241
DBH238
DBH239
DBH240
DBH208
DBH210
DBH237
TM338

DBH55 hfq-1::Ωcat; TetRCmR
MC4100 [F- Δ(argF-lac)169* rpsL150]; StrR
DBH107/λDBH849; StrRKanR
DBH265 hfq-1::Ωcat; StrRCmRKanR
DBH265 dam::Tn9cat; StrRCmRKanR
DBH107/λDBH812; StrRKanR
DBH281 hfq-1::Ωcat; StrRCmRKanR
DBH281 dam::Tn9cat; StrRCmRKanR
DBH107/λDBH888; StrRCmR
DBH303 Δhfq722::kan; StrRCmRKanR
DBH303 Δcrp765::kan; StrRCmRKanR
DBH303 Δlrp787::kan; StrRCmRKanR
NK5830 [recA- arg- / F’ lacpro+]
DBH33 hfq-1::Ωcat; CmR
DBH33 dam::Tn9cat; CmR
DBH33/λDBH849; KanR
DBH238 hfq-1::Ωcat; KanRCmR
DBH238 dam::Tn9cat; KanRCmR
DBH33/λDBH812; KanR
DBH208 hfq-1::Ωcat; KanRCmR
DBH208 dam::Tn9cat; KanRCmR
W3110mlc rne-Flag-cat; rifSCmR

TM618

W3110mlc rne-Flag-cat Δhfq; rifSCmR

DH5α

recA-

Papillation Assay
Parent strain
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Parent strain
Parent strain
Parent strain
Miller Assay
Miller Assay
Miller Assay
Miller Assay
Milller Assay
Miller Assay
RNA half-life
measurements
RNA half-life
measurements
Plasmid propagation

(Bolivar & Backman,
1979)
NEB
This study
This study
This study
(Cuzon et al, 2011)
(Hoffman &
Wilhelm, 1970)
This study
This study
This study
This study
(Whitfield et al,
2009)
This study
(Casadaban, 1976)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
(Foster et al, 1981)
(Ross et al, 2010)
This study
This study
This study
This study
This study
This study
This study
(Morita et al, 2004)

Plasmids
pWKS30

pSC101-derived; low copy-number ori ; ApR

pDH700
pDH701
pDH713
pDH533

pWKS30-P3-hfqWT ; ApR
pWKS30-P3-hfqK56A ; ApR
pWKS30-P3-hfqY25A ; ApR
pUC18-derivative; Tn5 t’ase M56A; ApRCmR

E. coli
DBH13
ER2507
DBH179
DBH184
DBH270
DBH228
DBH233

Parent strain
Mating out donor
Mating out donor
Mating out donor
Papillation Assay

‘Empty vector’ for
Hfq expression
HfqWT expression
HfqK56A expression
HfqY25A expression
Source of Tn5
transposase (No Inh.)

(Morita et al, 2005)
Invitrogen

(Wang & Kushner,
1991)
(Ross et al, 2013)
(Ross et al, 2013)
(Ross et al, 2013)
(Whitfield et al,
2009)
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pDH752
pDH828
pNK81
pDH682
pDH838
pDH883
pDH849
pDH888
pDH658
pDH795
pDH804
pDH812
pDH753

pDH533 with t’ase mutated to G53A,C61A; ApRCmR
pDH533 with t’ase mutated to D97A; ApRCmR
pBR333-derivative; encodes his operon; ApR
pUC18-derivative; IS50-lacZ TCF; ApR
pDH682-derivative; TCF ‘marked’ with kanR
pDH682-derivative; TCF ‘marked’ with cmR
TCF-kanR from pDH682 cloned into BclI-cut
pNK81; ApRKanR
TCF-cmR cloned onto BclI-cut pNK81; ApRCmR
pRZ9905-derivative; full-length IS50-lacZ TLF; ApR
pDH658-derivative; ‘deletion’ TLF used in this
study; ApR
pDH795-derivative; TLF ‘marked’ with kanR
TLF-kanR cloned into BclI-cut pNK81; ApRKanR

Dam-insensitive t’ase
Catalytic- t’ase
Lambda crosses
Source of TCF
Parent of pDH849
Parent of pDH888
For crossing TCF
onto λ
For crossing TCF
onto λ
Parent of pDH795
Parent of pDH804

This study
This study
(Way et al, 1984)
This study
This study
This study
This study

Parent of pDH812
For crossing TLF
onto λ
Parent of pDH798

This study
This study

This study
(Guillier &
Gottesman, 2006)
(Vanderpool &
Gottesman, 2004)
(Wadler &
Vanderpool, 2009)
(Mandin &
Gottesman, 2010)
(Mandin &
Gottesman, 2010)
(Mandin &
Gottesman, 2010)

pDH798
pDH763

pWKS30-derivative; contains IS50-lacZ TLF from
pDH658; ApR
pDH753-derivative; ApSKanR
pBR-plac; ApR

pDH764

pBR-plac-sgrSWT; ApR

Miller Assay
Vector for sRNAinduction
SgrS-induction

pDH895

pBR-plac-sgrS1; ApR

SgrS1-induction

pDH766

pBR-plac-rybB; ApR

RybB-induction

pDH768

pBR-plac-micC; ApR

MicC-induction

pDH772

pBR-plac-ryeB; ApR

RyeB-induction

Encodes his operon
IS50-lacZ translational fusion (TLF) from pDH812
marked with kanR
IS50-lacZ transcriptional fusion (TCF) marked with
kanR
IS50-lacZ transcriptional fusion (TCF) marked with
cmR

Parent phage
Chromosomal TLF
construction
Chromosomal TCF
construction
Chromosomal TCF
construction

Phage
λNK1039
λDBH812
λDBH849
λDBH888

This study
This study
This study

This study

(Haniford et al, 1989)
This study
This study
This study
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4.4.3

Papillation assay

Isogenic hfq+/- strains (DBH55 and DBH124) encoding mini-Tn5 lac tetR on the F’ were
transformed with plasmids encoding either WT IS50 transposase (pDH533), a
catalytically ‘dead’ transposase (pDH828) or a Dam-insensitive transposase (pDH752).
Transformants were selected on MacConkey agar plates supplemented with lactose (1%
w/v) and ampicillin (100 mg/mL). Plates were incubated at 37˚C for up to 6 days.

4.4.4

β-galactosidase assays

Cells were grown in M9 glucose (with arginine and thiamine) or LB. In situations where
strains contained plasmids, plasmids were maintained by including the appropriate
antibiotic. Overnight cultures (0.05 mL) were used to seed subcultures (1.5 mL), which
typically were grown to mid-log phase before being processed for the Miller assay as
previously described (Ross et al, 2010).

4.4.5

RNA isolation, primer extension and Northern blot analysis

Total RNA was isolated essentially as described in (Garrey & Mackie, 2011). For steadystate analysis, cells were grown to mid-log phase in LB before RNA isolation. For halflife analysis, rifampicin (dissolved in DMSO) was added to cell cultures (to 200 µg/mL)
to arrest transcription and RNA was isolated immediately before and after rifampicin
addition at the indicated time intervals. Primer extension analysis was carried out using
32

P-labeled primers oDH230 or oDH231, end-labeled with OptiKinase (USB) according

to manufacturer’s instructions. Extension reactions used 5 µg of RNA, and Superscript III
reverse transcriptase essentially as described in (Wilkinson et al, 2006), except that
annealing was performed at 65°C (with no ice treatment) before extending at 55°C for 45
minutes. Extension products were resolved on a 6% denaturing polyacrylamide gel. For
Northern blot analysis, 2 µg of RNA was mixed with an equal volume of denaturing load
dye (95% deionized formamide [v/v], 10 mM EDTA, 0.5x TBE, 3% xylene cyanol
[w/v]), heated to 95°C for 2 minutes, and resolved on a 6% polyacrylamide gel
containing 7 M urea. Separated RNAs were electro-transferred to Hybond N (GE
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Healthcare) in 0.5x TBE and fixed with UV. Annealing and washing was performed in
ULTRAhyb buffer (Ambion) according to the manufacturer’s instructions, using RNA
probes complimentary to SgrS or the 5S rRNA (internal standard). To construct the
radiolabeled RNA probes, DNA templates for in vitro transcription were made by PCR
with primers oDH232/233 (SgrS) and oDH234/235 (5S rRNA)—note that, for each
primer pair, the forward primer includes the T7 core promoter. These templates were
transcribed in vitro in the presence of 32P-UTP to generate uniformly labeled RNA
probes. In vitro transcription reactions were performed in 25 µL volumes with ~ 1 µg
DNA template, 1x T7 RNA polymerase buffer (NEB), 20 units RNasin (Promega), 4 mM
DTT, 0.16 mg/mL BSA, 0.4 mM each of rGTP, rCTP and rATP, 0.01 mM rUTP, 50 µCi
[α-32P]UTP, and 100 units of T7 RNA polymerase.

4.4.6

Western blot

Cells were centrifuged (2 minutes at 21,000 x g), resuspended in SDS load mix (2%
[w/v] SDS, 10% [v/v] glycerol, 50 mM Tris-HCl pH 6.8, 0.25% [w/v] bromophenol blue,
0.8 M β-mercaptoethanol) and heated at 95°C for 5 minutes. To normalize for differences
in growth between the various samples, the OD600 of each sample was measured and the
volume spun normalized to give an equivalent to OD600 ≈ 0.35. The resulting lysates were
subjected to SDS-PAGE on a 12% polyacrylamide gel, proteins transferred to PVDF
(Roche) and Crp was detected by Western blot with a polyclonal rabbit anti-Crp antibody
(kind gift of H. Aiba). The primary antibody was diluted 1:20,000 in TBST; the
secondary antibody (anti-rabbit IgG-HRP conjugate; Promega) was used at 1:5000. Crp
was visualized with a Pierce ECL 2 Western blotting substrate (Thermo Scientific) and
PhosphorImager. The membranes were stripped and GroES detected (rabbit anti-GroES
antibody from Sigma-Aldrich at 1:10,000) for use as an internal standard; GroES is not
sensitive to hfq status (Guisbert et al, 2007). Bands were quantified (ImageQuant) and
Crp levels plotted relative to GroES.
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Chapter 5

5

General Discussion

The work presented in this thesis expands on the knowledge of host-factor involvement
in transposition, establishes host-imposed post-transcriptional regulation as a mechanism
for potent repression of transposition, and investigates transposon mobilization during
stress-response. I show that the global post-transcriptional regulator Hfq plays a
previously unknown role as a negative regulator of two separate transposons, and that this
regulation is imposed at the level of transposase expression. In the case of Tn10/IS10,
Hfq down-regulates transposase expression at the post-transcriptional level. Conversely,
Hfq down-regulates Tn5/IS50 transposase expression at the transcriptional level, possibly
through the Crp regulon. Finally, investigation of Hfq-dependent sRNAs as mediators of
stress-response pathways led to the finding that nutrient starvation activates IS50
transposase transcription and stimulates Tn5 mobility, linking the Tn5 system to this
form of environmental stress for the first time. My insights into the regulation imposed
on Tn10 and Tn5 transposase expression by Hfq and Crp are summarized in Figure 5.1.
In this section, I further discuss the general implications of linking mobility of
transposable elements to the global regulatory protein Hfq, which is also central to many
pathways for bacterial stress-response.

5.1 Transposase expression is a major point of hostimposed regulation
It is beneficial to a given transposon to mobilize frequently enough to be maintained
without unnecessarily harming the host cell by causing destructive levels of genomic
instability. This evolutionary pressure has resulted in tight negative control of
transposons. Transposase proteins catalyze the chemical steps in bacterial transposition
reactions. It follows that the regulation of expression of these genes is a critical feature in
dictating the transposition frequency of most transposons (Kleckner, 1990). The
endogenous promoters of bacterial transposase genes are typically transcribed
inefficiently. Examples include IS10 (Simons and Kleckner, 1983), IS21 (Reimmann et
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Figure 5.1. Summary of major insights into host-imposed regulation of Tn10/IS10
and Tn5/IS50 gained in this work.
Dashed lines indicate unverified potential points of regulation. Green and red arrows
indicate positive and negative regulation, respectively. The IS10 and IS50 transposase
promoters may be transcribed by RNAP-σS during starvation (and other forms of stress).
Hfq is expected to be required for efficient translation of σS (and therefore starvationinduced transcription of transposase); however, starvation experiments were not
conducted in an hfq- strain for technical reasons. Hfq positively regulates Crp (probably
at the post-transcriptional level) while Crp-cAMP negatively regulates hfq transcription
(Lin et al., 2011), completing a regulatory feedback loop. Crp negatively regulates
expression of IS50 transposase, either directly or via some other component of the Crp
regulon. Through Crp, Hfq negatively regulates IS50 transposase transcription. Hfq also
exerts a small regulatory effect on IS50 transposase mRNA (T1) stability. Hfq negatively
regulates IS10 transposase expression at the post-transcriptional level. Hfq might act
indirectly on the transposase mRNA (RNA-IN) via an unknown component of the Hfq
regulon, or it might act directly to block translation initiation (with or without an sRNA
partner). Hfq also enhances antisense regulation by RNA-OUT. This probably entails
increasing the rate of initial RNA-IN/OUT interaction by binding both species and
increasing their relative local concentrations. Hfq can also restructure both RNA-IN and
RNA-OUT (at least in vitro), revealing the appropriate sequences in each species to
maximize the number of inter-molecular base pairs that can form in a minimal amount of
time (i.e. without requiring the intra-molecular base pairs to melt spontaneously). A
summary of the predicted structures of RNA-IN and RNA-OUT, as well as their base
pairing interaction, is highlighted in green and red for the absence versus presence of
Hfq, respectively. Increased antisense pairing will yield less translation of transposase
and thus, less frequent transposition. The TIR is denoted by asterisks representing the
Shine-Dalgarno (SD) sequence and the AUG codon.
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al., 1989), IS30 (Dalrymple and Arber, 1985) and IS911 (Duval-Valentin et al., 2001).
Host-encoded factors can also be co-opted to facilitate repressive mechanisms. There are
at least two host proteins known to limit Tn5 transposase expression. The IS50
transposase promoter contains sequences for Dam methylation that overlap the -10
sequence; when fully methylated, transcription initiation is repressed (Yin et al., 1988).
The same mechanism is used for IS10 and IS903. LexA, a transcriptional repressor of the
SOS regulon, has also been implicated in repressing IS50 transposase expression, with
modest increases in transposase transcription and Tn5 transposition in a lexA-deficient
strain (Kuan and Tessman, 1991; Kuan et al., 1991). As described in Chapters 2 and 4,
the impact of Hfq on transposase expression in the Tn10 and Tn5 systems is greater than
that of either Dam methylase or LexA. Notably, these are the first instances in which a
host-factor involved in post-transcriptional regulation has been implicated in transposon
mobility. Based on the magnitude of the transposition increase seen in hfq-null strains,
Hfq is the strongest host-encoded repressor of Tn10 or Tn5 transposition described to
date. As discussed below, Hfq exerts this negative regulation via multiple mechanisms,
including post-transcriptional regulation (through both an antisense dependent and
independent pathway) for Tn10/IS10 and transcriptional regulation (possibly involving
the Crp regulon) for Tn5/IS50.

5.2 Post-transcriptional regulation of Tn10/IS10
transposase expression
Intrinsic mechanisms for post-transcriptional transposon regulation have been well
established (reviewed in Nagy and Chandler, 2004). For instance, Tn10 and Tn5 (and
probably other transposons) encode DNA sequences that protect them from readthrough
transcription by forming translationally repressive secondary structures only in the
context of mRNA expressed from an exogenous promoter (Davis et al., 1985; Krebs and
Reznikoff, 1986). In the case of Tn10/IS10 (and a few others, e.g. IS30), a transposonencoded antisense RNA blocks translation initiation by sequestering the TIR in basepairing interactions between perfectly complementary regions of the asRNA and
transposase mRNA (Arini et al., 1997; Ma and Simons, 1990). However, my work
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constitutes the first demonstration that a bacterial host factor has been co-opted to help
impose translational silencing of a transposase.

5.2.1

Hfq participates in regulation by a cis-encoded antisense
RNA

Genetic evidence in Chapter 2 suggests that Hfq down-regulates IS10 transposase
translation, in large part, by enhancing antisense regulation by RNA-OUT. The
magnitude of repression of transposition by Hfq appears to correlate with the expected
levels of RNA-OUT-imposed negative regulation (i.e. the higher the IS10 copy number,
the larger the de-repression when hfq is disrupted). Further evidence in Chapters 2 and 3
suggests that Hfq functions in the RNA-IN/OUT system in analogous fashion to its
canonical role in sRNA/mRNA systems. To this point the general perception has been
that, due to the perfect complementarity between cis-asRNAs and their targets, the
regulatory function of asRNAs will not be dependent on Hfq (Waters and Storz, 2009). In
the case of RNA-OUT, and other systems, the presence of base pairing discontinuities in
structured regions of asRNAs has been shown to be critical for antisense regulation,
likely because they provide a thermodynamic incentive for breaking intra-molecular base
pairs (e.g. 23 in RNA-OUT) in order to form inter-molecular base pairs (e.g. 35 between
RNA-IN and RNA-OUT) (see Chapter 3 and Wagner et al., 2002). Nevertheless, it is
unclear if these discontinuities are sufficient for a robust antisense response in vivo.
RNA-OUT, for instance, forms a stable secondary structure (see Chapter 3 and Case et
al., 1989), and we also show in this work that RNA-IN possesses secondary structure that
could impede RNA-IN/OUT pairing. Though it might be favourable to melt these
structures in order to allow extensive base pairing between RNA-IN and RNA-OUT, it is
conceivable based on the results in Chapter 3 that Hfq would enhance the rate and/or
stability of antisense regulation by bringing RNA-IN and RNA-OUT into close proximity
(to enhance the rate of initial interaction) as well as to increase the number of unpaired
bases in the IN/OUT pairing region of each RNA. In this regard, it will be interesting to
see if the effectiveness of other antisense systems shows any reliance on Hfq. Hfq has
been shown to function in one other antisense system by stabilizing the asRNA (GadY),
but it was not determined if Hfq played any role in antisense pairing (Opdyke et al.,
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2004). My work represents the first report of binding determinants and other mechanistic
insights into Hfq-aided base pairing in a classical antisense system. Overall, Hfq treats
the mRNA and asRNA components of this system like a canonical mRNA/sRNA system.
The demonstration that Hfq can play an active remodeling role for both the mRNA and
asRNA (at least in vitro) in order to facilitate pairing supplements the existing sRNA
literature, in which only a few such examples have been investigated (Geissmann and
Touati, 2004; Soper et al., 2011).
This work raises the possibility that Hfq participates in antisense regulation of
other transposition systems, as well as other antisense regulatory systems in general.
Notably, genome-wide RNA sequencing has begun to shed light on the quantity and
diversity of cis-antisense RNAs in the bacterial genome. For instance, a recent study in E.
coli used deep sequencing of double-stranded RNAs—on the basis that functional
asRNAs should base pair to their cognate target—to identify 316 potentially functional
asRNAs expressed from the E. coli genome. These putative asRNAs were further
characterized based on their location relative to annotated genes; most were found to be
encoded opposite the 5’ end of mRNAs, but several were also found opposite 3’ ends,
non-coding RNAs and gene junctions (Lybecker et al., 2014). A role for Hfq in
regulation by cis-encoded asRNAs would thus greatly expand the already extensive
repertoire of this highly pleiotropic regulator.

5.2.2

Hfq can silence IS10 transposase expression by an
antisense-independent pathway

Genetic evidence presented in Chapter 2 also indicates that Hfq can post-transcriptionally
repress transposase expression independently of antisense regulation: hfq-disruption still
caused increased transposition and transposase translation—albeit with a reduced
magnitude—when the asRNA was either destabilized or titrated. Since hfq deficiency
caused no significant increase in steady-state levels of transposase mRNA as measured
by semi-quantitative RT-PCR (Chapter 2) or RT-qPCR (R. Trussler, unpublished data), it
does not appear that this alternative pathway for repression involves destabilization of the
transposase mRNA. I have not investigated this antisense-independent mechanism of
repression in this thesis, but I discuss here the formal possibilities.
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Given the large number of Hfq-regulated proteins (Ansong et al., 2009), it is
possible that repression of transposase translation is indirect, resulting from Hfqregulation of an unknown factor that itself regulates translation of RNA-IN. For instance,
Hfq might activate (or repress) the expression of some translational repressor (or
enhancer). In this regard, Hfq has been shown to regulate components of the translational
machinery. For example, several ribosomal proteins including RpsM, RpsG, RpmD, and
RplN exhibit a marked reduction in protein levels under conditions of Hfq-deficiency in
Salmonella enterica. Moreover, Hfq was shown to down-regulate expression of 11
aminoacyl-tRNA synthetases at the post-transcriptional level (Ansong et al., 2009). It has
also been proposed that Hfq might compete with the ribosomal protein S1 for binding to
some mRNAs, as both proteins bind similar A/U-rich sequences (Hajnsdorf and Boni,
2012; Hook-Barnard et al., 2007). Reduced S1-binding due to competition with Hfq
would be expected to reduce the efficiency of translation initiation.
On the other hand, Hfq could still play a direct role in transposase repression that
involves regulation by a trans-encoded sRNA. There are many non-coding RNAs in E.
coli. Given the fact that sRNAs can have multiple mRNA targets (due to their ability to
impose efficient regulation via imperfect base pairing along short stretches or ‘seed
regions’) (Lease et al., 1998; Repoila and Darfeuille, 2009), it is conceivable that at least
one Hfq-dependent sRNA fortuitously contains enough sequence complementarity to
repress transposase expression. This possibility is supported by a bioinformatics search
using the program INTARNA, which revealed several sRNAs that might base pair to the
IS10 mRNA; however, base pairing between RNA-IN and several of these sRNAs was
not verified in vitro (Smith et al., 2010; Munshaw, 2012). Either indirect regulation or
sRNA-based regulation of transposase translation by Hfq is consistent with the
observation that both proximal and distal-impaired mutants of Hfq were unable to repress
IS10 transposition in vivo (Chapter 3).
Alternatively, Hfq has been shown to directly interfere with ribosome binding and
translation initiation of some messages. Little is known about this form of regulation
other than that it requires Hfq to bind the mRNA near the TIR (Desnoyers and Masse,
2012; Salvail et al., 2013). Preliminary evidence shows that Hfq can efficiently interfere
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with a 30S ribosome ‘toeprint’ of RNA-IN in vitro (M. Ellis, unpublished data), strongly
suggesting that Hfq can act independently of antisense regulation, at least in part, by
directly interfering with translation initiation. Analysis is currently underway to
determine which of the Hfq-binding sites identified in Chapter 3 are important for this
form of repression in vitro and in vivo. This raises the possibility that Hfq can directly
interfere with translation of transposase in other transposition systems. Most transposons
lack antisense regulatory systems and direct translational repression provides a means by
which Hfq could regulate these elements. Notably, transposase genes tend to have
suboptimal Shine-Dalgarno (SD) sequences (Jain and Kleckner, 1993; Krebs and
Reznikoff, 1986). As guanine is the nucleotide that is least amenable to Hfq-binding
(Link et al., 2009; Sauer and Weichenrieder, 2011), deviations from the consensus SD (5’
AGGAGGU in E. coli) (Shine and Dalgarno, 1974) would tend to bind more tightly to
Hfq. One intriguing possibility is that the deviations that make transposase SD sequences
less optimal for translation also make these sequences into better Hfq-binding sites,
linking suboptimal translation with Hfq-imposed repression.
In the case of Tn10/IS10, multiple mechanisms of repression could be relevant to
two opposing situations in vivo. When the transposon is present in the chromosome (in
single copy), RNA-OUT levels are low and regulation by the mci pathway is negligible.
However, given the high affinity of Hfq for the 5’ region of RNA-IN (Chapter 3), Hfq
would still be an effective repressor of transposition in single copy by interfering with
translation initiation. If the element transposes into a multi-copy plasmid, RNA-OUT and
Hfq cooperate to ensure that transposition per copy stays low, thus avoiding detrimental
effects of increased transposition on the host. Antisense regulation becomes more potent
as the copy number of Tn10/IS10 increases. Recall that Hfq actively cycles on sRNAs,
such that sRNA concentration in the cell is the primary determinant of which RNAs bind
to the proximal surface of Hfq at a given time (Fender et al., 2010; Hussein and Lim,
2011; Moon and Gottesman, 2011; Wagner, 2013). It follows that Hfq would more
efficiently facilitate RNA-IN/OUT pairing (and thus, more potently repress transposition)
as the copy number of Tn10/IS10 increases within a given cell.
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5.3 Transcriptional regulation of Tn5/IS50 transposase
expression
Hfq regulation in the Tn5/IS50 system appears to be exercised primarily at the level of
transcription initiation (Chapter 4), although an extensive search of the literature
confirmed that Hfq is not expected to directly repress transcription. In the search for a
transcriptional repressor or activator of IS50 transposase transcription that is itself
regulated by Hfq, I found that Crp repressed transcription to a similar degree as Hfq.
Further work showed that Hfq is a positive regulator of Crp protein levels. While it was
already known that Crp-cAMP can negatively regulate hfq expression (Lin et al., 2011),
this was the first demonstration in E. coli that Hfq also positively regulates Crp
expression, thus completing a self-regulatory feedback loop. It has been shown in
Yersinia pestis that Hfq positively regulates crp expression at the post-transcriptional
level (Lathem et al., 2014). As Crp-cAMP levels increase in stationary phase (as glucose
is depleted), one consequence of this regulatory loop could be the slight reduction in Hfq
levels that has been reported upon entry into stationary phase (Ali Azam et al., 1999).
Interestingly, this is not the first time that Hfq has been shown to play a role in
catabolite repression. In Pseudomonas putida, Hfq was shown to cooperate with a posttranscriptional regulatory protein (Crc) which silences translation of target mRNAs as a
component of catabolite repression. Evidence suggests that Hfq recruits Crc to the ‘CA’
motif in the 5’ UTR of targeted genes (Moreno et al., 2014). While my data strongly
suggest that Hfq and Crp act in the same pathway to repress IS50 transposase
transcription, they do not rule out the possibility that Hfq can act independent of Crp to
exert some negative regulation on transcription. Nonetheless, I note that Hfq-regulation
of Tn5/IS50 transposition requires both the canonical sRNA- and mRNA-binding
surfaces to be intact (Chapter 4), which is entirely consistent with Hfq regulating
transposase expression via Crp if Hfq regulates Crp post-transcriptionally.

5.4 Hfq might be a general repressor of mobile DNA
This thesis has established that Hfq is a potent negative regulator of at least two
transposition systems, Tn10 and Tn5. Preliminary data indicate that Hfq represses
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transposase expression in two additional systems, IS200 (R. Trussler, unpublished data)
and IS1413 (Munshaw, 2012). Furthermore, a bioinformatics search for Hfq-binding
sequences corresponding exactly to the 5’ AAYAAYAA motif—which is known to
confer tight Hfq-binding affinity (Lorenz et al., 2010)—revealed several IS elements
encoding such sequences, suggesting that Hfq can tightly bind the mRNA of other
transposases (Munshaw, 2012). Hfq might also repress other forms of mobile DNA. For
instance, Hfq is also a negative regulator of F-plasmid transfer in E. coli. In this case, Hfq
destabilizes the transcripts encoding TraJ and TraM, which are encoded by the E. coli F
factor and important for positive regulation of the F-encoded transfer genes (Will and
Frost, 2006).
Given that Hfq can apparently down-regulate mobility directly (e.g. RNAIN/OUT pairing; destabilizing traJ and traM transcripts; probably interfering directly
with IS10 transposase translation) or indirectly (e.g. Tn5 transposase transcription via the
Crp regulon), it seems likely that Hfq will be revealed as an important host factor for
regulating other mobile genetic elements. Since Hfq is present in roughly half of
proteobacterial species and these Hfq homologues tend to have similar structure and
function (Sun et al., 2002), these findings raise the intriguing possibility that mobile
genetic elements can be subject to post-transcriptional or other Hfq-mediated silencing
mechanisms in many bacterial species. These findings provide a link between bacterial
post-transcriptional regulation and silencing of mobile genetic elements—an interesting
link, given that eukaryotic RNAi may well have evolved to perform a similar function.
It is tempting to speculate that Hfq provides a general means of silencing
‘foreign’ DNA, allowing the bacteria to gradually integrate the invaders into existing E.
coli regulatory networks. Could one of its original functions have been to repress
expression of mobile DNA? It has been proposed that H-NS acts in Gram-negative
bacteria to generally repress incoming ‘foreign’ DNA at the transcriptional level; the
phenomenon is dubbed ‘xenogeneic silencing’ (reviewed in Ali et al., 2012). It is
hypothesized that the identifier of foreign DNA is A/T-richness (Gordon et al., 2011;
Navarre et al., 2006). Along these lines, Hfq preferentially binds A/U-rich RNA and this
binding tends to lead to enhanced turnover and/or translational silencing.
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5.5 Bacterial stress-response is linked to transposon
mobility
It has been proposed that mobile genetic elements are sensitive to the environmental
conditions of their hosts. Perhaps the oldest and best-characterized example of
mobilization due to external stress is the bacteriophage lambda (λ), which responds to
stress stimuli by virtue of the ‘λ-switch’. There are two possible outcomes when lambda
injects its DNA into E. coli. In one scenario (lysogeny), only the repressor gene is
expressed. The repressor protein activates transcription of the repressor gene in a positive
feedback loop, even as it down-regulates expression of the remaining fifty phage genes.
The bacteria multiply as usual, and the phage DNA (present in the bacterial chromosome)
replicates passively as the bacteria divide. Lysogeny is perpetuated over many
generations of the host cell until a signal (e.g. UV light) inactivates repressor, switching
the phage to the lytic phase. Expression of the repressor gene is down-regulated while the
previously silenced phage genes are expressed. Lambda DNA replicates rapidly, its
structural proteins are produced and the bacterium is destroyed, releasing a new crop of
phage (reviewed in Ptashne, 2011).
I show in Chapter 4 that IS50 transposase expression and Tn5 transposition
increase in response to glucose starvation, and I speculate that this might be mediated
through the stationary phase sigma factor (σS). Glucose starvation is known to induce
expression as well as stabilization of σS (Mandel and Silhavy, 2005). Both σS and σ70
recognize similar promoter sequences, but σS is more tolerant of sequence variations
from the consensus (Landini et al., 2014). The IS50 transposase promoter matches
somewhat poorly to the consensus sequence of σ70 and σS, so it is possible that certain
deviations would be better tolerated by σS. In particular, the IS50 promoter matches
poorly to the -35 consensus sequence, which is more important for σ70 than σS
recognition. Additionally, a guanine at the -14 position (where the first nucleotide of the 10 hexamer is arbitrarily designated -12) is a distinguishing feature of σS promoters
(Landini et al., 2014) and there is a guanine at this position in the IS50 transposase
promoter. It follows that if the IS50 transposase promoter is better suited for σS-bound
RNA polymerase (RNAP), an imbalance in σS to σ70 would increase expression from this
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promoter during glucose starvation or growth in deep stationary phase. If this is true, then
glucose starvation might not be the only nutrient deficiency that triggers transposase
expression. For instance, during the stringent response, amino acid starvation triggers
production of (p)ppGpp. The region between the -10 element and the transcriptional start
nucleotide (in particular the -3 to +1 bases) is called the ‘discriminator’ since its
nucleotide composition affects sensitivity to (p)ppGpp, which favours transcription by
alternative sigma factors (Condon et al., 1995; Magnusson et al., 2005; Travers, 1980).
One difference between the promoters preferentially transcribed in vitro by RNAP-σS is
higher A/T content in the discriminator, while promoters more efficiently transcribed by
RNAP-σ70 tend to be have G/C-dinucleotides (Maciag et al., 2011). A G/C-rich
discriminator is a signature of promoters negatively affected by (p)ppGpp (Zacharias et
al., 1989), in agreement with its role as a selective inhibitor of transcription by RNAP-σ70
during amino acid starvation (Bernardo et al., 2006). The IS50 transposase promoter has
50% G/C content in this -3 to +1 region, suggesting it would not be strongly repressed
during the stringent response. In terms of the aforementioned attributes for discrimination
of σ70 versus σS recognized promoters, the promoters for IS50 and IS10 transposase are
very similar. Notably, an experiment showed that IS10 transposition increased roughly
tenfold when E. coli cells were grown to a deep stationary phase, but this increase was
not seen in rpoS- cells, suggesting that IS10 transposase is transcribed at increased levels
by RNAP-σS during starvation (Munshaw, 2012).
Hfq and Crp are also important for responding to fluctuations in environmental
conditions. Crp is activated by cAMP when glucose levels are low, leading to
transcriptional activation or repression of many genes involved in carbon usage (e.g.
activates expression of the lac operon) (reviewed in Busby and Ebright, 1999; Kolb et al.,
1993). Hfq-dependent regulation during stress-response is exercised via several
pathways. For instance, indirect regulation results from enhanced translation efficiency of
the rpoS mRNA encoding σS (Muffler et al., 1996; Muffler et al., 1997), the downregulation of σE-mediated envelope stress response (Figueroa-Bossi et al., 2006; Guisbert
et al., 2007) and the maintenance of σH-mediated cytoplasmic stress response (Guisbert et
al., 2007). As previously discussed, the regulation of many genes depends on the
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differential induction of Hfq-dependent sRNAs during specific stress responses. As
regulators of transposons and integral factors in responding to changes in growth
conditions, Hfq and Crp may provide a link between environmental stimuli and
transposition rates.
There are relatively few examples demonstrating the direct impact of
environmental stimuli on transposition. For example, transcription of the transposase
genes of various IS elements is increased in response to high levels of certain metals,
resulting in metal tolerance (Brocklehurst and Morby, 2000) and Mu has been implicated
in transposon-based adaptive mutations by forming araB-lacZ fusions in nutrient-starved
cultures (Casadaban, 1976; Shapiro, 1997). There are also few examples of host factors
that regulate transposition in response to growth conditions. Nevertheless, host proteins
involved in metabolism, transport and other cellular pathways have been proposed to link
the status of the cell to transposition (Twiss et al., 2005).
The biological significance of Hfq regulation of mobile genetic elements could be
multi-faceted. As a potent repressor of transposition, Hfq might protect the cell from
harmful genomic instability. As a protein central to stress-response, Hfq might link
external stimuli to transposition rates.

5.6 Conclusions and future directions
5.6.1

What other mobile genetic elements are regulated by Hfq?

It will be interesting to see what other transposons are regulated by Hfq. To date the
impact of hfq deficiency on four transposition systems has been investigated, and in all
four cases Hfq was found to play a repressive role in transposase expression. If other
transposition systems are negatively regulated by Hfq at the level of transposase
expression, it will support the notion that a major role of Hfq is to generally repress
transposition. These transposon targets of Hfq might be broken into two functional
groups: those that are subject to post-transcriptional regulation of transposase expression,
and those that are indirectly regulated. Regarding the latter group, it will also be
interesting to determine whether Tn5 transposase transcription is directly regulated by
cAMP-Crp and, if so, how many other transposases are subject to Crp-regulation. For the
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former group, a further sub-classification might well be appropriate based on the
presence versus absence of a cis-encoded antisense RNA. For instance, IS200 encodes an
asRNA (Sittka et al., 2008) that likely represses transposase translation and experiments
are currently underway to examine whether Hfq facilitates this regulation (R. Trussler,
unpublished data). IS1413, on the other hand, lacks any known asRNA-imposed
regulation but does possess a putative Hfq-binding site in the vicinity of its TIR (Hubner
and Hendrickson, 1997; Munshaw, 2012); further experiments are required to confirm
whether Hfq regulates translation initiation or turnover of the IS1413 transposase mRNA.
A search for mobile genetic elements that are subject to regulation by Hfq need
not be limited to transposons and insertion sequences. As previously discussed, Hfq plays
a repressive role in the conjugal transfer of F plasmids, and Hfq itself was originally
identified as a host factor essential to replication of the RNA phage Qβ (August et al.,
1970).
Although Hfq is not an essential protein under optimal growth conditions (which
are, of course, atypical for bacteria outside of the laboratory), it is strictly required for
stress-response and virulence. If a major role for Hfq is indeed to generally repress
mobile genetic elements (and perhaps link them to the host’s environment), this would
expand the regulon of this pleiotropic regulator and provide another clue as to the
importance of Hfq to bacterial fitness.

5.6.2

Hfq, Crp and transposase transcription

A logical follow-up regarding Crp regulation of IS50 transposase expression is to confirm
that in vivo transposition of Tn5 increases in crp- cells. Does Hfq regulate IS50
transposase expression solely in concert with Crp? This could be tested genetically: if
Crp and Hfq regulate IS50 transcription by independent pathways, then expression of an
IS50-lacZ transcriptional fusion (or transposition of Tn5) should increase synergistically
in an hfq-/crp- double mutant.
Does Crp directly bind to and repress the IS50 promoter? In vitro binding assays
and footprinting of IS50 promoter DNA with purified Crp-cAMP would be a reasonable
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starting point. If Crp does bind the promoter, point mutations should impair this binding
in vitro, and abrogate regulation in vivo.
By what mechanism does Hfq positively regulate Crp levels? In Yersinia pestis,
regulation was shown to be post-transcriptional, as protein levels of Crp decreased in hfqnull cells and a similar drop was not seen for the crp transcript. Moreover, Hfq regulation
was exercised on the 5’ UTR of the crp transcript. However, it was not established
whether Hfq participates in a canonical (i.e. sRNA-mediated) form of positive regulation
(Lathem et al., 2014). In E. coli, one could measure the half life and steady-state levels of
crp mRNA in hfq+/- cells to establish whether positive regulation is exercised via
transcript stabilization. In order to investigate whether an sRNA is involved, one could
use a bioinformatics approach (e.g. INTARNA) (Smith et al., 2010) to find sRNAs that
might target the Crp mRNA. If any putative Crp-regulating sRNAs are found, they can be
validated genetically as Crp protein levels are expected to decrease in strains wherein the
putative positive regulator is disrupted. Alternatively, one could screen a library of
plasmids constructed for the individual over-expression of known Hfq-dependent sRNAs
(Mandin and Gottesman, 2010); if any of these sRNAs is responsible for positively
regulating Crp translation, then Crp protein levels should increase significantly during
induction of the appropriate sRNA(s).
Does Crp regulate other transposable elements? Interestingly, Crp has already
been shown to negatively regulate expression of one transposase (IS2) by binding the
transposase promoter and potential Crp-recognition sequences were identified in (or near)
several other transposase promoters, including IS50 (Hu et al., 1998). However, in the
case of IS50, the putative Crp-binding site is located at bp 78 to 98; only the first 80 bp of
IS50 were included in the IS50-lacZ transcriptional fusion used in Chapter 4, and the
Crp-binding consensus was absent from the lacZ sequence included, meaning the putative
Crp-binding site was absent from the transposase-lacZ fusion and therefore not
responsible for the negative regulation imposed by Crp. This does not rule out the
possibility that Crp acts directly on IS50 transposase expression by binding an alternative
site located within the first 80 bp of IS50. It would be worthwhile to investigate whether
other transposons are regulated by Crp, as this would represent another previously
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unrecognized mechanism for host-factor regulation of transposase expression and provide
a potential link between catabolite repression and transposition.

5.6.3

Nutrient stress and transposition

A logical extension of starvation-induced Tn5 transposition is to observe transposition or
transposase transcription as cells transition into a deep stationary phase, with the
expectation that prolonged growth in stationary phase leads to a similar starvationinduced phenotype. If increased transposase expression is abrogated by disruption of the
σS-encoding rpoS gene, this will confirm the notion that transposase is preferentially
transcribed by RNAP-σS during nutrient starvation. Similar experiments should be
conducted in the Tn10/IS10 system, as this promoter is similar to the IS50 promoter in
terms of σS-recognition determinants and Tn10 transposase expression should therefore
also be induced by nutrient starvation or prolonged stationary phase growth. Moreover, in
vitro binding assays and in vitro transcription assays with RNAP-σS versus RNAP-σ70
would confirm whether the IS50 and IS10 promoters are preferentially recognized by σS
over σ70. Additionally, one could mutate the IS50 promoter in order to abrogate σSrecognition (e.g. bring the -35 and -10 elements closer to the σ70 consensus, or mutate the
-14 Guanine nucleotide) and observe whether this impairs transposase expression during
nutrient stress in vivo.
It would also be worthwhile to investigate whether glucose starvation induces
transposase expression in other transposition systems, and whether any such responses
are mediated by σS, since this could represent a general mechanism to link environmental
stress conditions to transposon mobility.
Overall, my work raises some intriguing questions that can be investigated in the
years to come. Did the post-transcriptional regulator Hfq evolve, in part, to repress
mobile genetic elements? If so, can Hfq-dependent regulatory networks in bacteria be
viewed as analogous to si/miRNA-mediated regulation in eukaryotes? Do global
regulators of gene expression like Hfq, Crp and alternative sigma factors provide a means
to link transposition to the environmental conditions of bacterial cells? The future
promises exciting revelations into the nature of host-transposon interactions in bacteria.
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Figure S2. RNA-IN-160 RNase footprinting. 5’ 32P-IN-160 (65 nM) was incubated in the absence (-) or presence
(+) of Hfq
nM) before digestion
with RNase
A, T1, or V1 (lanes 5-10) or hydroxyl radical (3,4). A G-lane
Appendix
A.(365
RNA-IN-160
RNase
footprinting.
(G, 1) and untreated RNA (UT, 2) are shown. Changes in reactivity in the presence of Hfq are indicated by
upward- or downward-facing triangles (increased and decreased reactivity, respectively). Sensitivity to single32 strand specific nuclease A/T1 are indicated in red, while sensitivity to double-strand specific V1 is indicated in
5’ P-IN-160
(65 nM) was incubated in the absence (-) or presence (+) of Hfq (365 nM)
blue.

before digestion with RNase A, T1, or V1 (lanes 5-10) or hydroxyl radical (3,4). A Glane (G, 1) and untreated RNA (UT, 2) are shown. Changes in reactivity in the presence
of Hfq are indicated by upward- or downward-facing triangles (increased or decreased
reactivity, respectively). Sensitivity to single-strand specific nucleases A/T1 are indicated
in red, while sensitivity to double-strand specific V1 is indicated in blue.
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Figure S6. (A) Hfq expression in donor strains used in mating out assays. Just prior to mating, aliquots of
donor cultures were pelleted and resuspended in denaturing SDS load mix (2% SDS, 10% glycerol,
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B. Hfq expression and purity.
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After heating at 95°C for 5 minutes, cell lysates were subjected to
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membrane (Roche) and Hfq was detected by Western blot with polyclonal rabbit anti-Hfq
antibody (gift of G. Storz). The primary antibody was diluted 1:4000 in TBST; the
secondary antibody (anti-rabbit IgG-HRP conjugate; Promega) was used at 1:10,000. Hfq
was visualized with a SuperSignal West Pico kit (Thermo Scientific) and an
AlphaImager. The position of monomeric Hfq and species (X) that cross react with the
antibody are shown. Samples analyzed are described in Figure 3.13. (B) SDS-PAGE to
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assess the purity of Hfq preparations. Purified Hfq at the indicated concentrations was
mixed with an equal volume of denaturing SDS load mix, heated to 95°C for 5 minutes,
and 20 µL were run on a 12% SDS polyacrylamide gel. The gel was stained with
Coomassie R250 an destained with 10% Acetic acid/30% Methanol (v/v). The species
corresponding to the monomer, and a species we presume to be hexamer, are indicated to
the right of the image. The Hfq in lanes 9-11, denoted “CP”, were purified by cobalt
column chromatography and polyA resin as described in Materials and Methods (section
3.4.2).
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C
hfq+ donor (Insetion site: MG1655 bp 253027)
…AAAACCTTTGATTAAGTCTGAATCCGAACCTGACTCTTATACACAAGTA…TACTTGTGTATAAGAGTCAGAATCCGAACTTACGGTGGACGCAAGCATA…

hfq- donor (Insertion site: MG1655 bp 342027)
…ATCGGGTGGTTTAAATATTGGCTATATTCCTGACTCTTATACACAAGTA…TACTTGTGTATAAGAGTCAGGCTATATTCAATGGACGCGTTTTGCCGCG…

Appendix C. Screening colonies selected on ‘hop plates’ for transposition events.
(A) Genomic DNA isolated from five KanR SmR colonies selected on ‘hop plates’ (Figure
4.2A) from DBH184 (hfq-) or DBH179 (hfq+) was digested with AccI, which cuts once
within Tn5 (in the kanR gene). The digested DNA was subject to Southern blot analysis
using a Tn5-specific probe. For a positive control (+), the analysis was carried out on
plasmid DNA encoding Tn5. For the negative control (-), the analysis was performed on
DNA isolated from DBH33, which does not encode Tn5. (B) Overview of the ST-PCR
approach for mapping Tn5 insertion sites. (C) Partial DNA sequences deduced using STPCR for two colonies selected on ‘hop plates’ is shown. Tn5 sequence is shown in red,
with flanking DNA in black. Note the presence of a 9 basepair target-site duplication
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(underlined), typical of Tn5 transposition (Berg et al, 1983). The flanking DNA matched
sequence at the indicated positions of the MG1655 reference sequence; these sequences
are from the F’ episome present in the donor strains, which includes the lac-pro region.
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Appendix D. Transposase expression from IS50-lacZ translational and
transcriptional fusions in DBH33 and derivatives.
Transposase expression was measured in the indicated strains grown to stationary phase
(A) or mid-log phase (B) using a β-galactosidase assay. Values shown are the mean and
standard error from 3 independent experiments, each of which contained at least 3
replicates for each experimental group.

209

A
ReT
T1+ReT
oDH240

oDH239

oDH238

T1
Readthrough(ReT)

OE

-35

-10

B

-35

SD

AUG

- R.T.

+ R.T.
T1+ReT
pDH682
(TCF)

WT

hfq-

ReT
crp-

WT

hfq-

T1+ReT
crp-

ReT

WT hfq- crp- WT hfq- crp-

ReT
T1+ReT

24 cyc.

16S rRNA

5 cyc.

C
16S rRNA Signal Intensity
(AlphaImager Units)

T1 Signal Intensity
(AlphaImager Units)

1600
1200
800
400
0
24

26
Cycles

28

WT
hfqcrp-

700
600
500
400
300
200
100
0
4

5

6

Cycles

Appendix E. Transposase transcript profiling in DBH303 and derivatives.
RT-PCR analysis was used to assess the ratio of transposase transcripts originating from
the transposase promoter (T1) in Tn5 TCF strains versus promoters upstream of the Tn5
TCF (i.e. read-through transcripts – ReT). Total RNA was isolated from DBH303 (WT),
DBH306 (hfq-) and DBH307 (crp-) cells used in the transposase expression assay
reported in Figure 4.6. As shown in (A) primer oDH238 was used to make cDNA. After
cDNA synthesis, primers oDH239 and oDH238 were used to make an amplicon
indicative of T1 plus ReT transcripts and primers oDH240 and oDH238 were used to
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make an amplicon indicative of ReT transcripts only. (B) An ethidium bromide stained
agarose gel containing RT-PCR samples from the indicated strains is shown. Note that
the first two lanes on the left-hand side contain RT-PCR reactions performed with a
plasmid (pDH682) encoding the Tn5 TCF, as opposed to purified RNA (all other lanes).
As an internal control RT-PCR was also performed on 16S RNA using primers oDH204
and oDH205 (5 cycles). (C) Bands from (B) and other gels were quantified and plotted
versus cycle number, to indicate that signal increased with cycle number, as expected.
Signal at 24 cycles (for IS50-lacZ) and 5 cycles (for 16S rRNA) was used for the
quantitation shown in Figure 4.6B in the main text.
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Appendix F. Cell growth and SgrS levels after SgrS induction.
(A) Growth curve for DBH33 cells harboring the SgrS-encoding plasmid pDH764 with
and without IPTG treatment. Cells from a saturated culture were sub-cultured (in
duplicate) into M9-glucose and grown for 4 hours, at which point 0.1 mM IPTG was
added to one of the sub-cultures. Cell density (OD600) was measured at the indicated time
points. (B) Northern blot demonstrating SgrS induction. Cells from the cultures in (A)
were removed at the indicated times after sub-culture and RNA was extracted. Northern
blot analysis with 32P-labeled RNA probes complementary to SgrS or the 5S rRNA
(internal standard) was performed.
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Appendix G. Supplemental Methods for Chapter 4.

Plasmid constructions
IS50 transposase expression plasmids: Plasmids for in vivo expression of transposase
from its native promoter are derivatives of pRZ9905 (Naumann & Reznikoff, 2000),
obtained from W.S. Reznikoff. The transposase gene has the M56A mutation, which
blocks translation of the inhibitor protein. In addition, a mini-Tn5 encoding the
chloramphenicol resistance gene from IS1 was cloned into the BglII site just downstream
from the transposase stop codon to create pDH533. Mutant forms of this plasmid
including cat- transposase (D97A — pDH828) and Dam-Insen transposase (G53A; C61A
— pDH752) were generated by site-directed mutagenesis. We used the mini-Tn5 element
to test the functionality of various transposase-producing genes.
IS50-lacZ translational fusion plasmids: A PCR fragment containing a portion of the
lacZ gene (starting at codon 10 and terminating at the stop codon) was generated with
primers oDH185 and oDH186 and E. coli genomic DNA. Primer oDH185 includes a
SacII site and oDH186 includes a BglII site. After digestion with SacII and BglII, the
lacZ PCR fragment was cloned into pRZ9905, which had also been digested with SacII
and BglII, generating pDH658. The IS50 translational fusion from pDH658 was also
cloned on an XmnI-SalI fragment into XmnI-SalI digested pWKS30 (Wang & Kushner,
1991) to create pDH753. The IS50 transposase coding sequence in pDH658 (includes up
to codon 122 of transposase) was further truncated to include only the first 12 codons of
transposase by digesting pDH658 with XmnI and SacII and cloning a PCR fragment
generated with primers oDH187 and oDH188 (and cut with XmnI and SacII) into the
aforementioned backbone to generate pDH795. The IS50-lacZ translational fusions
pDH753 and pDH795 were linked to a kanamycin resistance gene from IS903 (generated
by PCR using primers oDH189 and oDH190) by cloning the kanR gene present on a
SpeI-XbaI cut PCR fragment into the XbaI site just downstream of the lacZ gene to
create pDH798 and pDH804, respectively. The IS50-lacZ-kanR fragment in pDH804 was
PCR amplified with primers oDH191 and oDH192, each of which includes a BamHI site,
and cloned into the large fragment (~ 6 kb) of pNK81 (Foster et al, 1981) generated by
BclI digestion, creating pDH812. In this context, the IS50 transposase-lacZ-kanR
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fragment is flanked by his operon sequences and can be crossed onto λNK1039 (Bender
et al, 1991), which also contains his operon sequences.
IS50-lacZ transcriptional fusion plasmids: A PCR fragment including the 5’UTR to the
stop codon of the lacZ gene, generated with primers oDH193 (includes an AflII site) and
oDH194 (includes a BamHI site) was cloned into pRZ9905, which had also been cut with
AflII and BamHI, to create pDH682. The IS50-lacZ transcriptional fusion in pDH682
was then linked to either the kanR gene of IS903 (pDH838) or the cmR gene of
pACYC184 (pDH883); the latter was generated with primers oDH195 and oDH196, each
of which contains an XbaI site. The IS50 transposase-lacZ-kanR and the IS50
transposase-lacZ-cmR segments of pDH838 and pDH883 were then PCR amplified using
primers oDH191 and oDH192 and, each of which contains a BamHI site, and cloned into
BclI-digested pNK81 as previously described, generating pDH849 and pDH888. The
latter plasmids were used to cross the transcriptional fusions onto λNK1039.

Southern blot analysis of colonies selected on ‘hop plates’
Genomic DNA was isolated from KanR SmR colonies selected on ‘hop plates’ using
Sigma Genomic DNA kit; 1.5 µg of genomic DNA was digested with AccI (cuts once in
Tn5 in the kanR gene) and resolved on a 1% agarose gel, before capillary transfer to
Hybond N membrane (GE Healthcare) as follows: the gel was soaked in alkaline
denaturing buffer (1.5 M NaCl, 0.5 M NaOH) for 40 minutes, neutralized (30 minutes
and then 15 minutes) in neutralizing buffer (250 mM Tris-HCl, pH 7.5, 750 mM NaCl),
and transferred overnight in 10x SSC. The membrane was UV cross-linked and then
incubated with a 32P-labeled RNA probe (complementary to the 5’ portion of the Tn5
kanR gene) in UltraHyb buffer (Ambion) according to the manufacturer’s protocol for
RNA:DNA hybridization. The probe was generated by in vitro transcription, as described
for Northern blot analysis, from a DNA template made by PCR with primers oDH236
and oDH237.
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Mapping Tn5 tranposition events
Putative transposition events from mating out assays were characterized using a semirandom, two-step PCR protocol (ST-PCR) for uncharacterized transposon-linked
sequences (Chun et al, 1997). Briefly, genomic DNA from KanR SmR colonies selected
on ‘hop plates’ was PCR-amplified with a Tn5-specific primer (oDH225) and a partially
randomized primer (oDH167). The resulting amplicons were ligated into the pGEM Teasy vector (Promega), transformed into DH5α by electroporation and transformants
were selected on LB plates containing kanamycin (50 µg/mL). Plasmid DNA was
isolated (Sigma miniprep kit) and the inserts were sequenced using M13 primers.
Sequences thusly obtained were aligned to the E. coli MG1655 reference genome
(BLAST) to identify the ‘target’ sequence immediately flanking one host-OE junction.
This information was used to design ‘insert-specific’ primers (different for each insertion
event), complementary to DNA flanking the Tn5 insertion site. These primers were used
to amplify and sequence DNA flanking Tn5 in each of two colonies.

β-Galactosidase assay
WT cells (DBH33) were lysogenized with λDBH849 or λDBH812 (described in the main
text) to produce DBH238 (TCF – single copy) and DBH208 (TLF – single copy).
DBH238 was transduced to hfq-1::Ωcat (DBH239) and dam::Tn9cat (DBH240) and
DBH208 was transduced to hfq-1::Ωcat (DBH210) and dam::Tn9cat (DBH237). Cells
were grown in M9-glucose media to mid-log or stationary phase and a β-galactosidase
assay was performed as described in the main text. To compensate for endogenous lacZ
expression in DBH33 derivatives (which contain the lac operon under the control of
lacIQ), the number of Miller units obtained from each strain lacking the transposase-lacZ
reporter gene (DBH33 — WT; DBH16 — hfq- and DBH241 — dam-) was subtracted
from that of the isogenic strains containing the reporter gene.

RNA-extraction, RT-PCR and Northern analysis
Cellular RNA was extracted as described in the main text. For RT-PCR, 4 µg of RNA
was reverse transcribed with primers oDH238 and oDH205 essentially as described for
primer extension analysis in the main text. The resulting cDNA was purified with a PCR
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cleanup column (Quiagen) and PCR amplified using Taq DNA polymerase (Promega)
and primer pairs oDH238 and oDH239 (for T1 and read-through IS50-lacZ transcripts),
oDH238 and oDH240 (for read-through IS50-lacZ transcripts), or oDH204 and oDH205
(for 16S rRNA). The PCR parameters for IS50-lacZ were: 95°C, 30 s; 60.5°C, 30 s;
72°C, 60 s and 24, 26 or 28 cycles were run. The PCR parameters for 16S rRNA were as
above, except that the annealing temperature was 61.5°C and 4, 5 or 6 cycles were run.
Northern analysis for monitoring SgrS induction during the growth curve was performed
as described in the main text.
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Appendix H. List of oligonucleotides used in Chapter 4.
Name

Sequence (5’ to 3’)

Use

oDH167
oDH183
oDH184
oDH185
oDH186

Partially-randomized primer
pDH700-construction
pDH700-construction
pDH658-construction
pDH658-construction

oDH233
oDH234
oDH235
oDH236

GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
NNAAGCTTNNTTATTCGGTTTCTTCGCT
NNTCTAGANNCAGGTTGTTGGTGCTATC
NNNCCGCGGAGTCGTTTTACAACGTCGTGACTGGGAAAACCC
NNNAGATCTTTATTTTTGACACCAGACCAACTGGTAATGGTAG
CG
CATCATTGGAAAACGTTCTTCGGGGCG
AACGACTCCGCGGCTGTCGGCCGCACGATGAAGAGC
GGACTAGTGCCAGTGTTACAACCAATTAACCAATTCTGA
GCTCTAGACTGAGAGATCCCCTCATAATTTCCCCTCAGCAAAA
GTACGATTTATTCAAC
GCCCCCCGGATCCCCTGACTCTTATACACAAGT
ATTTTTGGATCCGCGAGGAAGCGATGCCTGC
NNCTTAAGCACACAGGAAACAGCTATGACCATGATTACGG
NNGGATCCCACCTGGAAGATCAGATCCTGGAAAACG
GAATAATCTAGACCTGGTGTCCCTGTTGATACC
GCTTATTCTAGATTATTCAGGCGTAGCACCAGG
CGTGTTGTGAAATGTTGGGTTAAGT
AACCCACTCCCATGGTGTGACGGGC
GTCATTTCGAACCCCAGAGTCC
CGTTGGGATTGCGGATAAATCGGTAAG
TATTTAGTAGCCATGTTGTCCAGACGC
TAATACGACTCACTATAGGGAAAAAAAACCAGCAGGTATAAT
CTGCTG
GATGAAGCAAGGGGGTGC
TAATACGACTCACTATAGGCCTGGCAGTTCCCTACTCTCG
CGGCAGTAGCGCGGTG
TAATACGACTCACTATAGGGCATCGGCAGGGTCATC

oDH237
oDH238

AGGTGACCTCTTAAGATGGTAACGTTC
AGGCTGCGCAACTGTTGGG

oDH239

AGGTGACCTCTTAAGCACACAGG

oDH240

CTGACTCTTATACACAAGTAGCGTCCTG

oDH187
oDH188
oDH189
oDH190
oDH191
oDH192
oDH193
oDH194
oDH195
oDH196
oDH204
oDH205
oDH225
oDH230
oDH231
oDH232

pDH795-construction
pDH795-construction
pDH798/804-construction
pDH798/804-construction
pDH812-construction
pDH812-construction
pDH682-construction
pDH682-construction
pDH883-construction
pDH883-construction
RT-PCR, 16S rRNA
RT-PCR, 16S rRNA
Tn5-specific primer
IS50 Primer Ext.
lpp Primer Ext.
SgrS in vitro transcrip.
template
Reverse primer for above
5S in vitro transcrip. Template
Rev primer for above
T’ase in vitro transcrip.
Template
Reverse primer for above
Reverse primer, RT-PCR of
IS50-lacZ TCF
Forward primer for above:
Readthrough+T1
Forward primer for above:
Readthrough only
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